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ABSTRACT 
 
Pancreatitis is a debilitating disease with complex etiology, prognosis and pathology, limited 
treatment options and a burden on health resources. The main lesions of acute pancreatitis are injury 
to acinar cells and inflammation of the pancreas. Mild interstitial pancreatitis (or oedematous 
pancreatitis) is characterized by acute inflammation with oedema in the stroma and acinar tissue. 
Necrosis of acinar tissue, stroma or peri-pancreatic fat is absent and complete recovery, or 
regeneration of the gland is usual. Whilst there is universal agreement on many of the cellular changes 
that accompany acute pancreatitis, there is no clear distinction between the factors that determine 
whether regeneration can occur. The mechanism of regeneration and the cellular processes that 
influence regeneration form the primary basis of this study. 
 
Experimental models of pancreatitis have been produced in rats, mice, dogs, cats and swine by various 
methods. The time course and final tissue regeneration, if it occurs, vary considerably among different 
models, with many having the limitation that pancreatic injury is extended, so that degenerative 
processes are superimposed on regenerative activity. Three in vivo models of pancreatitis in rats were 
chosen for this project, to study pancreatitis and pancreatic regeneration that occurs in the recovery 
phase. These models evolve slowly, allowing detailed morphological study. In general, they have 
similar early events but vary considerably in regenerative outcome. (1) The infusion of caerulein is a 
well-established model for inducing experimental pancreatitis in rats and pancreatitis is followed by 
a great reparative capacity.  Caerulein is a decapeptide with biological activity on gastrointestinal 
smooth muscle contraction and pancreatic and gastric secretion. (2) In 1-cyano-2-hydroxy-3-butene 
(CHB)-induced pancreatitis, acinar cell regeneration is limited to small islands of acini which fail to 
endure. CHB is known to induce cell death in pancreatic acini. (3) The model of partial pancreatic 
duct ligation leads to atrophy of the gland with little or no regeneration ensuing. Although some 
characteristics are known about these models of pancreatitis, there is a general lack of information on 
the association between pancreatic atrophy and inflammation and investigating this association was 
one of my overall aims. In addition, as well as investigating the three different models of pancreatitis 
in rats, I aimed to compare the same initiating event in other animals. Because of the selective nature 
of CHB pancreatotoxicity, and the ease of producing the model in rats, I sought to investigate this 
method in a mouse model. In addition, I sought to establish and characterise a canine CHB model. 
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The pancreatic atrophy induced in the chosen models typically involved apoptosis of acinar cells and 
its removal by macrophages. In some situations, if acinar redifferentiation did not occur, development 
of fibrosis and scarring was a key to pancreatic repair. This atrophy took place in a coherent fashion 
with normal architectural relationships being maintained. Loss of the potentially dangerous enzyme-
secreting cells by apoptosis led to regression of the underlying duct structure such that regeneration 
might occur should the circumstances change. This thesis has had a prolonged history because of 
part-time enrolment, through departure from the University of Queensland of my original Principal 
Advisor Dr Neal Walker, transfer of my Associate Advisor Dr Lyndell Kelly to Dunedin, New 
Zealand and necessary changes in my Advisory Team, an attempt to complete some of the research 
in New Zealand and the unfortunate death of the scientist I was working with, as well as my own 
personal and family issues. I am hoping to complete the project with my current re-enrolment.  
 
The hypothesis tested was that different models of pancreatitis can be used to describe the processes 
of atrophy and regeneration in the pancreas. The specific aims of this study were: 
1. To investigate rat models of pancreatitis using caerulein, CHB and duct ligation; 
2. To validate a pancreatitis model with CHB in the mouse;  
3. To establish a canine model of pancreatitis with CHB;  
4. To compare and contrast the models with respect to: 
Stellate cells and the production of fibrosis   
The role of mast cells and macrophages 
The role of survivin in pancreatic regeneration 
 
Summary of outcomes of this study 
 Study of the three rat models of pancreatitis facilitated a comparison of markers and 
mechanisms within the lesion. 
 All of the pathological processes studied, including fibrosis, stellate cells, mast cells and 
macrophages had specific roles in the different models that correlated with the initiation of 
pancreatitis, the deposition and degradation of fibrosis, and the ability of the pancreas to 
regenerate. 
 Resorption of fibrosis may depend on the type of collagen deposited. 
 Survivin appears to be maintaining conditions for the survival of cell populations. 
 The models of CHB in mouse and dog were not suitable for the study of pancreatitis as the 
liver showed more severe damage at low doses than the pancreas    
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CHAPTER ONE 
LITERATURE REVIEW 
 
1.1 INTRODUCTION 
 
Pancreatitis is a term that describes inflammation of the pancreas. More broadly, the term designates 
a group of diseases in which the basic lesions involve injury and death of acinar cells and 
inflammation of the pancreas. A spectrum of clinical pictures occurs with variety in the severity, 
duration and outcome of the disease. Due to the complexity of the disease, treatment is considered in 
terms of etiology and prognosis and remains largely supportive, with management to relieve 
symptoms and prevent further disease progression. Pancreatitis causes a significant burden on 
medical resources, and patients with chronic pancreatitis have reduced quality of life with 
substantially reduced employment and income.1  
 
The worldwide incidence of acute pancreatitis ranges from 4.9 to 73.4 per 100,000 people per year 
with the risk of recurrence in the vicinity of 20%.2 The incidence of chronic pancreatitis ranges from 
4 to 14 per 100,000 per year. Approximately 35% of patients with at least one recurrence of acute 
pancreatitis risk progression to chronic pancreatitis, with the mortality rate of chronic pancreatitis at 
approximately 28-35%.3  
 
Historically, pancreatitis has been divided into acute and chronic types. Acute pancreatitis is 
associated with elevated pancreatic enzymes in blood and urine due to inflammation and systemic 
responses of varying severity.4 Mild interstitial or oedematous pancreatitis with acute inflammation 
and oedema generally resolves to normal morphology and function, however, the often fatal, severe, 
form of acute pancreatitis is haemorrhagic with necrosis and abscess, leading to the complete 
destruction of the gland, systemic complications and organ failure.5 Chronic pancreatitis is an 
inflammatory disease, with the end result irreversible fibrotic destruction of the gland with 
impairment of exocrine and endocrine function.1 The current view is that recurrent attacks of acute 
and chronic pancreatitis may represent a disease continuum due to repeated tissue destruction and 
subsequent remodelling.6 Several classification systems have attempted to include etiology as an 
important criterion for the characterization of pancreatitis, particularly chronic pancreatitis.7 These 
classification proposals attempted to include all relevant features of the disease: clinical presentation, 
outcome, pathology, and etiology. Currently, chronic pancreatitis is usually diagnosed when the 
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disease is already fully established with uncertain pathogenesis, unpredictable clinical course and 
unclear treatment, hence life expectancy is reduced.8 
 
There is no reliable molecule, genetic biomarker or imaging system currently available for predicting 
the severity of acute pancreatitis.9 These diagnostic aids would improve the ability to treat the early 
manifestation of the disease to prevent morbidity and mortality, as the early systemic inflammatory 
response has already occurred by the time patients present for treatment.9 The models presented in 
this thesis allow pre-clinical analysis of etiology, outcome and pathology. In some experimental 
models of acute pancreatitis, acinar cells die by apoptosis. Without severe inflammation, the pancreas 
is able to regenerate and recover. In other models, no recovery takes place and the gland becomes 
fibrotic with loss of exocrine function. Although experimental studies do not completely mimic the 
human clinical situation, it is possible that a similar scenario is occurring in the human condition. It 
appears that the mode of cell death, apoptosis or necrosis, is important to the outcome, as is the 
production and resolution of fibrosis with accompanying interaction of inflammatory mediators. As 
evidence-based treatment options are limited, further exploration of the biomarkers and mechanisms 
involved in regeneration of exocrine pancreatic tissue is required to answer the question of how to 
prevent recurrence and progression of this disease. To do this, various animal models may be utilised.  
 
Current treatment regimens have improved considerably over recent years with advances in intensive 
care medicine and pain relief, however, treatment is mainly symptom alleviation. In mild, acute 
pancreatitis, treatment is based on hydration and nutrition with laparoscopic cholecystectomy for 
biliary pancreatitis. Aggressive intravenous fluid, enteral feeding and intensive care monitoring are 
required for severe acute pancreatitis.9, 10 For chronic pancreatitis, treatment is for maldigestion, and 
nutritional deficiencies resulting from exocrine insufficiency. Diabetes therapy is required for 
endocrine deficiencies. Complications such as obstruction of the pancreatic duct, gastric outlet and 
vessels, common in chronic pancreatitis, are treated with endoscopy and surgery.1, 3 There is no 
current treatment for the fibrosis that causes the pathophysiology of chronic pancreatitis.  
 
Chronic pancreatitis is considered a risk factor for pancreatic cancer.6 The cancer is usually at an 
advanced stage at diagnosis, and it is rare to have complete resection of the tumour, and conventional 
cancer therapies such as radiation and chemotherapy have limited results with significant side 
effects.11 1-Cyano-2-hydroxy-3-butene (CHB) may represent a potential treatment for pancreatitis 
and acinar cell carcinoma of the pancreas as it may eliminate all or virtually all acinar cells and 
malignant cells derived from them. It is unknown whether the effect of CHB on the pancreas occurs 
in representative members of other species and whether this can be achieved safely. 
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This project aimed to improve descriptions of mechanisms and processes of acute and chronic 
pancreatitis. It used several pre-clinical animal models to complete this aim. 
 
1.2 ANATOMY AND HISTOLOGY OF THE NORMAL PANCREAS 
 
The human pancreas is an elongate, firm, gastrointestinal gland lying in the upper abdomen behind 
the stomach. It divides into the head near the duodenum, body, and tail approaching the hilum of the 
spleen (Figure 1.1). The pancreas is covered by a loose, thin connective tissue capsule which extends 
inwards as septa dividing the parenchyma into distinct lobules. The gland performs both exocrine and 
endocrine functions. The human exocrine portion forms the greatest volume (84%), ductular cells and 
blood vessels about 4 % of the gland, while endocrine cells comprise only 2%, and the remainder 
occupied by extracellular matrix. The exocrine pancreas is a branched, acinar gland responsible for 
secreting digestive enzymes into the intestine: the endocrine tissue, organized into islets of 
Langerhans, secretes hormones involved in stabilization of blood glucose homeostasis. In the human 
pancreas, the splenic artery provides the blood supply to the neck, body and tail, the superior and 
inferior pancreaticoduodenal arteries supply the head.12 Most of the arteries are accompanied by veins 
that run into the splenic vein and by the pancreaticoduodenal veins into the portal and mesenteric 
veins.13 Lymphatics from the pancreas follow the course of the arteries. The pancreas is richly 
innervated both by parasympathetic (cholinergic) fibres from the vagus nerve and by sympathetic 
fibres arising from the celiac, superior mesenteric and hepatic plexis.14  
 
Pancreatic juice secretion is stimulated by parasympathetic activity and inhibited by sympathetic 
activity.15 Rodent autonomic nerve distribution is homologous with human distribution, however 
innervation of exocrine tissue is poor in comparison to the rich innervation in humans.15 Generally, 
the blood supply, lymphatics and nerves accompany the duct system to its terminus in the acini. The 
pancreas drains via a large pancreatic duct that penetrates the wall of the duodenum in association 
with the common bile duct. In the rat, the pancreas and biliary tract share a common conduit into the 
duodenum that results in the passage of bile into the proximal portion of the pancreatic duct prior to 
drainage into the duodenal lumen.16  
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Figure 1.1 The pancreas as an accessory organ to the intestine 
The human pancreas is an elongate, firm, gastrointestinal gland lying in the upper abdomen behind 
the stomach. It divides into the head near the duodenum, body, and tail approaching the hilum of the 
spleen. 
Accessory organs of the digestive system. Physiology Plus 2017 278 
http://physiologyplus.com/accessory-organs-of-the-digestive-system-and-their-functions/ 
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There is interspecies variability in the proportion and distribution of endocrine tissue.15, 17 The 
pancreas in rodents is soft and diffuse within the mesentery loosely attached to the stomach, 
duodenum and spleen and often described as gastric, duodenal, and splenic lobes.15, 17 Adipose, 
connective and lymphatic tissues are dispersed in the rodent lobes.15 The dog pancreas is solid, caudal 
to the liver and divided into three lobes, right, body and left, which form a reasonable V-shape.17 Dog 
and rodent pancreatic blood supply is generally homologous to the human system.15  
 
1.2.1 Light and electron microscopy  
 
The exocrine pancreas is a complex anastomosing tubular network. The main functional unit is the 
acinus, comprised of approximately 50 cells bordering a common luminal space that with a few 
centroacinar cells forms the beginning of the duct system. In haematoxylin and eosin (H&E) sections, 
the closely packed acini appear as rounded units bounded by nuclei. Individual cells cannot be 
discerned. The endocrine Islets of Langerhans and ducts are randomly distributed (Figure 1.2). Cells 
appear pyramidal shaped with numerous darkly eosinophilic spherical zymogen granules situated in 
the apical cytoplasm. The basal cytoplasm is basophilic due to the high content of RNA in rough 
endoplasmic reticulum (RER) and the rounded nucleus eccentric towards the base. Nuclei contain 
one to two nucleoli (EM in Figure 1.3). The Golgi apparatus at the junction of the apical and basal 
poles appears as a paler zone. A basal lamina surrounds each acinus and the acinar unit is buttressed 
by a thin extracellular connective tissue matrix that contains numerous blood capillaries, nerves and 
connective tissue. The acinar cell height, granule content and the relative volume of the cell occupied 
by RER and zymogen granules vary with the stage of protein synthesis and secretion and this affects 
staining features. RER increases during synthesis, then, as zymogen granules increase, they occupy 
a greater proportion of the cell and RER is decreased.18-20. 
 
Centroacinar cells constitute the beginning of the duct system continuous with the intercalated ducts 
that interpose between the acini and the intralobular ducts. The irregularly shaped centroacinar cells 
invaginate partly into the acinus, remaining in contact with the lumen that is not always obvious in 
light microscopy.21, 22 Centroacinar cells are distinguished from acinar cells by a more irregularly 
shaped nucleus, less RER, no secretory granules and therefore paler cytoplasm. The intercalated and 
intralobular ducts have low cuboidal epithelium supported by a thin coat of connective tissue. The 
lumens of the ducts may contain homogeneous eosinophilic pancreatic proteinaceous secretion. 
Intralobular ducts comprise the largest percentage of all duct cells in the rat.21 In the septa outside 
pancreatic lobules, the larger interlobular ducts are lined by cuboidal to columnar epithelium with 
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occasional goblet cells and are surrounded by a thick layer of connective tissue. Periacinar and 
periductular interstitial cells are predominately fibroblasts and macrophages.23   
 
 
 
 
Figure 1.2 Histology of pancreas 
The pancreas is made up of the exocrine segment (E) consisting of acini and randomly spaced ducts 
(D). The endocrine portion of the pancreas consists of the Islets of Langerhans (I). (Original 
magnification x400; haematoxylin and eosin stain). 
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The endocrine Islets of Langerhans, with a range of size of 50-250 µm, are mostly spherical in shape 
and dispersed throughout the lobules. They comprise approximately 1-2% of the pancreas in most 
mammalian species.24 In rodent islets, the location of glucagon secreting α-cells is on the periphery 
of the islet with the insulin secreting β-cells mainly in the middle, whereas in human islets α-cells 
appear mixed with β-cells within the islets. The smaller α-cells can be seen with a trained eye in 
rodent islets with H&E staining but are particularly prominent with immunohistochemical (IHC) 
staining.24 The distribution of organelles seen by electron microscopy (EM) in the acinar cell is highly 
polarised. Using EM to describe the ultrastructure of the pancreas, the nucleus has dispersed 
chromatin and the nucleoli are prominent (Figure 1.3). The basal pole of the cell is packed with 
abundant lamellar arrays of RER with ribosomes studded to the cytosolic surface of the membrane or 
occasionally free between the cisternae. The RER occupies approximately 20% of the cytoplasm and 
its membranes account for approximately 60% of the surface area of the cell’s membranes.18 The 
cytoplasm contains numerous mitochondria. Supranuclearly is a prominent Golgi apparatus with 
parallel arrays of stacked cisternae, many small vesicles, condensing vacuoles filled with low-density 
flocculent material, microtubules and microfilaments.18, 25 Apical zymogen granules have a single 
limiting membrane; when well preserved their matrix has a high-density homogeneous electron 
opaque content, in pathological conditions or in immature granules the matrix may vary to pale 
staining with a dense irregular core. They vary in size from about 0.5-1.4 µm.24  
 
Acinar lumina are approximately 1-3 µm in diameter and contain varying amounts of electron dense 
material.25 The luminal end of the acinar cell has a few microvilli coated with a thin layer of fine 
filamentous material. The acinar basal plasma membrane is about 60 Å thick inside an amorphous 
basement membrane (BM) of 150-400 Å with associated collagen fibres.25 The plasma membranes 
of adjacent cells fuse into well-developed zonulae occlendentes that seal the apical zone from access 
to digestive enzymes following exocytosis of zymogen granules.  The relatively straight lateral cell 
membranes are separated by a narrow space joined by occasional desmosomes and adhering 
zonules.18, 26 The acinar cell may also contain some dense, membrane-limited lysosomal bodies and 
multi-vesicular bodies. Connective tissue with capillaries and autonomic nerve fibres occupy the 
small spaces between the acini.27 
 
Centroacinar, intercalated and intralobular duct cells similarly have little ER, a modest Golgi 
apparatus, ribosomes are free in the cytoplasm and mitochondria are few and smaller than those of 
the acinar cell.28 A less extensive Golgi apparatus is found usually at the apical aspect of the nucleus.25 
The cytoplasm of duct cells contains considerable amounts of delicate fibrils but appears empty in 
contrast to acinar cells. The nucleus is large, mostly oval with marginal indentations. At least some 
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cells in each category of pancreatic duct possess cilia that project into the luminal space from a basal 
body in the supranuclear region.21 The non-motile cilia have nine peripheral doublets but no central 
microtubules.21, 29 Blebs are found on the surface of intralobular cells25 but only occasionally on 
intercalated or centroacinar cells.25 Intralobular duct cells have elaborate interdigitations at the lateral 
and basal plasma membranes.28 Close packed and long microvilli border the surface of cells lining 
interlobular and main ducts. These cells contain mucin granules, have a more developed RER and 
some goblet cells.21 The surface of duct cells secrete a coat of sialoglycoprotein that acts as a barrier 
to bicarbonate ions or pancreatic enzymes.30  
 
 
 
Figure 1.3 Electron microscopy of acinar cell of normal pancreas 
The nucleus has dispersed chromatin (N=nucleus, open arrow=chromatin).  The normally prominent 
nucleoli are not visible in this image. . There are abundant lamellar arrays of rough endoplasmic 
reticulum (RER) basally. The cytoplasm contains numerous mitochondria (short black arrows). 
Apical zymogen granules have a high-density homogeneous electron-opaque content (long black 
arrows). L= lumen.  
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The EM of fibroblasts and stellate cells has been well described. Fibroblasts have a spindle shape, an 
often elongated thin nucleus, long cytoplasmic extensions and lack of lipid droplets. In comparison, 
pancreatic stellate cells have a large triangular nucleus, more cytoplasm, prominent RER active in 
protein synthesis, abundant ribosomes, few mitochondria, and long cytoplasmic projections. Dilated 
cisternae of the RER may contain flocculent material. The cell surface has caveolae and closely 
aligned collagen fibres.  
 
In the islets of Langerhans, the alpha cell secretory granules are round to ovoid with an eccentric core 
of high electron density separated from a limiting membrane by a halo of medium dense granular 
material. The more numerous beta cell secretory granules have an electron dense core surrounded by 
empty space. Dog and human granules have a dense core with bar like appearance. Delta cells have 
a similar distribution to alpha cells. Their secretory granules are larger, less dense than alpha granules 
and more uniform than beta granules.31 
 
1.3 PANCREATITIS 
 
Acute pancreatitis, chronic pancreatitis and pancreatic cancer account for the burden of exocrine 
pancreatic disease with high morbidity and mortality in severe cases.1, 32, 33 More broadly, the term 
pancreatitis designates the group of diseases in which the basic lesions are injury of acinar cells and 
inflammation of the pancreas with a spectrum of pathologies displaying variety in the severity, 
duration and outcome.34 Due to the complexity of the disease, treatment is considered in terms of 
etiology and prognosis and remains largely supportive with management to relieve symptoms and 
prevent further disease progression. Pancreatitis causes a significant burden on medical resources, 
and patients with chronic pancreatitis have reduced quality of life with substantially reduced 
employment and income.1  
 
The worldwide incidence of acute pancreatitis ranges from 4.9 to 73.4 per 100,000 people per year 
with the risk of recurrence approximately 20%.2 The prevalence of chronic pancreatitis ranges from 
4 to 14 per 100,000 per year with mortality at approximately 28-35%.3 Alcohol and gallstones make 
up the majority (80%) of all causes of pancreatitis and the overall risk of recurrence, 50% in alcoholic 
and 32-61% in gallstone pancreatitis.35, 36 A retrospective study of patients with a first episode of 
acute pancreatitis of various causes showed recurrence in 17% of patients with 8% progressing to 
chronic disease within 5 years.37 The risk was higher with smokers who abused alcohol. Generally, 
the causes of pancreatitis include obstructive (biliary and duct), toxic -metabolic (alcohol, tobacco, 
hypercalcaemia), vascular, trauma, autoimmune disorders, infectious, idiopathic, genetic 
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predispositions (cystic fibrosis). Hereditary and tropical pancreatitis are rare manifestations.38, 39 
Some examples of causes of pancreatitis are presented in Table 1.1. Patients with these rare types of 
pancreatitis pose an approximately 50 fold greater risk than the general population of developing 
pancreatic cancer however the risk for all chronic pancreatitis patients is approximately 5%.38  
 
Table 1.1. Causes of Pancreatitis 
Alcoholism 
Gallstones 
Abdominal surgery/haemorrhage 
Certain drugs/medications 
Cigarette smoking 
Cystic fibrosis 
Family history of pancreatitis 
High calcium levels in the blood (hypercalcemia), which may be caused by an overactive 
parathyroid gland (hyperparathyroidism) 
High triglyceride levels in the blood (hypertriglyceridemia) 
Infection 
Injury to the abdomen/haemorrhage 
Pancreatic cancer 
Adapted from Kleefe, J., et al (2017).  Talukda P., Vege S., (2015) 
 
 
Current treatment regimens have improved considerably over recent years with advances in intensive 
care medicine and pain relief, however, treatment is mainly symptom alleviation. In mild, acute 
pancreatitis, treatment is based on hydration and nutrition with laparoscopic cholecystectomy for 
biliary pancreatitis. Aggressive intravenous fluid, enteral feeding and intensive care monitoring are 
required for severe acute pancreatitis.9, 10 For chronic pancreatitis, treatment is for maldigestion, and 
nutritional deficiencies resulting from exocrine insufficiency. Diabetes therapy is required for 
endocrine deficiencies. Complications such as obstruction of the duct, gastric outlet and vessels, 
common in chronic pancreatitis, are treated with endoscopy and surgery.1, 3 There is no current 
treatment for the fibrosis that causes the pathophysiology of chronic pancreatitis.  
 
Diagnosis of pancreatitis is made primarily on the basis of abdominal pain, serum amylase/lipase 
levels and abdominal imaging.32, 40 Scoring systems to predict severity have high false positive rates 
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and individual assessment of patients is critical for recognition of the inflammatory response and 
local complications.40 Diagnosing chronic pancreatitis is challenging as it can be easily confused with 
recurrent attacks of acute pancreatitis or features of other disorders, biopsy and direct visualisation 
are difficult and symptoms can be subtle and vague.1, 38 There is no reliable molecule, genetic 
biomarker or imaging system currently available for predicting the severity of acute pancreatitis.9 
These diagnostic aids would improve the ability to treat the early manifestation of the disease to 
prevent morbidity and mortality as the early systemic inflammatory response has already occurred by 
the time patients present for treatment.9  
 
Chronic pancreatitis is usually diagnosed when the disease is already fully established as the pancreas 
has a considerable functional reserve such that the symptoms of pancreatic insufficiency are not 
clinically recognised until most tissue destruction has occurred. Uncertain pathogenesis, 
unpredictable clinical course and unclear treatment result, so life expectancy is reduced.8 There is no 
current treatment for the fibrosis that causes the pathophysiology of chronic pancreatitis as well as 
the lack of specific laboratory parameters for non-specific clinical symptoms.3  
 
The classification of acute and chronic pancreatitis is multifaceted and has changed often due to the 
diverse aetiologies, symptoms, morphological patterns, the stage (early/late) and complications. 
Determinant-based classification (PANCREA) 201241 and Atlanta classification42 for acute 
pancreatitis; and the M-ANNHEIM classification 43 and S3 Guideline for chronic pancreatitis are 
recent classification systems that introduce unifying concepts to pancreatitis.3 
 
1.3.1 Acute pancreatitis 
 
Acute pancreatitis is associated with elevated pancreatic enzymes in blood and urine due to 
inflammation and systemic responses of varying severity.4 Mild interstitial or oedematous pancreatitis 
with acute inflammation and oedema generally resolves to normal morphology and function , 
however, the often fatal, severe form of acute pancreatitis is haemorrhagic with necrosis and abscess, 
leading to the complete destruction of the gland, systemic complications and organ failure.5  
 
1.3.2 Chronic pancreatitis 
 
Chronic pancreatitis is a fibro-inflammatory disease, the end result being irreversible destruction of 
the gland with impairment of exocrine and endocrine function.1 The current view is that recurrent 
attacks of acute pancreatitis and chronic pancreatitis may represent a disease continuum due to 
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repeated tissue destruction and subsequent remodelling.6 Chronic pancreatitis is irreversible once 
established but progression and symptoms can be modified by clinical intervention.1 Chronic 
pancreatitis is considered a risk factor for pancreatic cancer.6 The cancer is usually at an advanced 
stage at diagnosis, and it is rare to have complete resection of the tumour, and conventional cancer 
therapies such as radiation and chemotherapy have limited results with significant side effects.11 
 
1.3.3 Cell death and its role in pancreatitis 
 
Cell death is critical for tissue sculpting in development, in immunity and destruction of damaged 
cells. Best researched are necrosis, or accidental cell death, and apoptosis, or programmed cell death 
or cell suicide. Recently it has been suggested that there is cross talk between these forms of cell 
death, with necroptosis and pyroptosis utilising mechanisms distinct from necrosis and apoptosis to 
activate cell death.  
 
Apoptosis, named by Kerr et al (1972), is an evolutionarily conserved innate process of regulated cell 
death executed to dispose of cell contents in a conservative manner. It is intentional cell suicide based 
on genetic mechanisms and activated in normal development and morphogenesis as well as in cellular 
injury and stress.44 Apoptosis is regulated by extrinsic stimuli such as cell surface death receptors, 
tumour necrosis factor (TNF)α, Fas and TNF related apoptosis inducing ligand (TRAIL) leading to 
the activation of caspase-8, or by intrinsic stimuli via the mitochondrial signalling pathway through 
cytochrome c and Smac/Diablo that activate caspase-9.45 Activated caspase-8 and -9 cleave and 
activate further caspases to result in apoptosis. The morphology of apoptosis is distinct. The nuclear 
chromatin becomes condensed and often marginated against the nuclear envelope, simultaneously 
with convolution of the nuclear outline. These sharply-defined chromatin masses often appear as 
crescent shaped.  The cytoplasm condenses, microvilli disappear and protruberances, or blebs, appear 
on the cell surface. Cell attachments fail and cells separate from their neighbours. Cytoplasmic 
condensing causes crowding of organelles, ER rearranges into circumscribed whorls or circular 
profiles. Cell fragmentation occurs as the nucleus breaks into discrete fragments and the blebs on the 
cell surface separate with membrane sealing to form membrane bound apoptotic bodies of varying 
size and composition. Apoptotic bodies usually are rapidly phagocytosed by macrophages and 
adjacent epithelial cells or occasionally extruded into intercellular spaces or the pancreatic lumen. 
Most estimates are that apoptotic cells are recognized, ingested and degraded within approximately 
1-2 hrs.46  
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Necrosis is regarded as an un-programmed cell death lacking signalling cascades, initiated by noxious 
or physical insult or lack of blood supply. Morphologically, the cytoplasm swells (oncosis) and 
nuclear chromatin clumps. Mitochondria swell with the appearance of densities in their matrix. The 
irregularly clumped nuclei become dispersed (karyorrhexis) leaving ghost like nuclei (karyolysis). 
Nuclear, organelle and plasma membranes rupture with dissolution of lysosomes and ribosomes. Cell 
boundaries become indistinct with blebbing and the cell contents leak into the intercellular space 
leading to an inflammatory response. Tissue architecture is lost and tissue appears eosinophilic. 
Cellular debris is ingested by macrophages.   
 
Necroptosis resembles necrosis morphologically however it is a programmed form of necrosis driven 
by defined molecular pathways. It is induced by death receptors including TNF, Fas (under conditions 
of caspase inhibition), and involves activation of the receptor-interacting protein kinases/mixed 
lineage kinase domain (RIP1/ RIP3/ MLKL) pathway and other signalling pathways.47 ROS, rapid 
depletion of ATP and mitochondrial dysfunction are also key events. Mice lacking RIP3/MLKL are 
protected from pancreatitis in an induced model.48 Pyroptosis is a form of programmed cell death that 
depends on the action of caspase-1 therefore differs from apoptosis biochemically. Morphologically, 
pyroptosis is associated with cell swelling, plasma membrane lysis, nuclear fragmentation and lack 
of mitochondrial permeabilisation. It is suggested that pyroptosis functions to control infection or for 
release of inflammatory cytokines.49 
 
1.3.4 Regeneration  
Progenitor cell activity is active prenatally in the pancreas, however after birth, pancreatic cells do 
not regenerate continuously and lineage crossover is rare.  It is possible to alter the growth of the 
pancreas by various types of experimental intervention, for example, with cholecystokinin (CCK) 
and after pancreatic resection.50, 51 Mild pancreatitis in human and animal models appears to resolve 
through regeneration of acinar cells. Chronic pancreatitis endures with persistent inflammation, 
fibrosis and tubular complexes. Multiple mechanisms participate in regeneration including 
inflammation, metaplasia and differentiation. As well as acinar cells, cellular constituents 
contributing to repair are duct cells, inflammatory cells, and stellate cells. Fibrosis and the cellular 
interactions within the fibrotic milieu appears important in the regeneration process but is not well 
characterised. 
 
In experimental regeneration conditions, acinar cells depleted by cell death are replaced by tubular 
complexes composed of cells positive for ductal markers that then appear to regenerate into acinar 
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cells. Whether this acinar cell regeneration is due to population expansion or acinar-to-ductal 
transdifferentiation and duct-to-acinar dedifferentiation has been debated passionately in the 
literature.52 Recent knockout and genetic studies in mice, in particular the Cre-LoxP lineage tracing 
technique that links transcription factors to cell fate decisions have begun to unravel the molecular 
basis of regeneration.53 Lineage tracing studies have determined to date that there are no stem cells 
in the exocrine pancreas although this issue is still under investigation.  
 
Tamoxifen induced lineage tracing experiments show that when acinar cells are deleted and 
conditions support regeneration they are replaced by expansion of surviving acinar cells and not by 
progenitor cells. These acinar cells appear to retain lineage commitment as they do not differentiate 
into duct or endocrine cells.54, 55 In these experiments residual acinar cells remain after injury. When 
acinar cells are erased completely, in a diphtheria toxin induced model, duct to acinar 
transdifferentiation appears to be the method of acinar renewal.56 Furthermore, experimental models 
of regeneration from pancreatitis that have focused on the endocrine compartment have revealed a 
plasticity within acinar cells.52 As well, recent evidence from experiments with genetically engineered 
mice suggests that acinar cells become duct-like through acinar-to-ductal metaplasia and are the 
source of pancreatic cancer. Acinar cells express the differentiation factors PTF1A, Mist1 and Nr5a2.  
Loss of PTF1A from acinar cells causes acinar-to-ductal metaplasia.57 Under the influence of 
oncogenic KRAS, acinar-to-ductal metaplasia leads to the formation of precancerous lesions and 
thence to cancer. Mist1 and Nr5a2 normally expressed in acinar cells protect from transformation but 
equally, ductal fate controllers Sox9 and Pdx1 drive acinar cells toward a ductal state that may 
increase cancer cell growth.58, 59 Exocrine regeneration is dependent on cell-to-cell interactions 
through disrupted gap junctions and ductal defects.53  
 
Fibrosis is a common feature of failure to regenerate in pancreatitis. The persistence or withdrawal 
of pancreatic stellate cells affects regeneration, their role is uncertain and Cre lines for adult PSCs 
have not yet been developed. Macrophages and other immune cells such as dendritic cells, also persist 
in fibrotic pancreatitis. Their contribution to limiting or driving inflammation associated with injury 
resolution requires further investigation. Inflammatory signalling pathways associated in regeneration 
from pancreatitis are principally the nuclear factor-κB (NF-κB) and Janus activated kinase (JAK)-
Signal transducer and activator of transcription (STAT) pathways implicated in inflammation, PSC 
recruitment and dedifferentiation, however findings to date are conflicting. As well, signals from 
factors expressed in embryonic development such as the Notch and Wnt signalling pathways, Pdx1 
transcription factor, Hedgehog, Hippo and Wnt/β-catenin pathways may have regenerative roles 
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promoting acinar redifferentiation and proliferation. Communication between the fibrotic process, 
inflammation and developmental mechanisms may determine the outcome of regeneration. 
 
1.4 PANCREATIC FIBROSIS AND INFLAMMATION 
 
Progressive fibrosis is a characteristic feature of chronic pancreatitis of various etiologies. The 
cellular and molecular mechanisms leading to pancreatic fibrosis remain poorly understood.  
 
1.4.1 Extracellular matrix 
 
The extracellular matrix (ECM), the organic matter found between cells, is a framework that acts as 
a structural scaffold for the cellular components and determines cell function through cell-matrix 
biochemical and biomechanical interactions. It is indispensable in embryonic development and tissue 
remodelling, the ECM molecules playing a role in adhesion, migration, proliferation, differentiation 
and homeostasis.60 ECM is composed of multifunctional proteins grouped primarily into structural 
proteins (collagen, elastin), proteoglycans and glycosaminoglycans (hyaluronan, perlecan), 
glycoproteins (fibronectins, laminins), and matricellular proteins (thrombospondins, tenascin).61 
Collagen and elastin classify as fibre-forming molecules, proteoglycans and glycoproteins are 
interfibrillary whereas other molecules regulate cell-matrix interactions The ECM molecules are 
strictly organised such that genetic abnormalities in ECM proteins can produce an array of disorders. 
Disturbances in ECM occur in a variety of human diseases such as coronary heart disease, 
hypertension, asthma, chronic obstructive pulmonary disease (COPD), hepatic fibrosis, chronic 
pancreatitis, Crohn’s disease and some cancers.62  
 
1.4.2 Basement membrane 
 
The BM is a dense sheet-like structure that underlies and separates epithelial cells from interstitial 
tissue or endothelial cells, surrounds muscle, fat and Schwann cells and acts as a permeability filter 
in kidney glomeruli.63, 64 BM is a complex, highly cross-linked meshwork of proteins secreted in 
soluble state and then organised into insoluble cell frameworks.65 The essential BM components 
include collagen type IV in one or more variants, along with the proteoglycans laminin, heparin 
sulfate, perlecan and entactin/nidogen;63, 64, 66 and also non-essential components such as secreted 
protein acidic and rich in cysteine (SPARC) and the integrin ligand nephronectin.65 Collagens XV 
and XVIII are found tethered to the BM and stromal interfaces as are growth factors of the TGFβ 
family, proteinases and their inhibitors, and regulatory molecules.65 Together these mediate local and 
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distant signals with complex signalling cascades, and support and protect the physical interactions of 
cells and tissues.  
 
Morphologically, three layers of BM can be distinguished by EM; the electron dense lamina densa is 
20-300nm thick; the lamina lucida, at 10-50nm thick, is clear or not electron dense; the lamina rara 
interna is 10nm thick and is the basal portion. The lamina reticularis of 200-500nm borders the lamina 
rara interna. BM formation is a laminin/collagen self-assembly, multi-step process involving binding 
and adhesion at the cell surface and polymerisation.64, 65 Through laminins, the BM anchors to integrin 
and dystroglycan receptors65 and sulfatides, nidogen and perlecan feature in assembly with 
considerable heterogeneity, resulting in different structural and biological properties at different 
locations.63, 67, 68 
 
1.4.3 Collagen 
 
Collagen consists of a large family of approximately 28 different collagens encoded by 42 different 
collagen genes.60 Most bind and interact with other ECM proteins to form supramolecular aggregates 
that are classified into fibrillary, fibril-associated, network-forming, membrane-anchoring, 
interconnecting and developmental collagens.60 They localise differently in the BM and/or the 
interstitial matrix. 69 The composition of collagens changes with age and tissue type and mature fibres 
can consist of multiple fibril types.70 The collagen protein is elastic with a resilience of 90% thus 
collagen fibrils show reversible deformity and their mechanical properties are dependent on a variety 
of cross-linking pathways.60 Collagen type IV is produced mainly by endothelial and epithelial cells 
whereas types-I, -III and -V collagen are synthesised intracellularly in fibroblasts.69  
 
The common collagen triple helix forms by three polypeptide α-chains incorporating a repeating 
sequence of glycine X-Y, after which the molecule is called procollagen.71 The existence of several 
alpha chains and molecular isoforms increases the structural and functional diversity of the collagen 
family.60 The molecule is stabilised by covalent bonding along the chain before the formation of 
fibrils, end-to-end linear growth and lateral growth. In fibroblasts, collagen formation begins with 
translation of the protein in the RER. Packaging occurs in the Golgi apparatus. Two models of 
fibrogenesis are proposed; transport through the cytoplasm from Golgi to membrane by means of 
specialised, elongated compartments containing 28nm fibrils followed by exocytosis into the 
extracellular space via caveolae or membrane protrusions, or extracellular fibril assembly through an 
enzymatic fusion process.60, 72 
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EM can be used to illustrate the morphology of collagen. Collagen fibrils form from groups of 
filaments that contain proto-filaments of 0.5-0.3nm. In electron micrographs, the fibrils that form an 
aggregate of filaments 20nm-2µm in diameter often appear hollow or negatively stained due to 
artefact. Mature collagen fibrils show a full-banded and distinctive cross-striated pattern because they 
pack in a staggered arrangement. Very slender or young fibrils show only vague periodic structure. 
Each period consists of a light-dark band and 10-13 fine dark cross striations within each period. In 
ultra-thin EM sections, the length of period is approximately 52-62nm. Collagen fibres, often called 
heterotypic because they consist of a collection of several collagen fibril types, are usually 1-10µm 
in diameter and are wavy fibres of variable length.  Collagen I consists of five molecules of twisted 
microfibrils interdigitated with neighbouring fibrils.60 Reticular fibres are very fine branching 
collagen fibrils of collagen III. They are Periodic Acid-Schiff reagent (PAS) positive and 
argyrophilic, having an affinity for silver as used in a common histochemical stain. 
 
1.4.4 Laminins 
 
Laminins are a family of large molecular weight glycoproteins found in the BM. They function as 
structural components essential for BM formation and integrity and embryonic morphogenesis and 
mediate cell adhesion, proliferation, differentiation, cell shape and migration.64, 73 Laminins interact 
with cell surface receptors like heparins, integrins and dystoglycans to initiate intracellular signalling 
that regulates cellular organisation.64, 74  
 
Laminins are heterotrimers assembled from three genetically-distinct, disulphide-linked polypeptide 
chain subunits, and each laminin is named according to its chain constituents.74, 75 The chains fold 
into many combinations stabilized by disulphide bonding into either cross-shaped, Y-shaped or rod-
shaped trimers.  This shaping determines how the laminin trimers interact with each other and other 
BM proteins for example, in cross-shaped laminins, the short arms can bind to other laminin 
molecules forming sheets that initiate BM assembly; the long arm binds to cells in an anchoring 
manner.76 Laminins self and co-polymerise in the matrix; structure and assembly are reviewed 
elsewhere.63 In different tissue locations and in different cell types they show heterogeneity due to 
diversity of assembly of their chain domains and the variety of interactions mediated by different 
binding sites.63, 77 This leads to the formation of ECM with a diversity of laminin arrangement and 
biological properties.77  
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1.4.5 Fibrosis 
 
Fibrosis is the excessive accumulation of fibrillary, collagen-rich ECM occurring either in persistent 
tissue damage or in tissue repair. Following damage to tissue or organs through trauma or disease, 
fibrosis may aid the restoration of cell and ECM components beneficially. However, the prolonged 
presence of fibrosis detrimentally leads to dysfunction and chronic disease. In skin wound healing, 
during inflammation, a platelet plug forms followed by a fibrin matrix scaffold. Growth factors 
activate neutrophils, mast cells, macrophages and fibroblasts to infiltrate and populate the scaffold. 
These cells defend against microorganisms, clear debris, produce fibrosis and signalling factors.78 
New tissue formation follows keratinocyte migration over the injured site to restore a barrier of 
epithelium and angiogenesis occurs to replace the fibrin matrix with granulation tissue. The 
endothelial, mast and macrophage cells undergo apoptosis or exit the wound, leaving a mostly 
acellular protein and collagen matrix. Activated fibroblasts (myofibroblasts) form the fibrotic scar of 
mainly collagen III and use mechanistic contraction to remodel the injury. Over time, matrix 
metalloproteinases secreted by fibroblasts regulate collagen turnover from collagen III to collagen I, 
until skin integrity and homeostasis is maintained.79 
 
Studies of fibrosis are well documented in liver and have provided the basis for fibrosis research in 
pancreas. Although there are similarities to fibrosis in the pancreas, the liver has a population of 
resident macrophages (Kupffer cells), hepatic stellate cells have more and larger lipid droplets, the 
relationship with vasculature is different and a liver stem cell (oval cell) has been identified.80 In liver, 
the deposition of fibrosis by collagens I, III, IV and V is accompanied by change in immune cell 
composition, altered angiogenesis and architectural changes. The collagen is produced by activated 
hepatic stellate cells (HSC) located in the peri-sinusoidal space and myofibroblasts located in larger 
vessels, portal tract stroma and sinusoidal endothelial cells.81 In the liver, resident macrophages 
(Kupffer cells) and macrophages recruited from monocytes along with bile duct epithelial cells, the 
hepatic progenitor stem cells (oval cells)80 and activated fibroblasts secrete cytokines and other 
mediators to recruit and activate HSC and myofibroblasts.82  The environmental stiffness of ECM in 
advanced fibrosis activates HSC and MF and promotes the survival of HSC.80, 83 Kupffer cells recruit 
monocyte macrophages that infiltrate and produce TGFβ1, TNFα and interleukins 1β, 6 and 13, which 
are pro-inflammatory or pro-fibrotic. Oval cells produce TGFβ1, TGFβ2, PDGF and sonic hedgehog 
for HSC proliferation and activation: HSC maintain oval cell growth through production of survival 
factors.80 In acute liver disease, removal of excess ECM by matrix metalloproteinases (MMPs) leads 
to resolution of the disease state. However, in protracted or subsequent bouts of injury excess ECM 
deposition dominates permitting MMP downregulation and upregulation of tissue inhibitors of MMPs 
19 
 
(TIMPs). Fibrosis models optimised for liver fibrosis reversal include in rats treated with carbon 
tetrachloride (CCL4) or alcohol and bile duct ligation84 and in mice CCL4 or thioacetamide induced 
fibrosis.85 Factors associated with inefficient fibrolysis in the liver include advanced vascular 
remodelling with architectural distortion, extensive cross-linking of ECM components hindering 
proteolytic removal, and the disappearance of cells that digest and degrade scar tissue.85   
 
1.4.6 Fibrosis in the pancreas  
 
Injury to the pancreas, whether necrosis, apoptosis, inflammation or obstruction, leads to production 
and deposition of ECM depending on the site of injury and the tissue compartment or cell types 
involved.86-88 Fibrosis may replace the normal exocrine and endocrine cell populations leading to 
both exocrine and endocrine deficiency. Pancreatic fibrosis ranges from interlobular (for example, 
alcoholic chronic pancreatitis), periductal (hereditary pancreatitis) or periductal and lobular 
(autoimmune pancreatitis).89 It is the common pathological feature in chronic pancreatitis and a major 
risk factor for pancreatic cancer. There is a direct role of fibrosis in cancer invasiveness 90, apoptosis 
associated with cancer91 and through molecular interaction between PSCs and cancer cells controlling 
pro-tumorigenic properties.92-94 Treatment for pancreatic fibrosis remains problematic.   
 
In the pancreas, injury to acinar cells activates the cascade of events that leads to fibrosis. Activated 
acinar cells and recruited inflammatory cells, macrophages, neutrophils and eosinophils, platelets,95 
induce the release of pro-inflammatory cytokines such as interleukins (IL)-1,-6,-8,-18 to -33 and 
TNFα that activate pancreatic stellate cells.34 Matrix accumulates through activated pancreatic stellate 
cells (PSCs) secreting the ECM under the production of a wide range of cytokines and molecular 
signalling pathways, for example TGFβ/Smad, mitogen-activated protein kinase (MAPK), Rho 
kinase, JAK/STAT and phosphoinositol-3-kinase (P13K) pathways.34 Macrophages produce pro-
fibrotic cytokines such as TGFβ, platelet-derived growth factor (PDGF), fibroblast growth factor-2 
(FGF2) and insulin growth factor-1 (IGF1). PSCs also regulate the degradation of ECM by secreting 
MMPs and TIMPs such that the balance between resolution of fibrosis and progression to fibrotic 
chronic disease depends on a complex process with multifunctional modes of action.  
 
Dynamic autocrine and paracrine signalling pathways accompany the development of fibrosis in the 
pancreas. TGFβ regulates activation of PSCs in an autocrine manner through Smad and ERK 
pathways.96, 97 Transforming growth factor (TGF)α increases proliferation and migration of PSCs via 
upregulation of MMP-1.98 TGFβ also regulates other signalling pathways including the MAPK 
pathway whose members extracellular signal regulated kinase (ERK), c-Jun N terminal kinase (JNK), 
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p38 induce collagen synthesis.99-102 The Rho kinase family is linked to the invasive nature of 
pancreatic ductal carcinoma103, PDGF induces the proliferation of PSC by activating the JAK-
2/STAT-3 pathway.101 
 
Models used to study pancreatic fibrosis include repeated injections of caerulein104, duct ligation105, 
toxins injected into the pancreatic duct (trinitrobenzene sulfonic acid or IV dibutyltin chloride,106, 107 
over-expression of TGFβ,108, 109 the WBN/Kob spontaneous chronic pancreatitis rat,110 and alcohol-
induced pancreatitis in rats111 and in mice.112   
 
1.4.7 Resolution of fibrosis 
 
Fibrosis resolution depends on elimination of the pathological stimulus, clearance of PSCs and their 
stimulants such as macrophages, degradation and clearance of ECM components and regeneration of 
tissue epithelium. Identification and studies of the intracellular signalling pathways are important for 
the development of anti-fibrotic therapy. Reported pancreatic anti-fibrotic approaches in animal 
models include antioxidants;113-116 silencing of TGFβ117-119; inhibition of TNFα;113 anti-inflammatory 
drugs;120 troglitazone, the peroxisome proliferation-activated receptor-γ (PPAR-γ) agonist;121 
angiotensin receptor blocker;122 and a mouse model with inducible c-Jun.123   
 
The withdrawal of the etiological source of chronic injury, the disappearance of PSCs, the recruitment 
of macrophages and the prevalence of MMPs over their inhibitors TIMPs are necessary for the 
reversal of fibrosis.84 MMPs, a family of 28 members, also called matrixins, are zinc-dependent 
endopeptidases active in the degradation of most components of ECM.124-126 They are commonly 
classified into collagenases, gelatinases, stromelysins, matrilysins, membrane-bound and other 
MMPs. Originally studied for their role in the turnover of ECM by degradation of ECM proteins in 
wound repair and embryogenesis, they are now known to be active in pathological conditions such 
as rheumatoid arthritis, chronic obstructive pulmonary disease, myocardial infarction, cancer 
metastasis and neurological disorders.124, 126 
 
Through modulation of cellular and signalling pathways, MMPs have a role in cell proliferation, 
migration, differentiation, apoptosis, angiogenesis, cancer invasion and metastasis and immunity.125 
They are distributed in connective tissue as well as some vascular tissues and cells.125 Most MMPs 
are secreted as inactive proenzymes by multiple cells including fibroblasts, macrophages, neutrophils 
and lymphocytes however some are membrane anchored to the cell surface of cells or the 
mitochondria or nucleus.124 The core structure of MMPs consists of amino acids in a pro-peptide, a 
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catalytic metalloproteinase domain, a linker peptide and a hemopexin domain.125 Generally, MMP-1, 
-8, -13,-14 cleave collagens I, II, III; MMP-2 cleaves collagen I.126 TIMPs are a small family of four 
proteins that regulate the activity of all MMPs. In normal tissues, the ratio of MMPs to TIMPs is 1:1 
however this balance is disrupted under pathological conditions.124 Because the ratio of MMP/TIMP 
mostly determines the extent of protein degradation, MMPs are proposed as therapeutic targets for 
several pathological disorders.124-126 Transmembrane receptors, integrins, are involved in resolution 
of fibrosis through the finding that liver, lung and kidney fibrosis are attenuated in mice with a 
constitutive MF-specific knockout of the αv integrin chain.127 
 
1.4.8 Pancreatic stellate cells  
 
Activated PSCs produce most of the components of the ECM, increasing synthesis and secretion of 
ECM components including collagen types I and III, fibronectin, laminins, proteoglycans and 
hyaluronan.128-130 Historically, the activation of fibroblasts and fibroblast-like cells was observed in 
acute and chronic pancreatitis in the rat caerulein-induced pancreatitis.105, 131, 132 Walker et al. (1992) 
identified myofibroblasts and fibroblasts in fibrotic areas of duct ligation rats. The importance of 
fibroblast-like cells in the peri-acinar region of the pancreas for collagen synthesis and fibrosis was 
identified by several authors133-135 Cultured rat peri-acinar fibroblastoid cells were identified as 
myofibroblast-like cells producing the ECM proteins collagen, fibronectin and laminin.136 A similar 
observation was made in transgenic mice models by others.137,138 Alpha smooth muscle actin (αSMA) 
positive myofibroblast-like cells were recognised around the acini, ducts and vessels of the human 
pancreas.139 Further studies with isolated and cultured fibroblast/myofibroblast cells from normal rat 
pancreas140 and from human chronic pancreatitis, and from rats treated and untreated with caerulein129 
noted the similarity of the myofibroblast-like cells to hepatic stellate cells (HSC) and changed the 
terminology to PSCs. 
 
Stellate cells, in general, have a perivascular location and store retinoids, a feature shared with 
HSC.141, 142 In normal pancreas, quiescent PSCs (or inactive fibroblasts) are in low numbers 
(approximately 4% of the cells), have limited proliferation, rounded cell bodies with long cytoplasmic 
processes, possess vitamin A containing fat droplets129, 140 and are negative for α-smooth muscle actin 
(αSMA).140 They have a periacinar and interlobular distribution129, 140 however may be detectable in 
islets.143 When isolated and cultured in vitro129, 140 and when activated in vivo during both human and 
experimental fibrosis,144 PSCs transform to a myofibroblast-like phenotype. They lose their vitamin-
A containing lipid droplets, enlarge and proliferate, stain positive for the cytoskeletal marker protein 
αSMA and synthesise large amounts of ECM proteins.  
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Quiescent PSCs are believed to reside in the normal pancreas, however histological stains for their 
identification and comparison with resident fibroblasts are limited. For both PSC and HSC, vitamin 
A droplets in the cytoplasm provide a target for staining, however the lipid marker Oil Red O is 
reliable only with frozen sections as processing with solvents for formalin-fixed paraffin-embedded 
(FFPE) sections dissolves the lipid. Markers previously reported to be effective in quiescent HSCs or 
PSCs in rats and cell culture, glial fibrillary protein (GFAP), nestin, desmin and vimentin, are either 
not specific and/or are not positive in human PSCs.129, 140, 144-147 Many markers for quiescent PSCs in 
normal human pancreas have been evaluated recently.148 They identified the limitations of previously 
proposed markers and suggested cytoglobin and adipophilin as possible but not perfect replacements.  
 
Activated PSCs migrate and phagocytose.149, 150 Activated PSCs are thought to transform from 
quiescent PSCs residing in the pancreas129, 140 however, in mice with caerulein-induced pancreatitis 
approximately 5% of the total population of PSCs were derived from bone marrow.151, 152 The bone 
marrow derived cells contributed to both quiescent and activated PSC populations.153 Phillips et al. 
(2003) reported an increase in the numbers of PSC in pancreatic injury resulting not only from PSC 
proliferation but also via migration from surrounding areas to injured tissue. This migration of 
cultured PSC was stimulated by platelet-derived growth factor (PDGF)149 and the migration is 
dependent in part on cell proliferation.154 In an animal model of spontaneous chronic pancreatitis and 
diabetes mellitus using the male WBN/KOB rat, Shimizu et al. (2005) found phagocytic cells in the 
periacinar region with the same characteristic features of PSCs, suggesting that PSCs might act as 
resident phagocytic cells during pancreatic injury.  
 
PSCs produce MMPs and TIMPs to degrade collagen.155 PSCs therefore play an important role in the 
balance between synthesis and degradation of ECM. Proteins expressed in activated PSCs are 
different to those in the quiescent state according to proteomic studies of mouse, rat and human 
PSCs.156, 157 Chronic pancreatitis with fibrosis is a complication of alcoholism and ethanol metabolites 
along with oxidative stress may perpetuate activated PSC. PSC were activated by exposure to ethanol 
in culture158 via the metabolism of ethanol to acetaldehyde accompanied by oxidant stress.159 The 
antioxidant retinol supplements prevented alcohol-induced PSC activation.160 The authors propose 
that retinoic acid in quiescent stellate cells is responsible for keeping the cells in an undifferentiated 
state.160, 161 
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1.4.9 Fibrosis and the transforming growth factor beta family  
 
TGFβ is a multifunctional cytokine residing in the ECM and synthesized by macrophages, 
lymphocytes, fibroblasts and PSCs, epithelial cells, and platelets. It has roles in cellular and 
development pathways and tumour promotion or suppression and is linked to the tight control of 
apoptosis.162, 163 In mammals, TGFβ occurs as three isoforms, TGF-β1, TGF-β2, and TGF-β3, with 
TGF-β1 the most abundant. Stimulated TGFβ dimers mediate signalling via serine/threonine kinase 
Type-I and Type-II receptors.164 TGFβ can activate the MAPK signalling pathways ERK, JNK and 
p38 and mediate Smad-dependent or independent effects. Loss of function of the components of the 
TGFβ pathway results in aberrant organ development and physiological performance. The TGFβ 
family has a role in embryogenesis and may be necessary for normal development of acini. In the 
exocrine pancreas, acini express TGFβ1 whilst duct cells are reactive for all three isoforms.165 
Inactivating TGFβ in transgenic mice resulted in increased proliferation, defective acinar 
differentiation and fibrosis with macrophage infiltration, suggesting the necessity for TGFβ in normal 
exocrine function.166 TGFβ appears to support both fibrosis and hyperglycaemia in chronic 
pancreatitis. In fibrosis, TGFβ regulates PSC activation and proliferation through Smad 2, Smad3 and 
ERK-dependent autocrine pathways.97 PSCs actively secrete TGFβ1 and express TGFβ receptors I 
and II. Exogenous TGFβ1 increases collagen protein synthesis significantly.167  
 
1.4.10 Fate of pancreatic stellate cells 
 
Prolonged activation of PSCs results in progressive fibrosis. PSCs activate by autocrine pathways, 
thus they may achieve a perpetually-activated state when triggers, for example ethanol, have 
ceased.168 PDGF, TGFβ1 and activin A, cytokines (IL-1, IL-6 and TRAIL), and the pro-inflammatory 
molecules (cyclo-oxygenase-2/COX-2) can perpetuate the activated phenotype.169 Mechanisms to 
terminate PSC activation are required for fibrotic resolution and tissue regeneration. Several studies 
have found that PSCs may revert to quiescence, or undergo cell death or senescence. In vitro and in 
vivo immunity studies in mouse and rat models showed the necrotic cell death of PSCs after engulfing 
necrotic acinar cells and apoptotic neutrophils.150 The fate of rat PSCs in culture and in a chronic 
pancreatitis model was determined by senescence.170 PSCs isolated from rat pancreas were 
susceptible to CD95L and TRAIL-induced apoptosis in culture and, in a model of explant cultures of 
rat pancreatic tissues, some PSCs disappeared by apoptosis whilst some reverted to non-activated 
fibroblast phenotype.171 Apoptotic PSCs were demonstrated in an ethanol-fed endotoxin model of 
chronic pancreatitis.172 Exposure to retinoic acid may counteract PSC activation, or promote the PSC 
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quiescent phenotype or stage.102, 173 In cell culture of PSCs, studies demonstrated that activin A 
induced the expression of anti-apoptotic Bcl-xL.174  
 
1.4.11 Pancreatic inflammation 
 
Inflammatory cells (particularly macrophages), platelets, injured acinar cells and pancreatic cancer 
cells secrete cytokines and growth factors to activate PSCs in a paracrine manner. This stimulates 
PSCs to produce factors that act through autocrine signalling to regulate and sustain PSC activation.175 
The multiple signalling pathways involved in PSC activation and functions are summarised.175, 176 
They include the p38 MAPK pathway involved in activation and proliferation of PSCs; PPAR-γ in 
maintenance of quiescence; ERK mainly in proliferation with JNK and JAK-STAT3; Rho/Rho kinase 
pathway for regulation of the actin cytoskeleton and contraction; NF-κB , ERK, JNK, p38 kinase and 
activator protein-1  (AP-1) for cytokine production; and P13K/Akt for controlling migration.  
 
Members of the Smad family regulate activation, α-smooth muscle actin (αSMA) and COX-2 
expression and VEGF production. STAT1 and Smads are involved in growth inhibition. Mediators 
for the signalling pathways include growth factors such as platelet-derived growth factor (PDGF);128, 
130 TGFβ1177 and activin A;178 basic FGF (bFGF);129, 130 connective tissue growth factor 
(CTGF/CCN2);179, 180 and cytokines such as IL-1 and -6;181 IL-8 and TRAIL;169 and TNFα.130, 181 The 
vasoconstrictor, endothelin-1 is expressed by PSCs however they also contract and migrate in 
response to endothelin-1 expression.101, 182 Overexpression of the integrin ligand, periostin, produced 
by PSCs, may contribute to tumour desmoplasia in pancreatic ductal adenocarcinoma.183 Oxidative 
stress, ethanol and pressure also act to stimulate and perpetuate the activation of PSCs.158, 184, 185  
 
1.4.11.1 Macrophages in pancreatitis 
Macrophages are mononuclear phagocytes involved in mammalian development, trophic support and 
homeostasis of tissues and are major coordinators of both the initiation and resolution of inflammation 
after tissue injury. For simplicity and mechanistic cell culture studies, macrophages are divided 
primarily into classically activated M1 macrophages by secretion of pro-inflammatory cytokines 
TNFα, IL1β and IL6, and alternatively activated M2 macrophages treated with IL-4 and IL-13.186 
However, as macrophages appear to be highly plastic, other subsets, phenotypes and changed 
physiology are described that respond to changes in environmental signals.187 Studies in cancer and 
obesity indicate that macrophage populations do undergo a phenotypic switch associated with time 
and pathology.188 The pancreas contains an unknown proportion of resident self-sustaining 
macrophages, however they are known to reside in the peritoneal cavity near the pancreas and in the 
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peri-pancreatic tissue and are recruited from blood and bone marrow under inflammatory conditions. 
Following injury, they expand exponentially. Peritoneal macrophages, alveolar macrophages and 
Kupffer cells become activated at different stages of acute pancreatitis.189  
 
Macrophage-derived MMPs facilitate BM disruption and this expedites movement of inflammatory 
cells to the injury site.190 Macrophages recognise cell surface markers expressed by acinar cells and 
act as phagocytes to clear dying cells rapidly and efficiently. Clearance of cellular debris alters the 
physiology of macrophages through endogenous signals from ingested material including alterations 
in surface protein expression and the production of cytokines and pro-inflammatory mediators.188 
This removal of intracellular contents appears to simulate the macrophages to express either an anti-
inflammatory phenotype for the resolution of inflammation, or a suppressive phenotype that would 
continue inflammation.191  
 
Macrophages produce several growth factors that promote wound healing through proliferation and 
angiogenesis including PDGF, IGF-1, and VEGF and also produce mediators such as TGFβ to 
activate PSCs. Thus, they stimulate PSCs to synthesise ECM products that result in the development 
of fibrosis. If the trigger for injury is removed, macrophages direct tissue repair through mechanisms 
that suppress inflammation, remove collagen and restore tissue architecture. Dysregulated cross talk 
between macrophages and other cells or the ECM, and transcription of pro-fibrotic genes by cytokines 
PDGF, IL-6, IL-13 results in survival and proliferation of PSCs.79 This leads to pathological fibrosis 
and chronic pancreatitis. Studies of macrophages in cancers support a role of the ECM in guiding 
macrophage interactions where they support metastasis by mobilizing and co-migrating with tumour 
cells.79  
 
1.4.11.2 Mast cells in pancreatitis 
Mast cells are haematopoietic immune cells resident in all human tissues usually in close proximity 
to vasculature. Sensitive to pathological change, on activation they release a myriad of inflammatory 
mediators important in the context of allergic disorders and other inflammatory responses as well as 
in protection against toxins and infection.192 The secretion and the regulation of the extent of mediator 
release is controlled by stem cell factor (SCF), the ligand of the receptor c-kit.193 The precise role of 
mast cells in acute and chronic pancreatitis is not clear, however they are implicated in the 
development and progression of acute pancreatitis,194 and identified as the cells responsible for 
perpetuating chronic inflammation in chronic pancreatitis.195  
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Mast cells have a high content of secretory granules filled with preformed compounds including 
histamines, cytokines and growth factors (TNFα, FGF2, TGFβ, IL-4), and lysosomal hydrolases and 
proteases (tryptase, chymase).196 The many mediators and molecules that mast cells produce are pro-
fibrotic. They demonstrate biological effects modulating fibrosis through directly influencing 
fibroblasts/PSCs or through recruitment and activation of other inflammatory cell types (overview of 
mediators and biological effects.192 In particular, histamine, FGF-2, TNFα and proteases are 
implicated in fibroblast proliferation and migration, matrix protein and collagenase production and 
collagen synthesis in humans. Mast cells may be a source of TGFβ as TGFβ derived from cultured 
mast cells can enhance collagen 1 production.197 Animal studies, particularly in knockout mice, have 
provided contradictory results on the effects of mast cells on fibrosis with detrimental, protective and 
no effects noted. Data from human and in vitro studies favour a pro-fibrotic function for mast cells.  
 
1.4.12 Survivin and the processes of pancreatitis 
 
Survivin is a member of the inhibitor of apoptosis protein (IAP) family. The eight IAP family proteins 
are identified by one to three copies of an ~70-amino acid zinc finger fold designated Baclovirus IAP 
repeat (BIR). Other domains include a carboxyl-terminus RING and a caspase-recruitment domain. 
At 16.5kDa and 142 amino acids, survivin is the smallest IAP containing a single N-terminal BIR 
and a carboxyl-terminus α-helix.198 The human gene for survivin is found on chromosome 17q25.199 
Four alternative splice variants have been described, designated survivin 2B, survivin-ΔEx3, survivin 
3B, and survivin-2α.199 The splice variants appear to differ in subcellular localisation and function, 
however, anti-survivin antibodies recognise them all due to the existence of an identical amino-
terminal peptide.200 Survivin gene expression is activated by transcription factors for pathways of cell 
proliferation, cell survival or development, or inhibited by other molecules such as p53.198  
 
Survivin is localised intracellularly in the cytoplasm (approximately 80%), nucleus and mitochondria, 
and as components of the mitotic apparatus.201 It is present abundantly in embryonic tissues, and in 
fast dividing cells but is mostly absent in normal differentiated cells. It may be expressed in normal 
adult cells such as primitive haematopoietic cells, T-lymphocytes, polymorphonuclear neutrophils 
and vascular endothelial cells. It occurs prominently in nearly every human tumour where it is 
frequently associated with poor outcome and resistance to therapy. The IAP family is implicated in 
control of cell division or regulation of apoptosis however survivin is associated with both functions. 
Essentially, nuclear survivin is involved in cell proliferation, but cytoplasmic survivin participates in 
cell survival.  
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It is well established that survivin is essential for cell division with cell cycle dependent expression 
at G2/m and localisation of the mitotic apparatus. Many studies targeting deletion of survivin have 
shown mitotic defects.198 As a member of the chromosomal passenger complex, survivin targets the 
centromere in chromosome-microtubule attachment and may regulate the spindle assembly 
checkpoint by repressing microtubule dynamics.198 Survivin has an anti-apoptotic function at mitosis 
by inhibiting mitotic catastrophe (the activation of a dual necrotic/apoptotic pathway) through 
suppression of caspase-9 and segregation of Smac. During embryogenesis, the signalling pathways 
Wnt/β-catenin, Hedgehog, Hippo and Notch target survivin. Because human and mouse embryonic 
stem cells express survivin, it may be essential for the integrity of stem cells to have survivin 
protection from apoptosis.198 It is well documented that survivin is a biomarker of poor prognosis in 
human metastatic tumours through inhibition of apoptosis, increased drug resistance and maintenance 
of stem cells, however it appears that survivin may participate in cell motility and invasion.198  
 
Investigations with human cases of normal pancreas and chronic pancreatitis or pancreatic cancer 
have found conflicting results. Survivin expression was absent in normal pancreas and chronic 
pancreatitis but positive in tumour cells.202 Survivin expression in ducts, acini and islets increased 
with the extent of fibrosis in human chronic pancreatitis cases.203 In acute necrohaemorrhagic 
pancreatitis in rats, duct cells (cytoplasm and nucleus), acinar cells and infiltrating cells (nucleus 
only) were positive for survivin.204 
 
1.5. EXPERIMENTAL MODELS OF PANCREATITIS   
 
Exocrine pancreatic pathology is usually comprised of four conditions: acute and chronic pancreatitis, 
cancer and cystic fibrosis. Since it is difficult to study the pathophysiology of pancreatitis in humans, 
many animal models of pancreatitis have been established in an effort to elucidate the cellular and 
molecular mechanisms that initiate and precipitate the disease and the subsequent events that allow 
regeneration and recuperation of the pancreas. Experimental models attempt to mimic the clinical 
situation and whilst most do not in entirety, many result in the physiological and histological 
alterations that are relevant to clinical findings. Models using chemical administration, diet or 
surgical-induction have been developed in such diverse species as rats, mice, rabbits, dogs, cats, 
hamsters, pigs, opossum and ducklings.  
 
Model-based bias is a difficulty for the extrapolation of findings in animal models to the human 
disease. In the rat, pancreatic ductal epithelium is less well developed, and ductal secretion may occur 
predominantly in interlobular ducts compared with intralobular/intercalated ducts in humans. The 
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physiological profile of rodent pancreatic acini is different to human with respect to CCK receptors 
and amines, and fluid secretion from acini differs markedly. Other species, for example dog and cat, 
exhibit a pattern closer to that in human.205  
 
1.5.1 Caerulein 
 
Caerulein is a decapeptide, structurally and functionally related to the intestinal hormone 
cholecystokinin (CCK), and was originally extracted from the skin of the Australian tree frog Litoria 
caerulea. Since Lampel and Kern 275 first showed it to have a striking stimulatory action on exocrine 
pancreatic secretion by producing reversible, oedematous pancreatitis in rats, it has become well-
established as a model of experimental acute pancreatitis. In pharmacological doses, it also 
reproducibly induces acute pancreatitis in mice, dogs and Syrian hamsters.206 This model, often 
referred to as secretagogue hyperstimulation pancreatitis, may be induced by intravenous, 
subcutaneous or intraperitoneal injection routes, the course and severity of pancreatitis varying with 
dose and route. At low doses, acinar cells are stimulated to activate the consecutive steps in the 
secretory process and pancreatic growth is accelerated; at maximal doses the secretory process is 
disturbed and acute pancreatitis ensues.207 The model is found to be physiologically relevant to some 
aspects of human disease, although the effect of CCK is different in humans and rodents.205 Whereas 
in rat and mouse it regulates exocrine enzyme secretion, human acini lack CCK receptors, and are 
regulated by neurogenic CCK stimulation.208 Depending on dose and route of administration, 
caerulein induces a mild, self-limiting, reversible pancreatitis with oedema, increased serum levels of 
digestive enzymes, necrosis/apoptosis, inflammation and vascular permeability such that the early 
initial changes that occur in pancreatitis may be studied.209 Repeated episodes of acute pancreatitis 
may induce chronic pancreatitis. Neuschwander-Tetri (2000A,B) developed a chronic pancreatitis 
model in mice using repeated doses of caerulein which results in a pattern of fibrosis similar to that 
found in human chronic pancreatitis. However, repeated doses of caerulein are not sufficient to cause 
the endocrine and exocrine insufficiency normally found in human chronic pancreatitis.208 Wistar 
Bonn/Kobori (WBN/Kob) rats spontaneously develop chronic pancreatitis and may be supplemented 
with caerulein doses to produce a more severe effect.110 The repetitive caerulein model may be 
combined with toxic agents such as lipopolysaccharides, dibutyltin dichloride and ethanol to enhance 
its effect.208 
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1.5.2 Ethanol  
 
In humans, ethanol causes severe damage to liver but milder changes in the pancreas where ethanol 
may act merely as a sensitizer to chronic injury. Cofactors such as ethanol metabolites are probably 
responsible for producing the chronic pancreatitis that occurs in those who abuse alcohol. The 
majority of studies in rodents found that ethanol feeding and even continuous infusion of ethanol 
could not produce typical pancreatitis (comprehensively reviewed in Schneider et al 2002). However, 
supplementation with different feeding protocols for example, Lieber-DeCarli diet, Tsukamoto-
French diet, deliver higher doses of ethanol. Similarly, models combining ethanol with other factors, 
including pancreatic duct obstruction, trinitrobenzene sulfonic acid, dibutyltin dichloride and 
caerulein have been investigated.210 These models of ethanol administration do not produce classical 
acute or chronic pancreatitis however, they do facilitate the investigation of mechanisms that include 
enzymes, nutrition, metabolite changes and regeneration that are important in the course of alcoholic 
pancreatitis. 
 
1.5.3 L-Arginine 
 
A single intraperitoneal injection of high-dose amino acid L-arginine induces acute necrotizing 
pancreatitis.211 This model has established pancreatitis in rats and mice with selective dose-dependent 
pancreatic acinar cell necrosis and is suitable for varying the degree of severity of disease and for 
investigating early and late phases, regeneration and multi-organ characteristics of acute 
pancreatitis.212, 213 Results in chronic pancreatitis with administration of l-arginine for an extended 
time results in chronic pancreatitis with exocrine insufficiency.214 This model is of unknown clinical 
relevance and is not used in vitro. 
 
1.5.4 1-cyano-2-hydroxy-3-butene (CHB) 
 
CHB is the stable breakdown product of a glucosinolate present in plants of the Cruciferae family, 
particularly the Brassica genus that includes vegetables such as cabbage, turnip and kale, condiments 
such as mustard, canola oil and certain forage and pasture plants. It is now well-established that in 
rats, at a reasonably high dose, CHB causes cell death in pancreatic acinar cells only215, 216 but at 
higher doses lethality due to CHB is caused by extensive hepatocyte vacuolation and necrosis.217 In 
the CHB study by Kelly and colleagues,216 large animals were found to be more sensitive on a 
dose/weight basis than smaller animals, with females and males being equally sensitive. In rats, if the 
initial dose of CHB was high enough, death of virtually all acinar cells occurred with only very 
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occasional nests regenerating before 28 days. Subcutaneous administration gave a more consistent 
lesion, a more complete atrophic effect and liver toxicity could be lessened. An acute oedematous 
pancreatitis induced by synthetic CHB is non-invasive and requires but one subcutaneous injection 
of CHB. This model in rats has the benefit that the acinar cells are deleted completely by apoptosis 
so that regeneration and the fibrotic process can be assessed without the complication of residual 
acinar cells.216 Bhatia et al. (1998) studied the early events of pancreatitis with a combination of CHB 
administration followed by caerulein-induced pancreatitis. 
 
1.5.6 Ductal ligation 
 
Gallstone or biliary disease is a common cause of pancreatitis. Historically, this instigated extensive 
research into the cause of pancreatitis from obstructed ducts. Invasive models of pancreatitis 
including the closed duodenal loop model, and duct injection models involving the retrograde 
injection into the pancreatic duct of bile, bile salts, with or without trypsin and pancreatic enzymes 
and bacteria result in severe pancreatitis with necrosis and haemorrhage. These were used to study 
pseudocyst and abscess formation, duodenal juice components and fat necrosis.206 The perfusion of 
the bile acid sodium taurocholate induces biliary pancreatitis with severe haemorrhagic, necrotic 
pancreatitis with multi-organ failure.206 The infusion of trinitrobenzene sulfonic acid into rat 
pancreatic ducts produces chronic pancreatitis with mono- and polymorphonuclear cell infiltrates, 
fibrosis and gland atrophy within 3 weeks.106 Partial surgical ligation in rats as a model for ductal 
obstruction in the pancreas was modified by Pound and Walker.218 The technique of tying off the 
body of the pancreas, but not the splenic vessels close to the hilus of the spleen, avoids interference 
with biliary drainage, preserves the blood vessels, minimizes constitutional disturbance and leaves 
some pancreatic parenchyma as an internal control with retained organ function so that animal 
experiments may be extended.218 The resultant pancreatitis is considered to be precipitated by 
pancreatic ductal hypertension, due to pancreatic secretion into the obstructed ducts. In the exocrine 
portion of the pancreas, acinar cells progressively disappear by apoptosis and the lobules are reduced 
to groups of small ductular complexes lying in a fibrous stroma.218  
 
1.5.7 Vascular causes  
 
Vascular-induced pancreatitis includes methods to impair pancreatic vasculature, or disturbance of 
microcirculation.206 This is achieved by inducing hypovolemic shock, permanent occlusion of 
pancreatic arteries, by venous ligation or retrograde injection of microspheres and 
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ischaemia/reperfusion models. Microcirculatory disorders are a major cause of death in the course of 
severe acute pancreatitis in humans.194 
 
1.5.8 Genetic models  
 
Following the sequencing of the genome of the mouse, transgenic mouse models and gene deletion 
studies facilitated understanding of the role of specific proteins in the complex processes where 
different proteins interact and co-react in pancreatitis. Genetically engineered mouse models 
recapitulating chronic pancreatitis,219 and gene knockout models to examine the effects of cytokine 
and chemokine mediators plus their receptors have been targeted.206 Mutations in genes identified 
from families with hereditary pancreatitis have led to investigations with trypsin/trypsinogen (serine 
protease inhibitor kazal type 1/SPINK1) and bicarbonate secretion (cystic fibrosis/CFTR) in the 
pancreas and to the development of mouse models with these genetic manipulations.219 Mutations in 
genes PRSS2 (anionic trypsin), SPINK1, CFTR, CTRC (chymotrypsinogen C) and CASR (calcium 
sensing receptor) expressed in mouse models are associated with an increased risk of pancreatitis.208 
The connection that recurrent acute pancreatitis may precede chronic pancreatitis was identified by 
the PRSS1 mutations in chronic pancreatitis.   
 
WBN/Kob male rats endogenously develop morphological and biochemical changes typical of 
chronic pancreatitis and unique genes not found in other inbred rats.208 Other chronic pancreatitis 
genetic models are COX2, Sonic hedgehog, and knockouts KRAS, and TGFβ. Protein kinase R-like 
endoplasmic reticulum kinase knockout (PERK-/-) mice and mice overexpressing IL-1β have been 
developed to look at chronic inflammation.208 
 
Multiple mouse models for pancreatic cancer now exist. They include the subcutaneous xenograft 
model where cell lines or human cancer tissue are implanted subcutaneously in nude mice or 
immunodeficient mice and have been used to study chemotherapeutic agents. The technically 
challenging orthotopic model that uses pancreatic grafted tissue, either cell lines or cancer tissue in 
immunodeficient mice allows study in in vivo conditions. Genetically engineered mouse models of 
pancreatic cancer include mutant KRAS and the TGFβ family. 
 
1.5.9 Summary of models 
 
The models of pancreatitis, whether invasive or non-invasive, simple or complex, employing high or 
low dose chemicals, induce a variety of lesions from mild interstitial to severe necrotizing pancreatitis 
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with considerable variation between species and with unique advantages and disadvantages. Many of 
the models mentioned above go some way to reproducing human pancreatitis in terms of 
histopathology and pathophysiology. However, they still lack effectiveness for clinical relevance, 
etiology, symptoms, treatment and outcomes.  Ductal models have some relevance to gallstone 
disease, and none reproduce alcoholic pancreatitis. Nonetheless, the models of chronic pancreatitis 
are improving. 
 
1.6 HYPOTHESIS AND AIMS OF THIS THESIS 
 
The hypothesis tested was that different models of pancreatitis can be used to describe the processes 
of atrophy and regeneration in the pancreas.  
 
The specific aims of this study were:  
1. To investigate rat models of pancreatitis using caerulein, CHB and duct ligation;  
2. To validate a pancreatitis model with CHB in the mouse;  
3. To establish a canine model of pancreatitis with CHB;  
4. To compare and contrast the models with respect to: 
Stellate cells and the production of fibrosis   
The role of mast cells and macrophages 
The role of survivin in pancreatic regeneration 
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 INTRODUCTION 
 
This Chapter presents the general materials and methods for this thesis. More specific details are 
given in the original research Chapters (Chapters 3-6) for methods specific to those Chapters. 
 
2.2 STATEMENT OF ETHICS 
 
Animal experiments were performed under National Health and Medical Research Committee 
guidelines and approved by the University of Queensland Animal Ethics Committee prior to project 
commencement. Animals were closely monitored for clinical signs of pain and distress. Ethics 
approval numbers were PATH/527/97 (caerulein) and PATH/527/98 (rats with duct ligation); 
PATH/527/00 (rats with duct ligation with clips removed); PATH/QIMR/586/03 (CHB and duct 
ligation), PATH/457/04LF and PATH/725/05/LF (dogs); and PATH/102/04/PTPL (mice) 
 
2.3 MATERIALS 
 
All chemicals were of high purity and, unless otherwise indicated, were obtained from Sigma-Aldrich 
(St. Louis, MO, USA). Food for the rodent diet was from Specialty Feeds (Glen Forrest, Australia). 
 
2.4 ANIMALS, SOURCES, HOUSING AND CONDITIONS 
 
Randomly bred mature male Wistar or Sprague-Dawley rats, aged approximately 7-8 weeks and 
weighing 170-250gm were bred, supplied and housed by the Herston Medical Research Centre, 
Herston, Brisbane. Wistar rats were used for CHB experiments and Sprague-Dawley for caerulein 
and duct ligation experiments, based on the original models. CD1 Swiss outbred mice (20-35gm) 
were purchased from the Animal Resource Centre (ARC) Perth, transported by air and an air-
conditioned van then housed at the Herston Medical Research Centre. Randomly-bred dogs were 
obtained from Logan City Pound, transported by air-conditioned van and housed at the Herston 
Medical Research Centre. All of the above animals were acclimatised for one week before 
commencement of experiments. 
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Rats and mice were housed in standard stainless steel boxes. The animal house was maintained at 
21ºC ± 1ºC and supplied automatically with artificial light in a 12 hrs day/12 hrs night cycle. Animals 
were fed a standard pellet diet and were allowed free access to water. Environmental enrichment was 
provided in the form of shredded paper and cardboard rolls. Dogs were housed in pens that allowed 
social interaction. They were fed a normal dry dog food and had free access to water. Dogs were 
exercised in a free run on a daily basis. 
 
When tissues were to be fixed by immersion only, rats and mice were killed by CO2 asphyxiation or 
lethal dose of pentabarbitone sodium. When rats were perfused with solutions via the aorta the 
animals died during deep pentabarbitone anaesthesia. Dogs were euthanased by intravenous injection 
of pentabarbitone. Animal remains were disposed according to University of Queensland (UQ) 
regulations.  
 
Rats were divided randomly into three groups of four to six animals at each time point; normal 
animals not subjected to any experimental procedure; sham-operated animals subjected to the same 
procedures and handling as experimental animals but without caerulein, duct ligation or CHB, and 
experimental animals. Mice were divided into control sham and experimental animals. Dogs were 
experimental animals only; no control dogs were used in this experiment. Archival tissue from 
previous rat experiments by this and other researchers (with permission), as well as dog control tissue, 
liver and pancreas from the UQ Veterinary School, was accessed. A full necropsy was undertaken in 
one rat and mouse per experimental run and all dogs to assess the effect of the drugs in other organs. 
In rat, mouse and dog, pancreas and liver were the only organs affected.  
 
2.5 CAERULEIN MODEL 
 
Pancreatitis was induced in Sprague-Dawley rats using the method of Jurkowska et al (1992), by 
subcutaneous injection of caerulein (synthetic caerulein, C-9026, Sigma Chemical Co., St Louis, 
MO., USA), 24μg/kg, every 8 h for 2 days. The caerulein dose was dissolved in gelatine solution (G-
2625, Sigma Chemical Co) in the ratio 75% gelatine to 25% distilled water to prolong its absorption. 
The caerulein dose was determined by earlier trials as the least dose producing a relatively uniform 
but maximal pancreatic lesion. Sham control animals were subjected to the same procedures and 
handling as experimental animals, but with saline substituted for caerulein. Groups of 4 rats were 
assessed 8, 12, 16 hrs and 1, 2, 3, 4, 5, 6, 7 and 10 days after the first injection. After assessment of 
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the histology, the time points 2, 4, 7 and 10 days were chosen as representative time points for 
developments in the lesion. Additional pairs of rats were used for EM analyses.  
 
2.6 DUCT LIGATION MODEL 
 
Figure 2.1 gives a diagrammatical representation of duct ligation. Randomly bred adult male 
Sprague-Dawley rats weighing 190-210gms were anaesthetised with pentabarbitone sodium 
(60mg/mL) given intraperitoneally at a dose of 40mg/kg for early experiments and later as this regime 
was no longer considered as best practice with Ketamine 60mg/ml+ Rompun 20mg/ml. Analgesia 
with bupenorphine 0.1-0.5mg/kg sc. was administered to the rats for recovery. Partial ligation was 
performed through a left paramedian incision. The lienal pancreas was freed from the colonic 
mesentery, two clips (Hemoclip Pilling Weck Inc, Research Triangle Park, NC, USA) were clasped 
about the pancreas at the superior pole of the spleen after separation of splenic vessels. The abdominal 
wall was closed as a single layer with chromic catgut sutures (Ethicon G121, Ethnor Pty. Ltd., 
Sydney) and the skin closed with metal clips (Medicon, Germany). The whole procedure took 
approximately 10 minutes. Rats were euthanased at 1, 2, 3, 4, 5, 10, 12, 18 days following ligation. 
Sham controls were treated accordingly, the pancreas handled but not ligated. In an attempt to produce 
regeneration in the duct ligation model a further group of 15 rats were subjected to ligation of the 
pancreatic duct (as above) with one clip only. Atrophy was allowed to develop for 1 week, then under 
anaesthesia and analgesia (as before), a paramedian incision was made and the clip removed with 
care to not damage the surrounding tissue. The wound was closed the animals were allowed to recover 
and the pancreata harvested after 7 days.   
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Figure 2.1 Diagrammatical representation of duct ligation 
The technique of tying off the body of the pancreas, but not the splenic vessels close to the hilus of 
the spleen, avoids interference with biliary drainage, preserves the blood vessels, minimizes 
constitutional disturbance and leaves some pancreatic parenchyma as an internal control with 
retained organ function so that animal experiments may be extended. The lienal pancreas is freed 
from the colonic mesentery, and hemoclips are clasped about the pancreas at the superior pole of 
the spleen after separation of splenic vessels. 
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2.7 1-CYANO-2-HYDROXY-3-BUTENE (CHB) MODEL 
 
Synthetic racemic CHB was obtained from Research Directions, Brisbane, Australia. Adult male 
Wistar rats weighing 200-250gms were used. At time zero, test animals were injected subcutaneously 
with 150mg/kg of CHB mixed in 0.5ml sterile saline and sham controls were given 0.5ml sterile 
normal saline. Groups of 4 experimental and 2 control rats were euthanased 1, 2, 4, 5, 7, 10, 12, 14, 
16, 18, 28 days after the first dose. Pancreas was removed from all rats, liver was removed from 
selected rats.  
 
Adult mice between 27.0-34.5gms were randomly divided and housed in pairs. One pair used for 
sham control purposes was injected subcutaneously with 0.25ml normal saline. Experimental pairs 
of mice were injected subcutaneous doses of CHB starting at 70mg/kg through 90, 110, 150, 170, 
190, 210, 230, 250, 270, 290 and up to 310mg/kg. The dose increase was decided after review of 
histology of the previous dose pair. Euthanasia by carbon dioxide was performed 24 hrs later. 
Pancreas and liver were removed, a small piece of each placed in glutaraldehyde, some snap frozen 
in liquid nitrogen and the bulk placed in 4% buffered formalin. Three groups of eight mice were 
injected with a subcutaneous dose of 280mg/kg and one group euthanased at each time point of 12, 
18 and 24 hrs, liver and pancreas removed and processed as above. Four smaller CD1 Swiss mice of 
21 – 23 grams were given 280mg/kg subcutaneously and euthanased at 24 hrs, liver and pancreas 
removed and processed as above. This was performed to see whether some effect in mice was due to 
the adolescent status of the animals. Dogs (15-20kg) were given a pre-medication of 8mg of 
acepromazine and 8mg of methadone to induce drowsiness. CHB of the required dosage was placed 
in a 100ml bag of normal saline and infused intravenously over 15 minutes. Dosage for the first dog 
was commenced at 70mg/kg CHB and amended in subsequent dogs as required. Further intravenous 
Hartman’s solution was administered at the rate of one litre every 12 hrs. Blood was taken at regular 
intervals. Dogs were kept sedated and comfortable with regular acepromazine and methadone and 
with monitoring of behaviour and blood parameters. Dogs were killed at selected times as detailed in 
the appropriate chapter, necropsy was performed by a veterinary pathologist, pancreas and liver tissue 
removed and processed as above.  
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2.8 MICROSCOPY  
 
2.8.1 Light microscopy 
 
Pancreas for histological study was fixed in 4% formalin in phosphate buffered saline at pH 7.2, 
dehydrated in graded alcohols, cleared in xylene and embedded in paraffin wax. Four micron sections 
were cut by microtome onto glass slides and stained with haematoxylin and eosin (H&E). Specific 
stains are noted in chapters and methods for these are in Appendix 1. Sections were visualised under 
a Nikon Eclipse E800 microscope with lenses of x10, x20, x40 and x100 (oil). The microscope was 
fitted with a Nikon digital camera DXM 1200F. A graticule was used for counting cells in tissue 
sections. The total area of the graticule at x400 magnification measured 250µm2.  Each square of the 
grid measured 25 µm2. 
 
2.8.2 Frozen sections 
 
Small pieces of pancreas (1mm) were either placed into cryomatrix (OCT) and frozen on dry ice or 
small pieces were snap frozen in liquid nitrogen. Frozen sections (7µm) were cut onto glass slides on 
a Bright cryostat and fixed for 2.5 minutes in acetone. 
 
2.8.3 Electron microscopy 
 
Caerulein animals were deeply anaesthetised with intraperitoneal injections of pentabarbitone 
sodium. The abdomen was entered through a midline incision and a catheter (2mm outer diameter) 
was inserted into the abdominal aorta and secured using 6.0 silk (Ethicon, Ethnor Pty. Ltd., Sydney 
Australia) proximal to the coeliac artery. The ventricle was cut to allow free flow of the perfusing 
solutions. Fixation was carried out in sequence with 1) heparinised normal saline, 2) 1% 
paraformaldehyde and 1.2% glutaraldehyde in sodium cacodylate buffer and 3) 4% paraformaldehyde 
and 5% glutaraldehyde in sodium cacodylate buffer.220 Tissue from duct ligation and CHB animals 
was immersion fixed in 3% glutaraldehyde in 4% paraformaldehyde. In all models the pancreas was 
removed immediately, trimmed of fat and lymph nodes. Small pieces (1mm) were left in fresh fixative 
for 2 hrs. The tissue was post-fixed in Osmium Tetroxide, stained en bloc in 5% aqueous uranyl 
acetate, dehydrated through a series of graded alcohols, cleared in propylene oxide, and embedded in 
an Epon/Araldite mixture. Semithin sections (1µm) were cut on an ultratome V microtome and 
stained with toluidine blue for viewing. Ultrathin sections from selected areas were stained with lead 
citrate and examined with a JEOL-1200 EX11 electron microscope.  
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2.9 IMMUNOHISTOCHEMISTRY 
 
Heat antigen retrieval was performed in a decloaking chamber (Biocare Medical). Slides in 0.01M 
citric acid buffer pH6.0 or 0.001M Tris/EDTA buffer pH8.8 were subject to 5 minutes heat at 125ºC 
or 15 minutes heat at 105ºC respectively. After completion of the cool down cycle the container of 
slides was allowed to cool for a further 20 mins before transfer to Phosphate Buffered Saline. Enzyme 
pre-treatment consisted of prediluted Proteinase K (DAKO Corp., Carpinteria, California, USA.) or 
0.1% trypsin in 0.05M Tris buffered saline (TBS) with 0.1% calcium chloride. Endogenous 
peroxidase was inhibited by treating sections with 1% hydrogen peroxide and 0.1% sodium azide in 
Phosphate buffered saline (PBS). Non-specific antibody binding was inhibited by incubation with 
10% non-immune goat or donkey serum. Localization was demonstrated using peroxidase-labelled 
streptavidin biotin complex method (DAKO streptavidin AB Complex/Horseradish peroxidase 
(HRP) or DAKO Envision. Reactions were developed with 3,3'–diaminobenzidine tetrahydrochloride 
solution (DAB) (Zymed, San Francisco, California) or Vector VIP (SK-4600), Vector SG (SK-4700), 
Vector NovaRED (SK4800) peroxidase substrate kits (Vector laboratories, Inc. Burlingame, 
California, USA). Where double staining was performed with two mouse antibodies, Fab fragment 
was used after the first antibody. All sections were lightly counterstained with haematoxylin or 
nuclear fast red. Specificities of the antibodies used for identification was checked by inclusion of 
known positive control tissue (normal pancreas) in each run. Negative controls comprised test tissues 
without the addition of primary antibody. Antibodies used are detailed in Table 2.1.  
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Table 2.1   Antibodies for immunohistochemistry 
 
Primary 
Antibody 
Manufacturer Clone Antigen 
retrieval 
dilution 2° antibody 
α-amylase rabbit 
anti-human  
Sigma  Proteinase K 1:500 Jackson goat 
anti-rabbit 
Bax rabbit anti-
human 
Santa Cruz P-19 heat/citrate 1:100 Dako 
EnVision+ 
Bcl-xL rabbit 
anti-human 
Santa Cruz S-18 heat/EDTA 1:400 Dako 
EnVision+ 
caspase-3 rabbit 
anti-cleaved 
Cell signalling ASP-175 heat/EDTA 1:100 Dako 
EnVision+ 
CD68 mouse 
anti-human 
Dako PG-M1 heat/citrate 1:100 Dako 
EnVision+ 
CD117/c-kit 
rabbit poly 
Dako   heat/EDTA 1:600 Mach 1 
universal 
HRP kit 
Cytokeratin 
mouse anti-
human 
Dako AE1/AE3 Proteinase K 1:40 Jackson rat 
anti-mouse 
glucagon porcine 
anti-human 
Novocastra  Proteinase K 1:100 Dako 
EnVision+ 
Laminin 1+2 
Rabbit poly 
Abcam  chymotrypsin 1:300 mach 
PCNA anti-
mouse 
Calbiochem AB-1 HCl 0.2N  1:50 Dako 
EnVision+ 
αSMA mouse 
anti-human 
Sigma 1A4 no AR 1:250 Dako 
EnVision+ 
Survivin, rabbit 
anti-human  
 
Cell Signaling 
Technology 
71G4 heat/EDTA 1:50 Dako 
EnVision+ 
Survivin rabbit 
anti-human 
Novus 
Biologicals 
 heat/EDTA 1:150 Dako 
EnVision+ 
 
 
 
2.10 DIGITAL CAPTURE AND ANALYSIS FOR FIBROSIS AND STELLATE CELLS 
 
Figures 2.2 and 2.3 demonstrate some methods for digital capture of images. 
 
Semi-quantitative analysis of sections stained for Puchtler’s picro-sirius red and αSMA expression 
was performed. Sections were captured with a spot RT slider cooled CCD camera as digital images. 
Ten fields of 50μm2 from each slide were captured and variability associated with the light source 
was avoided by photographing all slides on the same day with the same settings. In particular, each 
field targeted a tubular complex or acinar cells, rather than interstitial areas, blood vessels, or large 
ducts. 
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ImagePro Plus® image analysis software was used to analyse image morphometry. This programme 
was adjusted to automatically calculate the area in square microns of defined stained proteins (as 
pixels) in each section. To define the pixels counted, coloured area ranges were selected that, through 
trial and error, selected a consistent intensity of the chosen colour, for example, in the fibrosis study 
the red of collagen staining; in the stellate cell study the brown of DAB, staining αSMA. The 
programme calculated ratios for each field and the average and standard error of the mean (SEM) 
were calculated for each time point in each animal model.  
 
 
  
 
Figure 2.2 Captured screen of ImagePro Plus® image analysis software for αSMA IHC 
Screen capture shows selected area on α-smooth muscle actin (αSMA) stained section (A) and 
corresponding calculated area of defined stained proteins for the brown pixels of αSMA staining 
(B), bright field image.  
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Figure 2.3 Captured screen of ImagePro Plus® image analysis software for fibrosis 
Screen capture shows selected area on Sirius Red sections (A, C, E) and corresponding calculated 
area under different filters of defined stained proteins for Sirius Red pixels of (B) red (D) yellow/red 
and (F) green. A,B bright field images, (B) shows area of collagen deposition; C-F polarised light 
images discriminates and shows area of collagen III (D) and area of collagen I (F).  
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2.11 CELL DEATH AND PROLIFERATION  
 
Apoptosis was identified using morphological criteria.221 Immunoperoxidase stains for amylase were 
used to confirm residual intact acinar cells, which were otherwise difficult to identify. The following 
criteria were used to identify apoptosis in H&E sections; a single condensed cell or large single 
apoptotic body with typically marginated nuclear chromatin was given a single count; many apoptotic 
bodies clustered together were given a single count; any doubtful cells were disregarded. Necrosis 
was identified by cell swelling, mitochondrial swelling, lysosomal rupture, and plasma membrane 
rupture. The morphological characteristics used to distinguish mitosis were (i) formation of mitotic 
spindles occurring during metaphase and remaining visible in anaphase, or (ii) cells in the later stages 
of mitosis, telophase or undergoing cytokinesis. Cell senescence was approximated morphologically 
by the presence of large cells, at least 3-4 times the diameter of non-senescing cells. 
 
2.12 STATISTICS 
 
Values reported are mean ± standard error of the mean (SEM). Where indicated, data were analysed 
using one-way analysis of variance (ANOVA) and Tukey’s post hoc analysis. Significance was 
established at P < 0.05. 
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CHAPTER 3 
RAT MODELS OF PANCREATITIS 
 
3.1 INTRODUCTION  
 
We do not yet fully understand the complex interactions that comprise human pancreatitis. The 
current animal models are not comparable to the full spectrum and complexity of the human disease. 
In human pancreatitis, when acinar cells die by any cause they either regenerate or are followed by a 
progressive and gradual replacement of the glandular tissue with fibrosis. In order to study 
regeneration after pancreatitis I sought to use a model where the pancreatitis was severe enough to 
cause loss of acinar cells and production of a fibrotic infiltrate, though still mild enough that the 
pancreas could regenerate partially or fully. Three models that were standardized and fitted with this 
criteria were caerulein, CHB and duct ligation. They all have apoptosis as the mode of cell death to 
satisfy the interpretation of mild pancreatitis. They all develop fibrosis and considerable inflammatory 
infiltrate. The interesting factor is that they differ in regenerative ability which allows comparison of 
their outcomes. The caerulein model regenerates readily and fully; the CHB model regenerates 
partially but does not proceed; the duct ligation model does not regenerate at all. As no one model 
would be expected to be more suitable than another to answer specific questions these three rat models 
appeared to be a good compromise for a comparable study of the cellular interactions that occur in 
regeneration from pancreatitis. The three rat models, caerulein, CHB and duct ligation were chosen 
because of our expertise in all models, and the facilities available to produce all models. These were 
ethically acceptable, minimally invasive techniques with low morbidity and no procedural mortality.  
 
3.1.1 Aim 
 
The overall aim of this Chapter was to develop, reproducibly, a mild pancreatitis with fibrosis using 
three rat models, caerulein, CHB, duct ligation and to investigate patterns of cell death and 
regeneration.  
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3.2 MATERIALS AND METHODS 
 
General materials and methods can be found in Chapter 2. Aspects of the three models have been 
described previously by this student, her PhD advisors and colleagues.105, 216, 222 Some results for early 
time points were developed from review of available archival tissue from these studies. 
 
A separate experiment was attempted with the duct ligation model to see if regeneration of acinar 
tissue could be achieved. This regeneration experiment, with rats subjected to duct ligation, clipped 
with one clip and the clip removed after one week, was abandoned. There was difficulty locating the 
clip after the first week due to adhesions and inflammation around the clip. Furthermore, the clip was 
difficult to remove without causing damage to the surrounding tissue. Whilst the distal pancreas of 
rats clipped with two clips was consistently atrophic, the pancreas of rats in trials with one clip showed 
variable results. Therefore, it was difficult to be certain whether the partial regeneration seen after the 
clip was removed and the pancreas allowed to recover for 7 days was due to actual regeneration or 
incomplete atrophy, or in cases where regeneration did not occur, whether this was due to the 
pancreatic duct being irretrievably damaged and failing to reopen.  
 
3.3 RESULTS 
 
3.3.1 Control  
 
Pancreas from control rats appeared normal with widely spaced ducts and islets separated by closely 
packed acinar cells. Acinar cells have basophilic cytoplasm at their base due to a high content of RNA 
and the presence of nuclei. The apical cytoplasm is eosinophilic due to the high content of zymogen 
granules. The lobules are closely aligned, separated by narrow interlobular spaces (Figure 3.1A). 
High power clearly shows the centroacinar cell and intercalated duct cell at the beginning of the ductal 
system (Figure 3.1B). Immunohistochemistry for cytokeratin demonstrates the spacing of the ducts 
in normal pancreas (Figure 3.1 C).  
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Figure 3.1 Control rat pancreas, light microscopy 
A. Normal pancreas with islet and closely packed acini. Acinar cell cytoplasm is basophilic at base 
due to the staining of the nucleus and eosinophilic at apex due to the staining of zymogen granules. 
Intralobular duct (long arrow), The lobules are closely aligned, interlobular space (short arrows). 
H&E x200. B. High power of an acinus (dotted lines) shows a typical rounded acinus with several 
acinar cells surrounding a lumen. The beginning of the duct system at the lumen, shows a centroacinar 
cell nucleus (arrow) next to the nucleus of an intercalated duct cell. The islet is easily identified by 
paler cytoplasm and pale nuclei. H&E magnified to x1200. C. Normal spacing of ducts stained for 
cytokeratin immunohistochemistry (brown), haematoxylin counterstain. 
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EM demonstrated the polarised arrangement of organelles in the acinar cell. A whole acinus with 
round nuclei arranged around a central lumen and distinctly electron dense apical zymogen granules 
is shown (Figure 3.2A). Microvilli protrude from the luminal surface and zonulae occlendentes seal 
the cells at the lumen (Figure 3.2B). A basal view of the acinar cells show prominent RER and 
mitochondria, lysosomal bodies, interdigitations in the lateral space between cells, and BM closely 
aligned with the cell surface (Figure 3.2C,D). Duct cell nuclei are elongated and indented. Compared 
with acinar cells there are fewer mitochondria and RER (Figure 3.3A). Blebs on the surface of the 
cells and lateral interdigitations are common on intralobular ducts (Figure 3.3B). Figure 3.3C shows 
the start of the ductal system within the acinus. Centroacinar cells are smaller than acinar cells with 
fewer organelles and no zymogen granules (Figure 3.3C). Cilia are seen randomly projecting into 
the ductal lumen (Figure 3.3D). 
 
3.3.2 Experimental results from three models  
 
From 2 hrs in the models CHB and duct ligation (tissue distal to the ligature), and 6 hrs in the caerulein 
model, secretion leaked from lumens into intercellular and interstitial spaces. Oedema persisted for 
48 hrs in CHB and duct ligation, less in caerulein. By 24 hrs all models had a cellular infiltration of 
mononuclear cells, fibroblasts and a moderate number of neutrophils. Acinar lumens began to extend. 
Apoptosis was the mode of acinar cell death in all models. Apoptotic nuclei were seen as pyknotic, 
condensed, rounded nuclei sometimes lying within cleared spaces or fragmented nuclei in 
eosinophilic or basophilic apoptotic bodies in H&E sections. Almost every acinus in the caerulein 
and duct ligation models had one or two apoptotic cells however in contrast in the CHB model, 
apoptosis was massive and synchronous with every cell affected (Figures 3.4A-C). In the EM images 
dilatation of RER and vacuoles were prominent early features of acinar cells with convolution of the 
cell membrane. There was disruption of junctional complexes between adjacent acinar cells. 
Zymogen granules discharged into increasingly dilated acinar lumens. Apoptotic cells were easily 
identified by their sharply demarcated condensation of chromatin against the nuclear envelope, with 
convolution of the nuclear outline, cell shrinkage and nuclear fragmentation to form apoptotic bodies 
(Figures 3.4 D-F). The apoptotic bodies contained pyknotic nuclear chromatin, intact or partially 
degraded zymogen granules, RER and mitochondria and later amorphous material and myelin figures.  
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Figure 3.2 Electron microscopy of control rat pancreas with focus on acini  
A. Control acinus. Note the pyramidal shaped acinar cells around a central lumen. The round nuclei 
are typically basal and apical electron dense zymogen granules congregate at the luminal pole. 
L=lumen. Electron microscopy (EM) x2000. B. High power of an acinar lumen with microvilli jutting 
into the luminal space. Zonulae occludentes form firm closures at the lumen to prevent unregulated 
release of zymogen granules (white arrows). Zymogen granules close to the lumen are ready for 
release ZG = zymogen granule EM x20000. C. Basal end of acinus. Interdigitations (long arrows) 
line the spaces between acinar cells, desmosome holds the acinar cells together (thin arrow), normal 
thin basement membrane (short arrow), lysosomal body (white arrow), rough endoplasmic 
reticulum=RER, mitochondria=M. EM x10000. D. High magnification of C showing the normal 
extent of basement membrane (arrow). Some collagen deposits are free in the intra-acinar space.  
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Figure 3.3 Electron microscopy of control rat pancreas with a focus on ducts 
A. Intralobular Duct. Indented, elongated nuclei. F=fibroblast with a little collagen deposition. EM 
x5000. B. Magnification of A, with interdigitations on lateral membranes (white arrows), and 
basement membrane (black arrow). Electron microscopy (EM) x15000. C. Start of ductal system in 
acinus. CA=centroacinar cell, D= intercalated duct cell, N= nucleus, nucl= nucleolus, 
M=mitochondria, star =lumen. X4000. D. Cilia at lumen of interlobular duct. EM x 30000. 
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Figure 3.4 Apoptosis of pancreatic acinar cells in rat models 
A. Caerulein at 24 hrs. Acinar cells undergo apoptosis as tubular complexes form. The inflammatory 
infiltrate is well advanced so that acini have lost adhesion to their neighbours. Haematoxylin and 
eosin (H&E) x400. B. CHB at 12 hrs. Apoptosis is present in most acinar cells in this model compared 
with only some to several in each acini of the other two models. The inflammatory infiltrate is not 
yet activated. H&E x400, insert x1000. C. Duct ligation at 24 hrs is similar to the caerulein model, 
H&E x400. D. Caerulein at 24 hrs, electron microscopy (EM) x 3000. E. CHB at 12 hrs EM x2500. 
F. Duct ligation at 24 hrs EM x4000. Figures A-C, short arrows show apoptotic nuclei, long arrows 
inflammatory infiltrate. Figures D-F, A=apoptotic nuclei, note crescent shaped chromatin. N=normal 
nucleus, arrows =zymogen granules; star=whorled rough endoplasmic reticulum; cp = capillary. 
51 
 
In the caerulein model, acinar cell apoptosis (Figure 3.5A) peaked at 3 days with a rapid reduction 
in acinar cell numbers, and by 4 days, few recognizable acinar cells remained. Similarly, by the 5th 
day in the duct ligation model all acini had disappeared. In contrast, in the CHB model, apoptosis was 
evident at 6 hrs and by 18 hrs almost all acinar cells had chromatin changes of apoptosis but also 
swollen vacuolated cytoplasm indicative of ‘secondary necrosis’ which subsequently progressed 
(Figure 3.5B,C). By 4 days no acinar cells remained.   
 
 
 
Figure 3.5 Typical apoptotic body and secondary necrosis in rat models 
A. Electron microscopy (EM) of apoptotic body in duct ligation at 60 hrs. Note the condensed nuclear 
chromatin, multiple nuclear fragments within an apoptotic body becoming free from the surrounding 
cytoplasm, zymogen granules of varying size, many reduced in size, and whorling RER. Autophagic 
vacuoles are seen within the cytoplasm as are adjacent viable acinar nuclei.  V=vacuole, 
arrows=zymogen granules of varying size, Star=whorled rough endoplasmic reticulum. B. 24 hrs 
after CHB massive apoptosis overwhelms the tissue until it appears degraded with both distended and 
condensed cytoplasm, however viable cells remain. Stars = degraded cytoplasm, arrows = viable 
cytoplasm. Haematoxylin and eosin x400. C. 18 hrs after CHB, stars = necrotic cytoplasm, black 
arrows = viable cells, white arrows = apoptotic bodies. EM x2000.  
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Apoptotic bodies were in the epithelium, in acinar lumens, free within the interstitium or 
phagocytosed within macrophages. In the CHB model, as apoptosis was a synchronous event, 
apoptotic bodies did not appear to be ingested by adjoining epithelial cells as in the other two models. 
The residual acinar tissue was mopped up predominantly by macrophages.  Macrophage numbers 
were greatly increased in all models compared to controls (Figure 3.6). The macrophage results are 
expanded on in Chapter 4.  
 
As a result of the depletion of acinar cells, lobules were rapidly converted into small groups of duct-
like cells forming tubular complexes (Figure 3.7). Tubular complexes were well established by 2 
days in the caerulein model, by 4 days in the CHB and duct ligation models. The lobules and tubular 
complexes within them were separated by fibrosis and a persistent mononuclear inflammatory cell 
infiltrate (Figure 3.7A-C). Tubular complexes stained positive for cytokeratin confirming their ductal 
origin. Amylase immunohistochemistry indicated the few acinar cells or acinar debris remaining 
(Figure 3.7D-F). In the caerulein model particularly, as tubular complexes formed, residual acinar 
debris and duct cells coexisted (Figure 3.7D). The tubular complexes had distended lumens lined by 
flattened epithelial cells with the appearance of duct cells (Figures 3.8A-F). Mitoses were rarely seen 
in control sections but considerable numbers of  cells lining tubular complexes showed mitotic 
activity by 2 days in all models (Figure 3.8E).  
 
In the caerulein model, at 3-5 days clustered regenerative acinar cells in demilunes could be seen 
arising from tubular complexes and contained sparse small luminal zymogen granules (Figure 3.9A-
c). Occasional cells were difficult to identify as ductal or acinar. Cytokeratin and amylase double 
staining showed clustered amylase positive cells around lightly stained brown tubular complexes 
(Figure 3.9C). Tubular complexes gave rise to islet cells with increased frequency (Figure 3.9D). 
By days 7-10 acinar cell mitoses were conspicuous, tubular complexes disappeared (Figure 3.9F). 
By day 10 the lobular architecture had returned to a near normal appearance though mild fibrosis and 
a mild patchy inflammatory infiltrate persisted. 
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Figure 3.6 Macrophage or adjacent epithelial cell removal of apoptotic bodies in rat models 
A. Caerulein 24 hrs, B. CHB 48 hrs, C. Duct ligation 48 hrs, all CD68 immunohistochemistry x 400, 
shows the extent of macrophage migration into the pancreas of each model. D. Caerulein day 4, 
apoptotic bodies being engulfed by a macrophage. Electron microscopy (EM) x 5000. E. CHB 48 hrs 
with secondary necrosis within a macrophage. EM x 4000. F. Duct ligation 60 hrs, apoptotic bodies 
were also engulfed by adjacent epithelial cells seen in this forming tubular complex with extended 
lumen and a viable acinar nucleus at the bottom of the complex. EM x2500 
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Figure 3.7 Acinar atrophy in rat models 
A. Caerulein, day 2. B. CHB, day 3. C. Duct ligation, day 3.These micrographs show the parenchyma 
devoid of, or with few, acinar cells in all models. Tubular complexes fill the lobules which are 
surrounded by inflammatory infiltrate. All haematoxylin and eosin x 200. D. Caerulein, day 2, tubular 
complexes brown, acinar tissue purple indicate that most of the cells are ductal with only small 
residual acinar cells present, Immunohistochemistry for amylase (purple) and cytokeratin (brown) 
x400. E. CHB, day 3, residual acinar material is sparse amongst tubular complexes. Insert= residual 
acinar material lying in the lumen of a tubular complex. IHC for amylase (brown). x400, insert x1000. 
F. Duct ligation, day 4. Tubular complexes shown by IHC for cytokeratin (brown) are all that remain 
in the duct ligation model. x400. D-F counterstain is haematoxylin. 
55 
 
 
 
Figure 3.8 Tubular complexes in rat models 
A. Caerulein, 36 hrs. B. CHB, day 5. C. Duct ligation, day 3. All toluidine blue stained semi-thin 
epoxy resin sections. Note the large lumens and flattened cells of the tubular complexes, surrounded 
by inflammatory infiltrate. In A, a tubular cell merges with a normal elongated duct and some dark 
condensed acinar material remains. All x1000.  Electron microscopy (EM) is presented in D-E. D. 
Caerulein, day 2. E. CHB, day 3. F. Duct ligation, day 3. D shows tubular complexes forming with 
residual acinar debris and duct cells (arrows). E. shows mitosis in a ductal cell (Mit). F depicts a 
formed tubular complex next to one still forming with inclusions of residual material. D.= x2000, E 
and F. = x2500. 
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Figure 3.9 Regeneration in the caerulein model 
A. Caerulein day 5, scattered regenerative acini are prominent because of eosinophilic cytoplasm and 
intense staining nuclei (arrow) in a lobule with residual tubular complexes and islet tissue. 
Haematoxylin and eosin (H&E), x400. B. Caerulein day 3, acinar cells regenerating in demi-lunes 
from tubular complexes was a particular feature of the caerulein model (arrows).Toluidine blue semi-
thin epoxy resin, x1000. C. Caerulein day 4, acinar regeneration and proliferation. This particular 
staining combination highlights the zymogen granules with amylase content and the extent of cycling 
cells in regenerating acini, immunohistochemistry for amylase (pink) and proliferating cell nuclear 
antigen (PCNA) (brown), counterstain haematoxylin. x400. D. Caerulein day 4, an example of acinar 
cell regeneration (arrow), erupting from a tubular complex with its large elongated nuclei. Islet cell 
regeneration was a prominent feature in tubular complexes in this model. TC=tubular complex, 
cp=capillary, star=islet cell regeneration. Electron micrograph, x2500. E. Caerulein day 7, lobule 
almost fully regenerated with acini. H&E, x200. F. Caerulein day 10, regeneration varied between 
lobules and by day 10 considerable inflammatory infiltrate remained around some acinar lobules. 
x400. 
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In the CHB model, small numbers of apoptotic bodies continued to be seen within duct lumens and 
epithelium and by day 7 tubular complexes had larger lumens and flattened lining epithelial cells. 
Collagen was deposited both in and around lobules. Regenerative islands of acini appeared by 10 
days but these were few and did not increase significantly in size or number (Figure 3.10A-F). The 
regenerative acinar cells displayed both mitosis and apoptosis (Figure 3.10B). Apoptosis was seen in 
the duct cells lining tubular complexes (Figure 3.10E) and the number of tubular complexes 
decreased with fewer remaining at 18 and 28 days. By 28 days the pancreas comprised largely fat, 
collagen, islets, blood vessels and nerves. 
 
The duct ligation model followed a similar progression initially (Figure 3.11A-F). By day 7 and up 
to day 18 lobules consisted of tubular complexes within a collagenous stroma. The tubular complexes 
were mostly smaller and more crowded than in the CHB and caerulein models. No regenerative acini 
were seen in this experiment except for a few sparse cells closely aligned with the ligature clips. 
Thickened basal lamina, and fibroblasts remained in the stroma with considerable adipose tissue 
around lobules.  
 
3.3.2.1 Apoptosis counts  
 
Figure 3.12 demonstrates mean ± SEM of counts of apoptosis for the three models over time points 
to 7 days. Compared with untreated controls (Time 0) where negligible apoptosis was found, all 
models had significantly increased apoptosis, but at varying periods of time after the cause of 
pancreatitis. The CHB model had massive apoptosis over 12 hrs, 1 and 2 days but this disappeared 
from 3 days where all acinar cells have disappeared through phagocytosis. While caerulein and duct 
ligation had a much lesser incidence of apoptosis compared with CHB, the incidence in caerulein was 
visible to 3-4 days, and the incidence with duct ligation to 5 days. Figure 3.13 presents counts of cell 
proliferation using PCNA IHC. The graphs demonstrate the expected pattern of cycling cells. In the 
caerulein model, acinar cells were regenerating until experimental end at 10 days. The CHB model 
had duct cell regeneration up to 12 days when acinar cell regeneration started then declined by end 
of experiment. With the duct ligation model, duct cells were proliferating from 3 days to end of 
experiment at 18 days, with decreasing incidence from day 12. 
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Figure 3.10 Regeneration in the CHB model 
A. CHB day 10, small clusters of acinar cells with eosinophilic zymogen granules and intense purple 
nuclei stand out amongst residual tubular complex cells, arrow =mitosis. Haematoxylin and eosin 
(H&E) x 400. B. CHB day 12, Many of the regenerative acini at this time point are undergoing 
apoptosis at the same time as the acini are regenerating (arrows). The insert depicts a typical 
regenerating acinus with eosinophilic luminal cytoplasm and intensely stained nuclei as well as 
apoptotic nuclei, H&E x 400, insert x1000. C. CHB day 16, complete acinus on edge of lobule. 
Regenerating acini were often closely aligned with adipocyte formation. A=adipocyte. Toluidine blue 
semi-thin epoxy resin, x1000. D. CHB day 7, cycling cells were prominent both in tubular complexes 
(black arrow) and acinar cells (white arrow). Proliferating cell nuclear antigen (PCNA) 
immunohistochemistry x400. E. CHB day 7, apoptosis was often quite extensive in tubular complexes 
(black arrows). H&E x1000. F. CHB day 18, acinus with large autophagic vacuoles (arrows) indicates 
that these cells may be undergoing damage. Electron microscopy x2500. 
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Figure 3.11 Regeneration in the duct ligation model 
A. Duct ligation day 12, tubular complexes identified by their large lumens fill the tissue. No acinar 
cells can be seen. Haematoxylin and eosin (H&E) x200. B. Duct ligation day 10, apoptosis (arrows) 
in tubular complexes. The fibrous inflammatory infiltrate is prominent H&E x1000. C. Duct ligation, 
tubular complexes and fibrotic infiltrate remain, Toluidine blue x400. D. Duct ligation day 18, cycling 
cells are prominent in the tubular complexes. Proliferating cell nuclear antigen (PCNA) 
immunohistochemistry (IHC) x 200. E. Duct ligation day 16, large ducts also show increased cycling, 
interlobular duct. PCNA IHC x200. F. Duct ligation day 18, tubular complex with extended lumen 
and flattened, elongated lining cells. The inflammatory infiltrate is closely packed with collagen 
deposition stellate cells and macrophages. Stellate cells are also closely aligned with the tubular 
complex. Toluidine blue x1500 
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Figure 3.12 Mean ± SEM of counts of apoptosis for the three models 
Apoptosis was counted in 10 random fields at x400 magnification of one 4µm thick section of whole 
pancreas per rat per time point. Data are the mean ± SEM of four rats (n=4) per time point from one 
experiment per model. Compared with untreated controls (Time 0) where negligible apoptosis was 
found, all models had significantly increased apoptosis, but at varying periods of time after the cause 
of pancreatitis. The CHB model had massive apoptosis over 12 hrs, 1 and 2 days but this disappeared 
from 3 days. While caerulein and duct ligation had a much lesser incidence of apoptosis compared 
with CHB, the incidence in caerulein was visible to 3-4 days, and the incidence with duct ligation to 
5 days (barely visible on graph). One way ANOVA was used to compare apoptosis counts between 
the experimental groups. Tukey’s multiple comparison test was used to compare individual groups. 
Apoptosis counts were significantly higher than controls in the caerulein, CHB and duct ligation 
models at days 1-2 (P=0.0002, P<0.0001, P<0.0001, respectively) and day 4 (P<0.0001, P<0.0001, 
P<0.0001, respectively).  
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Figure 3.13 Mean ± SEM of cell proliferation measured by PCNA immunohistochemistry 
Single nuclei stained for PCNA were counted in five to ten random fields at x200 magnification of 
one 4µm thick section of whole pancreas per rat (n=4) per time point. The number of fields counted 
varied with regard to reduced parenchyma at atrophic time points. Data are the mean ± standard error 
of the mean (SEM) of four rats (n=4) per time point for one experiment per model. Error bars 
represent the SEM. The graphs demonstrate cells that are undergoing cycling. In the caerulein model, 
acinar cells were regenerating until experimental end at 10 days. The CHB model had duct cell 
regeneration up to 12 days when acinar cell regeneration started then declined by end of experiment. 
With the duct ligation model, duct cells were proliferating from 3 days to end of experiment at 18 
days, with decreasing incidence from day 12. One way ANOVA was used to compare PCNA 
expression in control groups versus experimental groups. Tukey’s multiple comparison test was used 
to compare individual groups. PCNA expression in the caerulein, CHB and duct ligation models was 
significantly higher than controls at days 2, 4 and 7 (day 2, P<0.0001, P<0.0001, P<0.0004, 
respectively; day 4, P<0.0001, P<0.0001 P<0.0001, respectively; and day 7, P<0.0001 P<0.0001, 
P<0.0001, respectively). 
62 
 
3.4 DISCUSSION 
 
This chapter shows the results of three models of pancreatitis produced experimentally in rats to 
understand the pathology and the cell biological and pathophysiological disease mechanisms and, 
eventually, as a step towards developing targeted therapies. The rat models were developed to reflect 
specific changes of human acute and chronic pancreatitis. Data relating to the molecular mechanisms 
of the disease are presented in later Chapters.  
 
Although the timelines differed slightly, the models of caerulein, CHB and duct ligation successfully 
produced a mild pancreatitis with the mode of cell death as apoptosis. This was followed by fibrosis 
deposition with inflammatory cells prominent and differences in regeneration. Pancreatic atrophy in 
the caerulein model occurred randomly. In all rats the whole pancreas and every lobule was disturbed 
however there was considerable variation between the lobules from partial to complete atrophy that 
also varied between animals. In every rat pancreas there remained some viable acini. Loss of acinar 
cells by apoptosis, generation of tubular complexes, loss of tubular complexes and regeneration of 
acinar cells proceeded in concert. In the CHB model there was consistency between animals and the 
whole process seemed sequential. Acinar cells appeared to be completely absent from the lobules 
following apoptosis and re-emerged as small islands of regeneration later amongst tubular complexes. 
Compared with the caerulein model this was a slower process and regenerative acini in general often 
had a different appearance. In H&E sections the nuclei were larger and the cytoplasm was more 
intensely coloured as if the acinar cells were forming. Apoptosis occurred in the duct ligation model 
in a similar manner to caerulein, with one to several apoptotic cells visible in each acinus at any one 
time. However, in this case all of the acinar cells disappeared and no regenerating acini were seen. 
Tubular complexes were the only epithelia that remained in the fibrotic stroma. These models produce 
a mild pancreatitis with loss of acinar tissue. The inflammatory infiltrate proceeds to the deposition 
of fibrosis as may occur in humans. It is vitally important to elucidate the processes that lead to 
successful regeneration after fibrotic deposition in pancreatitis. 
 
Most current knowledge of the pathogenesis of pancreatitis comes from animal studies as the human 
pancreas is relatively inaccessible especially in the early stages of the disease. Commonly used animal 
models focus on rodents and although widely used they have failed to produce noticeable clinical 
benefits. No model fully reproduces the human disease and each model has its advantages and 
disadvantages. Shortcomings aside, animal models are necessary for understanding the 
pathophysiology of this disease. It is unclear and possibly questionable if caerulein and CHB are 
clinically relevant stimulants in humans though the duct ligation model mimics gallstone obstruction 
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pancreatitis. The question addressed is of importance and in this case the generic models allow the 
study of specific elements common to the pancreatic disease. By comparing more than one model 
and the mechanisms by which they differ this analysis will progress our understanding of pancreatitis. 
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CHAPTER 4 
FIBROSIS IN RAT PANCREATITIS 
 
4.1 INTRODUCTION 
 
Pancreatic fibrosis is a characteristic histopathological feature of many types of human pancreatitis 
including alcoholic, hereditary, autoimmune, idiopathic and tropical and obstructive chronic 
pancreatitis where it deposits in interlobular and periductal spaces.7 It is typified by proliferation of 
connective tissue consisting mostly of densely packed ECM. Initially, pancreatic injury which 
involves the interstitial mesenchymal cells, the duct or the acinar cells leads to necrosis or apoptosis 
of parenchymal cells. These death processes, and immigrating inflammatory cells, release cytokines, 
growth factors and chemokines which in turn stimulate pro-fibrotic stellate cells of the pancreas 
(PSC) to activate, proliferate and migrate to the area of injury.223 Activated PSC synthesise significant 
amounts of ECM, in particular collagens that are deposited in interstitial spaces.135 In normal 
pancreas, quiescent PSC are in low numbers, possess vitamin A containing fat droplets and stain 
negative for αSMA. When activated, they lose the lipid droplets, enlarge and proliferate and stain 
positive for αSMA. They then increase secretion of ECM including collagens I and III and laminin, 
under the influence of molecular signalling pathways and cytokines released from recruited 
inflammatory cells.130 In pancreatic pathology, the normal cell populations may be replaced by 
fibrosis, leading to both exocrine and endocrine deficiency. Accumulation of matrix leading to 
pancreatic fibrosis depends on an imbalance between ECM synthesis and degradation. PSC regulate 
this balance, however the role of other inflammatory cells such as macrophages and mast cells is not 
clear. As the three rat models of pancreatitis developed fibrosis and underwent different regenerative 
outcomes (Chapter 3), they have the potential to provide a good basis for comparison of the 
interactions between fibrosis and regeneration in pancreatitis.  
 
4.1.1 Aim  
 
The aim of this Chapter was to determine whether fibrosis in the three models of pancreatitis in rats 
followed a similar course with respect to inflammatory cell populations. The interaction of the PSC 
and other inflammatory cells (macrophages, mast cells) in the process of initiating, maintaining and 
degrading fibrosis was of particular interest.  
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4.2 MATERIALS AND METHODS 
 
General materials and methods for this Chapter can be found in Chapter 2. Collagen stained 
histochemically by Puchtler’s Sirius red (Appendix 1) was compared with an objective and 
quantitative scoring system of digital capture and image analysis of the histopathology. Comparison 
of collagen I and III was achieved by using a polarizing filter to visualise the birefringent collagen. 
Activated PSCs, mast cells and macrophages were identified by light and EM and IHC. 
 
4.3 RESULTS – FIBROSIS AND STELLATE CELLS IN PANCREATITIS  
 
4.3.1 Control pancreas for fibrosis studies 
 
In the normal pancreas, the exocrine lobules are delineated by a thin line of connective tissue in the 
interlobular space and around ducts and blood vessels (Figure 4.1A). At a higher power the small 
amount of collagen was evident in the space between an intralobular duct and an acinus. The BM was 
closely attached to the cells (Figure 4.1B). 
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Figure 4.1 Fibrosis in the control rat pancreas 
A. Collagen is indicated by the red staining of Puchtler’s Sirius red. It shows fine threads of collagen 
in between acini and delineates the lobules which are closely aligned. Interlobular connective tissue 
(white arrows), blood vessels (black arrows). Red = collagen, yellow = parenchyma; Puchtler’s Sirius 
red x400. B. Acinus and intralobular duct with small amounts of deposited collagen in the interstitial 
space. The basement membrane is a thin line along the extremities of the cells. Arrows = basement 
membrane. Electron microscopy x15000. 
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4.3.2 Fibrosis in the rat models 
 
The different timelines demonstrated in the photomicrographs of Figure 4.2 are used for specific 
features and as a comparison of fibrosis development in the different models. Figures 4.2A-I show 
the progression of fibrotic deposition through the course of the pancreatitis.  
 
The increase in deposition of collagen occurred earlier in the caerulein model. Apoptotic acini were 
clearly delineated by fine strands of collagen as early as day 1 whereas in the CHB and duct ligation 
models at days 2-3 oedema was present and fibrosis was limited to wispy intralobular strands and 
intralobular ducts (Figures 4.2A-C).  
 
By days 4-5, the caerulein model had reached the peak of fibrosis. Tubular complexes were 
surrounded by distinct wavy collagen, collagen was dense around intralobular ducts and ample in 
intralobular areas, wispy in interlobular areas (Figure 4.2D). By day 7 in the caerulein model, when 
acinar regeneration was widespread, collagen deposition was partially but not totally resolved. 
Collagen deposition was thin around newly formed acini but remained as wavy, thick strands in 
intralobular spaces and surrounding intralobular ducts (Figure 4.2G). 
 
By day 4 in the CHB model and day 7 in the duct ligation model, collagen deposition was 
approximately similar to that of the caerulein model (Figures 4.2E,F). In all models, the islets and 
nerves were surrounded by collagen but not infiltrated by collagen. Blood vessels were surrounded 
by dense collagen. From these times, collagen deposition in the CHB and duct ligation models 
increased in quantity and in density with thick, solid deposits around the tubular complexes and thick 
and wavy strands around intralobular ducts and in interlobular spaces (Figures 4.2H,I).  
 
The collagen deposition remained around tubular complexes and interstitial areas in both CHB and 
duct ligation models until the end of the experiments. In the CHB model, where there was 
regeneration, fibrosis was sparse around the acinar bundles.  
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Figure 4.2 Collagen deposition in the rat models  
Images show the deposition of fibrosis as collagen by Puchtler’s Sirius red histochemistry. Collagen 
production is increased early compared with the controls in Figure 4.1. It progresses to being laid 
thickly around tubular complexes in each model, however regresses substantially in the caerulein 
model and remains thickly deposited in the others. Each experimental row depicts a comparable 
stage in the course of the pancreatitis for each model but not necessarily the same time point. All 
x200. 
A, D, G. Caerulein, day 1, day 4, and day 7, respectively. 
B, E, H. CHB model, day 2, day 4, and day 16, respectively. 
C, F, I. Duct ligation, day 1, day 7, and day 18, respectively. 
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Polarised light was used to demonstrate how collagen deposition changed over time from green 
(collagen III) to yellow/red (collagen I), as the fibres became thicker and displayed more intensity. 
Figure 4.3 shows the bright field image with the corresponding polarised light image. Vertical 
columns give examples for each of the models, with Figures 4.3A-C presenting the bright field 
images and Figure 4.3D-F presenting the corresponding fields under polarised light.  
 
The type of collagen laid down varied in intensity and in type between the models (Figure 4.4). Early 
(days 1 and 4, Figures 4.4A,D) in the caerulein model and after regeneration (day 7, Figure 4. 4G), 
the collagen fibres were thin (green) around acinar cells. Blood vessels and ducts were easily seen as 
were occasional thicker strands (Figure 4.4G). At day 4 when tubular complexes were most prolific, 
collagen was a mixture of the collagen III type and the yellow colour of the denser strands of collagen 
I (Figure 4.4D).  
 
CHB and duct ligation models showed similar patterns of collagen III early (Figure 4.4B,C) and a 
similar but more dense yellow/red colour as the lesion progressed (Figure 4.4E,F). By the later 
stages, collagen visualised as predominantly collagen I (red). This occurred around tubular 
complexes, as interstitial collagen remained predominantly green as can be seen in Figures 4.4H and 
I. 
 
Figure 4.5 compares the types of collagen deposited in a comparison between the three models. 
Collagen III was seen predominantly in the caerulein model, with CHB and duct ligation having 
mainly collagen I.   
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Figure 4.3. Comparison of bright field and polarised light images 
Vertical columns are the same section example for each of the models. A-C present the bright field 
image, collagen=red, parenchyma=yellow. D-F demonstrate the corresponding field under polarised 
light. Collagen III=green, collagen I=yellow/red. Circular spaces portray the lumens of tubular 
complexes. Although the amount of deposited collagen looks similar in all models in the bright field 
images, the polarised light images show that the caerulein model has more green-coloured collagen 
III than the red of collagen I in the other two models. Puchtler’s Sirius red is photographed under 
bright field and polarised light x400. 
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Figure 4.4 Polarised light images of collagen in the rat models  
Vertical columns give examples for each of the models. Caerulein: A day 1, D day 4, and G day 7; 
CHB: B day 4, E day 14, and H day 16; Duct ligation: C day 4, F day 12, and I. day 18. Each 
experimental row depicts a comparable stage in the course of the pancreatitis for each model but not 
necessarily the same time point. Note how the progression of green collagen III deposition changes 
to collagen I deposition in the CHB and duct ligation models but does not progress to considerable 
amounts of collagen I in the caerulein model and regresses by day 7. Collagen III=green, collagen 
I=yellow/red. Puchtler’s Sirius red is photographed under polarised light. All x400. 
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Figure 4.5 Comparison of the types of collagen deposited in the three models 
Five fields of 50µm2 of defined pixels were counted at x400 magnification for each 4µm thick section 
of whole pancreas for the time point of comparable collagen deposition between the models: caerulein 
and duct ligation day 4, CHB day 5. Data are the mean ± SEM of four sections (n=4) per time point 
for one experiment per model. Error bars represent the standard error of the mean. Collagen III was 
seen predominantly in the caerulein model, with CHB and duct ligation having mainly collagen I. 
One way ANOVA was used to compare the area of collagen III to collagen I between the experimental 
groups. Tukey’s multiple comparison test was used to compare individual groups. Collagen III was 
significantly increased in the caerulein model compared to CHB and duct ligation (P<0.0001, 
P<0.00010, respectively). The CHB and duct ligation models were not significantly different from 
one another (P=0.5430). Collagen I was significantly increased in the CHB and duct ligation models 
compared to the caerulein model ((P<0.0001, P<0.00010, respectively). The CHB and duct ligation 
models were not significantly different from one another (P=0.5431). 
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Using light microscopy and IHC and under EM, a comparison is made of structural similarities and 
differences for fibrosis in the three models. From day 1 in the caerulein model, collagen was deposited 
beside acinar cells undergoing apoptosis. This occurred earlier than in the other models (Figure 
4.6A). By day 4 when there were few acinar cells left, the collagen deposition increased around 
tubular complexes as the complexes became surrounded by PSC (Figure 4.6B). As apoptosis and 
acinar atrophy occurred BM became disrupted and folded. By day 4 remnant BM, immature and 
mature collagen fibrils were mixed in the interstitial space (Figure 4.6C,D). As regeneration occurred 
collagen levels around acini returned to near normal levels, however around ducts collagen was still 
obvious (Figure 4.6E,F).  
 
During secondary necrosis negligible collagen was deposited in the CHB model (Figure 4.7A) 
however as tubular complexes formed more and more was laid down around them as typical long 
strands with striations (Figure 4.7B). By day 14, the interstitial space was distended with ECM. This 
was particularly obvious around tubular complexes (Figure 4.7C).  
 
In the duct ligation model, the accumulation of ECM was aligned with the removal of acinar debris 
and the formation of tubular complexes (Figures 4.8A-D). From then, as tubular complexes persisted 
so did the level of fibrosis (Figures 4.8C,D). In the CHB and duct ligation models (Figure 4.7 and 
4.8), no collagen was laid down in the adipose tissue.  
 
Figure 4.9 demonstrates patterns of fibrosis. Positive pixel counts of the red colour of Puchtler’s 
Sirius red was measured as an approximate estimate of fibrosis. The different timelines for the three 
models relates to the progression of fibrosis in the three models. In caerulein, fibrosis peaked at 4 
days then decreased. In CHB and duct ligation models, a similar pattern of fibrosis development was 
seen. 
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Figure 4.6 Fibrosis in the caerulein model  
A. These electron micrographs show how in the collagen in the caerulein model is laid down early in 
thick swathes around tubular complexes but resorbs as regeneration occurs. Some areas of deposition 
remain after regeneration but this is mainly around ducts. Collagen deposit close to acinus, 
star=collagen, day 1, EM x4500. B. Tubular complex surrounded by collagen, day 4, EM x2500. C. 
Interstitial space next to a tubular complex is filled with collagen, day 4, EM x5000. D. Magnification 
of depicted area in C. Collagen appears as rods and in transverse (stars) with disrupted basement 
membrane (arrows), day 4, EM x10000. E. Regenerated acinar cells showing basement membrane 
(thin arrows) and the process of a stellate cell (thick arrow). Day 7, EM x4000. F. Intralobular duct 
showing collagen deposition (stars). Day 7 EM x4000.  
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Figure 4.7 Fibrosis in the CHB model 
In the CHB model, collagen is deposited thickly around and separating tubular complexes. This 
collagen does not regress and remains until the end of the experiment. A Collagen deposition, 
longitudinal and transverse. Day 3, EM x2500. B. Collagen deposits next to a duct cell in mitosis. 
Collagen=stars; basement membrane= arrows. Day 4, EM x2500. C. Collagen fills the interstitial 
spaces (star) surrounding tubular complexes. Day 14, toluidine blue x400. 
 
Figure 4.7B is a cropped version of an electron micrograph from a publication by Kelly L, Reid L, 
Walker N.  Massive acinar cell apoptosis with secondary necrosis, origin of ducts in atrophic 
lobules and failure to regenerate in cyanohydroxybutene pancreatopathy. Int. J. Exp. Path. (1999), 
80, 217-226.216. 
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Figure 4.8 Fibrosis in the duct ligation model 
Similar to the other models collagen is deposited thickly around tubular complexes in the duct ligation 
model. It surrounds and separates tubular complexes and fills the interlobular spaces along with 
supporting inflammatory cells. A. Collagen deposition in the interstitial space. Collagen=star, tubular 
complex=TC. Day 3 EM x2500. B. High power image of collagen seemingly emanating from a 
stellate cell. Collagen shown as longitudinal rods and in transverse (stars). Day 3, EM x8000. C. and 
D. Fibrosis between tubular complexes shown as opaque colouring compared to the white lumens of 
the tubular complexes (TC). C = day 10; D = day 18. Toluidine blue x400. 
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Figure 4.9 Mean ± SEM of estimate of fibrosis for the three models 
Five to ten random fields of 50µm2 of defined pixels were counted for one 4µm thick section of whole 
pancreas per rat per time point. The number of fields chosen varied with regard to reduced 
parenchyma at atrophic time points. Data are the mean ± SEM of four rats (n=4) per time point for 
one experiment per model. Error bars represent the standard error of the mean. The different timelines 
for the three models relate to the progression of fibrosis in the three models. In caerulein, fibrosis 
peaked at 4 days then decreased. In CHB and duct ligation models, a similar pattern of fibrosis 
development was seen. One way ANOVA was used to compare the area of Puchtler’s Sirius red 
staining in control groups versus experimental groups. Tukey’s multiple comparison test was used to 
compare individual groups. Sirius red expression in the caerulein model was significantly higher than 
in the control group at day 2 (P<0.0001) but not significant at day 4 (P=0.9648) and day 7 (P=0.9996). 
In the CHB model, it was not significantly changed at day 2 (P=0.0783) but was significantly higher 
than controls at days 4 and 10 (P<0.0001 P<0.0001, respectively). The duct ligation model was 
significantly higher for days 2, 4 and 10 (P<0.0001; P<0.0001 P<0.0001, respectively). At day 18 
both CHB and duct ligation models were significantly higher than controls for Sirius red expression 
(P<0.0001).   
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Laminin IHC was used to investigate BM and ECM in the three models. There was progressive loss 
and disruption of the ECM in these models (Figure 4.10). Compared to the regular pattern of BM in 
the control image (Figure 4.10A), all three models showed considerable loss and disruption in early 
stages (Figures 4.10B,C and D). By day 4 in every model, the BM by laminin staining was disordered 
and thickened (Figures 4.10E,-G), as was seen in electron micrographs where BM appears folded 
and separated from the cell surface (Figures 4.10D and 4.10B). The laminin appears around tubular 
complexes randomly, with some surrounded thickly, some partially or thinly surrounded and some 
with a fuzzy appearance (Figure 4.10F and at higher power in 4.10K). Normal tissue such as blood 
vessels and pancreatic islets were not affected.  In the caerulein model, by day 10 (Figure 4.10H) the 
BM has returned to a more normal appearance around acinar cells. In the other models (Figures 
4.10I,J), with the persistence of tubular complexes, the BM remained denser. 
 
4.3.3 Control pancreas stellate cells 
 
Control pancreas stained for alpha-smooth muscle actin showed positive blood vessels but no 
activated stellate cells (Figure 4.11A). Electron micrographs show fibroblasts in high power and next 
to a normal acinus (Figure 4.11B,C).  
 
4.3.4 Stellate cells in rat models 
 
IHC of αSMA is demonstrated in Figure 4.12 in the three models. Stellate cells activated by day 1 in 
the caerulein and duct ligation models, later in the CHB model probably due to the massive insult of 
apoptosis in this model compared to the others (Figure 4.12A-C). By day 4, stellate cells were prolific 
in all models (Figure 4.12D-F). When the caerulein model regenerated stellate cells disappeared 
(Figure 4.12G). This also occurred around regenerative acinar cells in the CHB model but not around 
tubular complexes (Figure 4.12H). Tubular complexes in the duct ligation model remained 
surrounded by stellate cells (Figure 4.12I).  
 
A graph of the positive pixel counts for αSMA as an estimate of activated stellate cells is demonstrated 
in Figure 4.13. Staining of vessels by αSMA was not counted in these estimates. Similar to the figure 
for estimates of fibrosis (Figure 4.5), stellate cell area peaked earlier in the caerulein model than 
CHB or duct ligation, closely linking presence of stellate cells with development of fibrosis. 
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Figure 4.10 Laminin immunohistochemistry for basement membrane in the rat models 
Images show basement membrane with positive brown staining for laminin using 
immunohistochemistry. Each experimental row depicts a comparable stage in the course of the 
pancreatitis for each model but not necessarily the same time point. Compared to the controls (Figure 
4.10A), basement membrane of the treatments (brown staining) is much increased or disrupted. The 
disruption to the basement membrane is apparent in the caerulein model even at the stage of 
regeneration and very thickly evident in the other two models at the end of the experiment. All x200. 
A. Control section showing basement membrane surrounding normal acini. B,E,e,H. Caerulein B. 
day 1, E. day 4, H.) day 10. C,F,I. CHB C. day 2, F. day 4, I. day 18. D,G,J. Duct ligation D. day 2, 
G. day 4, J. day 18. K.) (Top right) High power image of selected area from 4.10I showing tubular 
complexes and normal ducts. Note: The caerulein experiment terminated on day 10 when tissue was 
almost completely regenerated. Duct ligation and CHB models were still proceeding at day 18 and 
were showing excess laminin positivity.  
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Figure 4.11 Stellate cells in control rat pancreas 
Stellate cells do not stain positively for α-smooth muscle actin. The positivity in A is around blood 
vessels. Fibroblasts were difficult to find and identify in normal pancreas sections A. Control pancreas 
with α-smooth muscle actin immunohistochemistry for activated stellate cells. Arrows depict blood 
vessels. No stellate cells are seen. x400. B. Normal fibroblast from control pancreas. EM x1200. C. 
Normal acinus with fibroblasts (arrows). EM x3000. 
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Figure 4.12 αSMA immunohistochemistry for stellate cells in the rat models 
Images show positive brown staining for α-smooth muscle actin immunohistochemistry for stellate 
cells. Each experimental row depicts a comparable stage in the course of the pancreatitis for each 
model but not necessarily the same time point. Stellate cells activated earlier in the caerulein model 
than the other two models however they were soon very active particularly around tubular complexes 
where they remained in the CHB and duct ligation models. In areas of regeneration in the caerulein 
and CHB models stellate cells were scarce. All x400. A,D,G. Caerulein A. day 1, D. day 4, G. day 7. 
B,E,H. CHB A.day1, E. day 4, H. day 18. C,F,I. Duct ligation C. day 1, F. day 4, I. day 18. 
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Figure 4.13 Estimate of activated stellate cell area using immunohistochemistry 
Five to ten fields of 50µm2 of defined pixels were counted at x400 magnification for one 4µm thick 
section of whole pancreas per rat (n=4), per time point. Fields were chosen randomly. The number of 
fields counted varied with regard to reduced parenchyma at atrophic time points. Data are the mean 
± SEM of four rats (n=4) per time point from one experiment per model. Error bars represent the 
standard error of the mean. Positive pixel counts for αSMA are demonstrated as an estimate of 
activated stellate cells. Similar to the figure for estimates of fibrosis, stellate cell area peaked earlier 
in the caerulein model than CHB or duct ligation. Staining of vessels by αSMA was not counted in 
these estimates. One way ANOVA was used to compare the area of αSMA staining in control groups 
versus experimental groups. Tukey’s multiple comparison test was used to compare individual 
groups. Α-SMA expression in the caerulein model was significantly higher than in the control group 
at time points days 2 and 4 (P<0.0001, P<0.0001, respectively) but not at day 10 (P=0.9999). The 
duct ligation model was significantly higher compared to controls at days 2, 4, and 10 (P<0.0001, 
P<0.0001, P<0.0001, respectively). Staining in the CHB model was not significant compared to 
controls at day 2 (P=0.9667) but was significantly higher at days 4 and 10 (P<0.0001, P<0.0001, 
respectively). At day 18 both CHB and duct ligation were significantly higher than the control group 
(P<0.0001, P<0.0001, respectively) and also both significantly different compared to the caerulein 
model (P<0.0001, P<0.0001, respectively). 
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Electron micrographs and semi-thin sections in the caerulein model show the stellate cells producing 
collagen around acini and tubular complexes (Figure 4.14). Stellate cells have copious RER and 
when activating lose their lipid droplets (Figure 4.14A). The stellate cells were closely aligned to 
apoptotic acini with processes wrapped around cells and apoptotic bodies (Figure 4.14B). Collagen 
can be seen in close vicinity to the stellate cells such that immature and mature collagen fibres were 
mixed together (Figure 4.14C). By day 4 tubular complexes were tightly enclosed by stellate cells 
and their processes (Figure 4.14D). With almost complete regeneration stellate cells disappeared and 
stellate cells were inactive (Figure 4.14C). 
 
Stellate cells were also activated in the CHB model as lipid droplets were extruded (Figure 4.15A). 
They were also closely aligned with tubular complexes (Figures 4.15B,C) becoming more tightly 
wound around them as the lesion progressed (Figure 4.15D). They were not around regenerative 
islands of acini or around adipose tissue but were in the interstitial space in the inflammatory infiltrate 
(Figure 4.15E).  
 
The duct ligation model has a similar account with lipid droplets in the cell process (Figure 4.16A) 
and stellate cells and their processes in close proximity to apoptotic acini and tubular complexes 
(Figure 4.16B,C,D). In some cases the stellate cells were fewer however their processes remained 
encircling the tubular complexes (Figure 4.16E). Figure 4.17 shows the extent of the stellate cells 
and their thin elongated processes producing collagen around an apoptotic body, acini and capillaries. 
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Figure 4.14 Stellate cells in the caerulein model 
Stellate cells contain lipids and extrude these as they activate. Stellate cells were closely aligned with 
tubular complexes, their nuclei and processes appearing to wrap the tubular complexes into bundles. 
The stellate cell nuclei were either narrower and elongated around complexes, or expanded with rough 
endoplasmic reticulum (RER). The cytoplasm of stellate cells often appeared to be extruding 
collagen. A. Activating stellate cell with lipid droplet (star), copious RER. Day 1, EM x5000. B. 
Large stellate cells with long processes around apoptotic acinus. Day 2, EM x2500. C. Stellate cell 
extruding collagen. Day 2, EM x12000. D. Tubular complexes with stellate cells (arrows) wrapped 
closely around them. Day 4, Toluidine blue x1000. E. Acinus with cells approaching fibroblast 
phenotype (arrows) and remnants of interstitial collagen. Day 7, EM x1500. 
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Figure 4.15 Stellate cells in the CHB model 
Similar to the caerulein model, the stellate cells were closely associated with the tubular complexes 
and remained so. When regeneration did occur in the CHB model, no stellate cells wrapped around 
acini however they were still noted in the inflammatory infiltrate. Note also in this model the presence 
of lipid droplets in the toluidine blue-stained sections. A. Activating stellate cell process with lipid 
droplets (star) in the cytoplasm. Day 3, EM x5000. B. Tubular complex with stellate cell in close 
contact. Day 1, EM x5000. C. Stellate cells around tubular complex. Day 4, EM x2500. D. Stellate 
cells (arrows) closely wrapped around tubular complexes (TC). Toluidine blue day 14, x400. E. 
Regenerative acini with absence of close stellate cells. Stellate cells (arrow) are in the inflammatory 
infiltrate. Day 16, toluidine blue x1000.  
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Figure 4.16 Stellate cells in the duct ligation model 
The same pattern of stellate cell activation and localisation was seen in the duct ligation model with 
multiple cells wrapped around each tubular complex. A. Activating stellate cell process with lipid 
droplet (star) in the cytoplasm. Day 3, EM x5000. B, C. Stellate cells (arrows) closely aligned with 
tubular complex (TC). B=day 3, C=day 4, EM x2500. D, E. Tubular complexes with stellate cells 
(arrows) wrapped around them. D=day 10, E=day 18. Toluidine blue x1000. 
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Figure 4.17 Stellate cells producing collagen 
This micrograph shows activated stellate cells in the early stages of the duct ligation model. Multiple 
stellate cells surround a large apoptotic body, their long thin processes sliding around the residual 
body and the adjacent acini. There is much collagen deposition associated with the stellate cells. Duct 
ligation model, day 3. Stellate cells and processes (stars) around an apoptotic body. A=acinar cell, 
M=macrophage. Electron microscopy x6000. 
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4.4 DISCUSSION - FIBROSIS AND STELLATE CELLS IN PANCREATITIS 
 
Traditionally, the pathological and physiological distinction between acute injury and chronic injury 
is blurred. Morphological characteristics which typify chronic pancreatitis are seen also in the model 
of acute pancreatitis. The three models of pancreatitis share a common pathogenesis in that atrophy 
of acinar cells via apoptosis leads to the formation of tubular complexes and the laying down of 
abnormal amounts of ECM. This study sought first to determine the differences in collagen deposition 
between the three models.  
 
The experiments described here show pancreatic fibrogenesis in the caerulein model where 
degradation of fibrosis occurs and gland architecture is restored. The CHB model where regeneration 
is limited, and the duct ligation model where regeneration does not occur, proceed to chronic fibrosis. 
Fibrosis developed earlier in the caerulein model. This may be in part due to the CHB and duct 
ligation models undergoing considerably more oedema in the early stages and undergoing a later 
infiltration of macrophages into the gland. Once established, all models developed considerable 
fibrosis. That the peak of fibrosis did not last long in the caerulein model may be accounted for by 
the insult being removed earlier. It has been estimated that physiological activity of caerulein is absent 
from Sprague Dawley rats 8 hrs after one injection.224 Resorption of fibrosis in this model proceeded 
swiftly once the insult ceased therefore the process for degradation of ECM is active in the caerulein 
model but not in the other models. 
 
Pancreatic fibrosis is the result of the deposition of collagens I, III and IV, fibronectin and laminin. 
225 One major difference between the models was in the type of collagen laid down. In the caerulein 
model the type of collagen laid down in intra- and inter-lobular areas was predominantly green under 
polarising light, typical of collagen type III and mostly of a wavy wispy nature. Around tubular 
complexes the collagen was a mixture of collagen type III and amounts of yellow, denser deposits 
that appeared to be collagen I. In contrast, in the CHB and duct ligation models under polarising light 
the collagen progressed from green to yellow then predominantly red, typical of collagen I. It was 
particularly thick around tubular complexes but also dense in swathes in the general tissue, with only 
a small amount of collagen III in some areas. Interestingly the overall amount of collagen laid down 
was approximately equal in all models at the peak of fibrosis respectively. It appears that in the 
caerulein model the process of degradation and resorption took place before collagen I fully replaced 
collagen III.  
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In the caerulein and duct ligation models, the BM became disordered and folded away from the cells 
as apoptosis and acinar atrophy progressed. In CHB, as synchronous apoptosis was followed by 
secondary necrosis BM was totally disrupted and scattered throughout the tissue. At the time point 
when tubular complexes were established in all models laminin staining showed the BM to be 
randomly dispersed around the complexes partially or fully encircling them and in thin or thick lines, 
Where regeneration occurred, the BM resumed an orderly thinner line around the acinar cells. Around 
tubular complexes, it remained thicker and disordered. BM is a highly cross-linked lattice of secreted 
proteins including collagen IV. The formation of BM depends on the binding and adhesion of 
laminin-collagen in a highly organised self- assembly process.65 It requires laminin to anchor 
integrins, dystroglycan and other receptors in the process of assembly.67 In all of the models laminin 
was disordered and dislocated to the same degree when tubular complexes formed after apoptosis. 
The laminin-collagen reassembly process occurs successfully around acinar cell regeneration as seen 
fully in the caerulein model and partially in the CHB model. The trigger for this is not yet known.  
 
Fibrosis occurs as a result of the net deposition of excess collagen I and II and other matrix proteins 
that are synthesised by stellate cells. PSCs also synthesis MMPs that activate the resorption process 
in the extracellular space. The MMPs that play a key role in regulating matrix degradation are in turn, 
regulated by a family of specific inhibitors, TIMPs. A complex interplay exists between TIMPs and 
MMPs. In the caerulein/SHOP-induced chronic pancreatitis model in rats, fibrosis resolved by 18 
days when MMP-1 and -2 expression was at a peak: MMP-9 did not significantly change.226 MMP-
2 and -9 also degrade BM proteins. Increased transcripts and protein for MMP-2 was reported during 
regeneration from caerulein-induced pancreatitis.227 Other cells also play a part in collagen 
degradation, for example, in the liver Kupffer cells in matrix degradation.228 Yokota et al. (2002) 
suggest that the MMP expression that is triggered by ECM injury enhances vascular basal membrane 
degradation and leads to an increase in polymorphonuclear leucocytes These leukocytes provide a 
further source of MMPs. Nakae and colleagues reported that the severity of disease in acute 
pancreatitis correlates with the ratio of TIMP-1/MMP-1.229 The role that MMPs and TIMPs play in 
the regulation of ECM development progression and degradation was not explored in this current 
study and is a consideration for future studies.  
 
Generally, fibroblasts with long thin nuclei and cytoplasm reside in the interstitial space closely 
aligned to parenchyma. These were identified in the control sections however they were not in great 
numbers. Non-activated stellate cells are reported to be identifiable by possessing vitamin A-
containing lipid droplets.142 These were not readily identified in controls in this study. Either the 
stellate cells were not resident in the controls, were too few to be easily observed and identified, 
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migrated into the injured pancreas, or activated from the resident fibroblasts. Others have observed 
that in the injured pancreas PSC populations resulted from bone marrow derived cells, migration from 
surrounding areas and PSC proliferation.153 New special stains may aid in the identification of stellate 
cells in controls.148 At the early stages of the experiments activating stellate cells were recognised by 
the presence of copious RER and lipid droplets in the cytoplasm and large regular shaped or elongated 
nuclei. The lipid droplets were seen up to three days in the CHB and duct ligation models, earlier in 
the caerulein model. After this no further lipid droplets were noted in stellate cell cytoplasm. The 
stellate cells were obvious by αSMA IHC, light and EM, migrating in the interlobular inflammatory 
infiltrate and in intralobular spaces and particularly closely arranged around tubular complexes. 
Mostly, the cells migrating in the inflammatory infiltrate had elongated nuclei and non-obvious 
cytoplasm more indicative of the shape of fibroblasts, however, in αSMA IHC sections they stained 
positively. In other areas their cytoplasmic processes were extremely long and thin and overlapped 
as they wrapped tightly around tubular complexes in a concentric fashion. By EM, they could be seen 
extruding preformed collagen into intercellular spaces. Stellate cells disappeared quickly as the 
caerulein model regenerated and were not apparent around regenerative acini in the CHB model. By 
the completion of the study in all models stellate cells remained around normal ducts and blood 
vessels. In the caerulein model they were there only; in the CHB model they remained also around 
residual tubular complexes; in the duct ligation model they were prevalent around tubular complexes. 
It was not obvious how the stellate cells departed other than they were seen migrating in the 
inflammatory infiltrate. Remaining cells in the caerulein model had an appearance approaching 
fibroblast morphology. No apoptosis or senescence was seen in stellate cells as were seen in other 
studies.170, 171 This may have been missed as time points of two to three days apart in all models in 
the later stages are not close enough to account for all eventualities.  
 
Future work could expand these parameters. It is apparent from this comparison of the models that 
stellate cells play roles in both the resorption of fibrosis and the ability of the pancreas to regenerate. 
Does the resorption of fibrosis first allow regeneration to occur? Do stellate cells drive regeneration? 
In the CHB model, fibrosis persists despite stellate cells waning. Does collagen I form a scar-like 
deposition in the CHB and duct ligation models that prevents the intercellular cross talk between other 
cells that promote regeneration?  
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4.5 MACROPHAGES IN INFLAMMATION AND FIBROSIS IN PANCREATITIS 
 
4.5.1 An introduction to the role of macrophages in pancreatitis 
 
The primary cause of morbidity and mortality in pancreatitis is the inflammatory response. Along 
with acinar cells, neutrophils, lymphocytes, monocytes and macrophages are a fundamental 
component of this immune response. Macrophages play a role in maintenance and resolution of tissue 
repair through communication with other immune cells. They are the major resident immune cell in 
the pancreas. They may be released into the blood stream from bone marrow to migrate into the tissue 
as monocytes and become activated and matured into macrophages. This section describes some of 
the potential roles that macrophages play in the inflammatory and fibrotic response of the injured 
pancreas. 
 
4.5.2 Materials and methods 
 
General materials and methods may be found in Chapter 2. Macrophages were identified by CD68 
IHC, light and EM and semi-thin sections stained with toluidine blue.  
 
4.5.3 Results for macrophages in inflammation and fibrosis in pancreatitis  
 
Macrophages in control rat pancreas are demonstrated in Figure 4.18. Only few macrophages were 
identified in periacinar tissue (Figure 4.18A), however in select areas on the edge of lobules they 
were seen in greater numbers in connective tissue (Figure 4.18C). Ultrastructurally, macrophages 
have large nuclei that are often elongate with indentations and a thin rim of condensed chromatin, 
variable amounts of RER, mitochondria and Golgi apparatus. Inactive macrophages have poorly 
developed lysosomal vacuoles and the cell surface may or may not have cytoplasmic processes 
(Figure 4.18B). Remnants of apoptosis were predominantly ingested by macrophages in the early 
stages of the lesions and later when duct and regenerative acinar cell apoptosis occurred. 
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Figure 4.18 Macrophages in control pancreas 
Macrophages were not obvious within the normal acinar population, however they were seen in 
numbers in connective tissue on the periphery of lobules. The macrophages were large cells with a 
large nuclear/cytoplasmic ratio, with or without chromatin clumped at the nuclear periphery and with 
obvious cytoplasmic rough endoplasmic reticulum. A. Rare macrophages were seen between acini in 
control pancreas. CD68, x200; B. A macrophage is seen next to an acinus. EM x5000; C. 
Macrophages are seen on the edge of a normal lobule, CD68 immunohistochemistry, x400. 
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Histology and EM are demonstrated in later figures. CD68 IHC showed that the macrophages 
appeared to migrate into the tissue through the inflammatory infiltrate and activate early in all of the 
models. They infiltrated into the spaces between apoptotic cells in great numbers as apoptotic 
cytoplasm was being scavenged (Figure 4.19A-C). In the caerulein model increased numbers of 
macrophages were seen early in the inflammatory infiltrate. The number peaked at 36 hrs in the 
infiltrate and in intralobular spaces however at 48 hrs they were mainly intralobular. By day 5-7 when 
there was less inflammatory infiltrate, fewer macrophages were seen (Figure 4.19D), however, by 
day 10 when regeneration was almost complete some lobules had few macrophages; other lobules 
had levels higher than normal with macrophages still in periacinar spaces and migrating in a residual 
inflammatory infiltrate (Figure 4.19G; also see 4.21D). In the CHB model the numbers of 
macrophages increased substantially up to 48 hrs (Figure 4.19B). Most macrophages were closely 
aligned with residual acinar cells rather than the inflammatory infiltrate. By day 5 macrophages were 
mainly in the inflammatory infiltrate but also singly around tubular complexes and close to stellate 
cells. From days 7-14 there remained considerable numbers of macrophages dispersed throughout the 
tissue, near tubular complexes, blood vessels and migrating (Figure 4.19E). Numbers decreased by 
days 18-28 but still remained above control levels (Figure 4.19H). In duct ligation the numbers of 
macrophages increased as apoptosis progressed up to day 4 when they were situated in the 
inflammatory infiltrate and around tubular complexes (Figure 4.19C,F). From days 7-18 numbers 
had declined but the macrophages were still active and occasionally formed giant cells (Figure 4.19I). 
As regeneration occurred in the caerulein model the number of macrophages decreased. In the CHB 
model the effect around regenerative nodules was varied with macrophages both absent and present 
in these areas (Figure 4.19H, also see 4.22D). In CHB and duct ligation models macrophages 
remained dispersed around tubular complexes, in the inflammatory infiltrate and randomly 
congregated in some areas (Figures 4.19H,I). A graph of the counts of macrophages (using IHC and 
CD68 antibody) is represented in Figure 4.20. In all experimental models, the number of 
macrophages increased from control levels.  
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Figure 4.19 CD68 immunohistochemistry for macrophages in the rat models 
IHC for macrophages showed clearly how activated they became early in pancreatitis in these models. 
They were mainly dispersed in all models but were seen both dispersed and congregated into large 
clumps in the CHB and duct ligation models. By regeneration in the caerulein model most 
macrophages had waned however large clumps persisted in the other two models. A-C. Increased 
numbers of macrophages in all models. A. caerulein, day1; (B. CHB, day2; C.duct ligation, day2. x 
200. D-F. Macrophages around tubular complexes and in inflammatory infiltrate. D. caerulein, day4; 
( E.) CHB, day7; F.) duct ligation, day4. x 200. G-I. Macrophages returned to almost normal numbers 
around regenerated acini but prolific around tubular complexes. G.) caerulein, day10; H.) CHB, 
day16; I. duct ligation, day18. x200. 
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Figure 4.20 Mean ± SEM of counts of macrophages using CD68 antibody 
Single macrophages were counted in five to ten random fields of x200 magnification for one whole 
pancreas section at 4µm per rat (n=4), per time point. The number of fields varied with regard to 
reduced parenchyma at atrophic time points. Data are the mean of four rats (n=4) per time point from 
one experiment per model. Error bars represent the standard error of the mean. In all experimental 
models, the number of macrophages increased from negligible numbers in controls. One way 
ANOVA was used to compare the number of macrophages in control groups versus experimental 
groups. Tukey’s multiple comparison test was used to compare individual groups. The number of 
macrophages in the caerulein, CHB and duct ligation models were significantly higher (all P<0.0001) 
than in the control group at time points days 2 and 4, and at day 10 for the CHB and duct ligation 
models. At day 10 in the caerulein model, the number of macrophages was not significantly different 
compared to the control group (P=0.2102). 
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Figure 4.21A shows a typical activated macrophage in the interlobular space with a chromatin 
rimmed, irregularly-outlined nucleus. The cytoplasm contains membrane-bound spherical 
phagolysosomes of various sizes filled with cellular cytoplasm and organelles in different stages of 
degradation. Apoptotic nuclear fragments were present in the same manner. The lysosomal vesicles 
were also represented by clear vacuoles or spaces where digestion had occurred and lipids remained. 
These lipids mostly leached from the tissue during tissue processing leaving white spheres, however 
may remain in some electron micrographs as grey-coloured areas or in toluidine blue sections as 
bright blue-coloured areas. Stellate cells often aligned closely with macrophages. The macrophages 
used long, thin pseudopodia to snake around and extract apoptotic bodies from acinar cells (Figure 
4.21B). In the caerulein model, the macrophages were very active in the periacinar space as acini 
underwent apoptosis and tubular complexes formed (Figure 4.21C). As regeneration progressed, 
macrophage numbers decreased quickly, however they were still found in periacinar areas and in 
residual inflammatory infiltrate in some lobules at day 10 (Figure 4.21D). 
 
In the CHB model, the macrophage response was different as they were prolific early due the massive 
apoptotic response and secondary necrosis (Figure 4.22A). As the more disorderly removal of debris 
progressed, macrophages of all shapes and sizes filled with cellular debris packed the lobules (Figure 
4.22B). By day 5, tubular complexes had formed although were undergoing continued apoptosis. 
Macrophages were often rounded up and lipid filled (Figure 4.22C). Where regeneration occurred, 
macrophages were often absent (also see Figure 4.19H) however in other areas they remained debris-
filled around the parenchyma and in the inflammatory infiltrate, and associated with adipose tissue 
(Figure 4.22D).  
 
Early in the duct ligation model, as acinar cells became vacuolated but not yet apoptotic macrophages 
migrated through the inflammatory infiltrate (Figure 4.23C). The macrophage response followed a 
typical procedure with respect to classic engulfment of apoptotic bodies in the same well-ordered 
manner as the caerulein model. Multiple macrophages filled with apoptotic bodies and lysosomal 
vesicles around apoptotic acinar cells and forming tubular complexes (Figure 4.23A,B). They 
persisted around tubular complexes and were seen migrating in the collagen rich inflammatory 
infiltrate (Figure 4.23D). Macrophages, mast cells and stellate cells shared the microenvironment in 
rat pancreatitis. They are illustrated in close proximity in the collagenous stroma in Figure 4.24. 
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Figure 4.21 Macrophages in the caerulein model 
Macrophages actively phagocytosed apoptotic bodies. They were close aligned with the acini, 
extending pseudopodia to remove detritus. They could be seen with inclusions in the inflammatory 
infiltrate well after most acinar cells has apoptosed. They were also still more visible than normal 
once regeneration had occurred. A. Macrophage in the interstitial space containing several 
phagolysosomes (black arrows) and apoptotic nuclear fragments (stars). N=macrophage nucleus, 
stellate cell (white arrow). Caerulein, day2. EM x5000. B. Macrophage (arrows) with thin 
pseudopodia removing an apoptotic body complex. Apoptotic nuclear bodies (stars). The macrophage 
nucleus is not visible. Caerulein, day2, EM x6000. C. Macrophages (arrows) within the interstitium 
around apoptotic acini and forming tubular complexes. Caerulein, day3, toluidine blue x1000. D. 
Macrophages (CD68+) remaining in intra- and interlobular spaces after regeneration. Caerulein, 
day10, CD68 x 400  
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Figure 4.22 Macrophages in the CHB model 
Macrophages were also active in the CHB model, engulfing the residue of secondary necrosis. They 
clumped together in numbers in this model and were seen in later stages with copious lipid inclusions 
in their cytoplasm which probably accounts for the large amounts of lipid in adipocytes in this model 
towards the end of the experiment. A. Macrophage in early activation (arrow) engulfing cells in 
secondary necrosis. CHB, day2, EM x4000. B. All cells in this image are macrophages engulfing 
residual acinar tissue. CHB, day3, EM x2500. C. Macrophages (white arrows) containing lipids in 
the inflammatory infiltrate around tubular complexes, apoptosis (black arrows). CHB, day 5, toluidine 
blue x1000. D. Large active macrophages in the inflammatory infiltrate around regenerating acini. 
Migrating stellate cells (arrows). CHB, day 10, CD68 x400 
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Figure 4.23 Macrophages in the duct ligation model 
Macrophages in the duct ligation model followed a similar pattern to the other models of engulfing 
apoptotic bodies in large numbers. Macrophages were numerous in the inflammatory infiltrate at all 
stages of the lesion. A. Macrophages (long black arrows) are seen engulfing apoptotic nuclear 
fragments (star) and residual lysosomal bodies (short arrows). Duct ligation, day2, EM x3000. B. 
Macrophages (long arrows). Duct ligation, day3, EM x3000. C. Macrophages entering the pancreas 
through the inflammatory infiltrate. Duct ligation, day1, CD68, x400. D. Macrophages in the collagen 
rich inflammatory infiltrate and around tubular complexes (long black arrows), neutrophil (thin 
arrow). Day7, toluidine blue, x1000. 
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Figure 4.24 Inflammatory cells in pancreatitis 
This electron micrograph shows a number of active macrophages within the inflammatory infiltrate 
with inclusions of detritus at various stages of degradation in lysosomes, and lipid droplets. 
Macrophages can be seen with residual bodies and lipid droplets (black arrows), mast cell (white 
arrow) and stellate cells (short arrows) in dense extracellular matrix at the edge of a lobule. Caerulein, 
day4, EM x2000. 
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The relationship between macrophages and adipose tissue is demonstrated in Figure 4.25. In the CHB 
and duct ligation models, macrophages filled with lipid droplets which coalesced to form large lipid 
filled cytoplasm (Figure 4.25A). Macrophages were noted often in adipose tissue presumably 
emptying lipid into forming adipocytes (Figure 4.25B, C).  
 
 
 
Figure 4.25 Relationship between macrophages and adipose tissue 
Macrophages in the CHB model, particularly, had copious amounts of lipid droplets in the cytoplasm. 
They often clumped together as giant cells and were seen closely associated with adipose tissue. A. 
Macrophages can be seen with spaces that contained lipid (the actual lipid has been dissolved by 
tissue processing). CHB, day4, EM x2500. B. Adipose tissue is demonstrated with macrophages 
closely aligned. Note the size of the activated macrophages compared with Figure 4.18C. CHB, 
day18, x1000. C. Adipose tissue with macrophages (brown stain). Duct ligation, x1000. 
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4.5.4 Discussion of the role of macrophages in inflammation and fibrosis in pancreatitis 
 
Macrophages are well known for their effectiveness as scavenger cells in wound repair and tissue 
injury. This was well demonstrated in the three rat models discussed here. Following apoptosis of 
acinar cells in all models macrophages, either recruited or resident, migrated within the inflammatory 
infiltrate to establish themselves within the parenchyma. There they effectively engulfed and removed 
injured cells until tissue architecture was reinstated as tubular complexes. 
 
From there, macrophages possibly acted in the reparative process in the caerulein model as they 
disappeared in numbers as regeneration progressed. In the CHB and duct ligation models where 
regeneration did not remain or did not occur, macrophages may have aided the continuing 
inflammatory process. They remained in these models in numbers excessive of control levels.  
 
Macrophages drive the initial inflammatory response by synthesizing inflammatory mediators such 
as chemokines and matrix metalloproteinases. Distinct roles for either resident or recruited 
macrophages as anti- or pro-inflammation have been proposed.190 However, in models of liver injury 
phagocytosis functions in the conversion of inflammatory macrophages into cells displaying a 
restorative phenotype.230 The removal of intracellular contents apparently stimulates macrophages to 
express an anti-inflammatory phenotype such that the depletion or diminution of macrophages may 
lead to the resolution of inflammation, resulting in repair and restoration. These macrophages 
suppress the immune system by expressing anti-inflammatory mediators such as IL-10 and TGFβ1 
under the influence of interleukins.190 Conversely, macrophages may adopt a suppressive phenotype 
that would continue inflammation and lead to the failure of the repair process. As well, fibrotic role 
of macrophages in chronic pancreatitis may be influenced by their release of cytokines such as IL-6. 
 
As well as promoting proliferation and angiogenesis through PDGF, IGF-1 and VEGF, macrophages, 
through TGFβ, also recruit and promote the survival of the stellate cells that produce ECM. They also 
do this by producing MMPs such as MMP-2 and -9 that aid stellate cell migration via degradation of 
basement membrane.186 Macrophages can secrete pro-fibrotic mediators such as TGFβ1, PDGF, 
FGF2, insulin-like growth factor–binding protein 5, CCL18, and Galectin-3, as well as various 
mediators that can influence fibrotic resolution such as IL-10, MMP-13, Relma-α, PD-L2, and 
Arginase-1.186 For the caerulein model to regenerate through macrophage influence, presumably the 
macrophages must differentiate into anti-inflammatory macrophages that secrete the anti-fibrotic 
cytokines. These would stimulate the production of the matrix metalloproteinases that can directly 
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degrade interstitial collagen. Essential amino acids required for T cell and stellate proliferation and 
stimulation would need to be depleted. As macrophages are found in close association with stellate 
cells in these models the equilibrium between different macrophage populations or phenotypes, and 
stellate cells probably determines whether the outcome of pancreatitis is regeneration or pathogenic 
fibrosis. 
 
4.6 MAST CELLS IN INFLAMMATION AND FIBROSIS IN PANCREATITIS 
 
4.6.1 An introduction to the role of mast cells in pancreatitis 
 
Mast cells are found in close proximity to vasculature in all tissues and are sensitive to pathological 
changes. On activation, they release a myriad of inflammatory mediators important in the context of 
allergic disorders and other inflammatory responses and are believed to play a role in fibrotic disease. 
The precise role of mast cells in acute and chronic pancreatitis is not clear however they are implicated 
in the development and progression of acute pancreatitis194, 231 and have been identified as the cells 
responsible for perpetuating chronic inflammation in chronic pancreatitis. This study looks at the 
differences in mast cell distribution in experimental models of caerulein-induced, CHB-induced, and 
duct ligation-induced pancreatitis to see if they are involved in the inflammatory response or fibrosis 
or both. Mast cells have not been described in this CHB model. 
 
4.6.2 Materials and methods  
 
General materials and methods have been described in Chapter 2. For this section of the study, mast 
cells were stained histochemically with Alcian blue/nuclear fast red (Appendix 1). The presence of 
mast cells was confirmed with IHC for c-kit (CD117). The histochemical method was chosen as the 
preferred method for identifying mast cells in light microscopy. Semi-thin toluidine stained sections 
and EM were also used. Mast cells stained with Alcian blue/nuclear fast red were counted in ten fields 
x200 magnification for each slide. There was lobular variation in numbers of mast cells in all models 
which accounts for the large error bars.  
 
4.6.3 Results for mast cells in inflammation and fibrosis in pancreatitis 
 
Mast cells were sparse to non-existent in periacinar spaces but were found in small numbers around 
connective tissue, blood vessels and in lymph nodes in control sections (Figure 4.26A-C). 
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Figure 4.26 Control rat pancreas stained for mast cells  
Mast cells were seen in control sections mainly close to blood vessels. They were not very numerous. 
With Alcian blue histochemistry, the mast cell granules stain brightly and distinctly. C-kit IHC may 
also be used however Alcian blue provides efficient identification, especially when degranulating 
when granules may be few. A. Control section shows a lone mast cell in connective tissue in the 
pancreas. Alcian blue/nuclear fast red, x200. B. High power image of a mast cell stained with Alcian 
blue/nuclear fast red. X1000. C. Mast cells stained with c-kit immunohistochemistry, counterstain 
haematoxylin. 
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In experimental sections, mast cells were distributed throughout the pancreas, congregated around 
blood vessels and nerves, in the interstitial and intralobular spaces and around tubular complexes and 
acini and close to adipose tissue (Figure 4.27A-I). Mast cell numbers increased by day 1 in the 
caerulein model, and to the same level by day 2 in the CHB model. In the duct ligation model, they 
increased slowly and by day 4 had reached the levels of the other models. Thereafter the caerulein 
model mast cell population rose markedly to an early peak at day 3-4 after which it decreased equally 
noticeably with regeneration. Mast cells in the CHB and duct ligation models increased slowly to a 
peak higher than caerulein by day 14 in the CHB model and day 28 in the duct ligation model. By the 
completion of the experiment in the caerulein model, the mast cell count remained considerably 
higher than the control levels in periacinar spaces. In the CHB model mast cell numbers decreased 
from the peak at day 14 however still remained high. In the duct ligation model there was no decrease 
in number. Mast cells were easily identified in light microscopy as their granules stain bright blue 
with Alcian blue. A graph of incidence of mast cells in the three models is depicted in Figure 4.28.   
 
A typical mast cell is shown in Figure 4.29. The granules in the rat contain either finely granular 
electron dense material or scroll formations of loosely organised lamellae (Figure 4.30A-C). The 
appearance of the granules is affected by maturity of the granules and by degranulation. Immature 
mast cells demonstrate a smaller size and a higher nuclear cytoplasmic ratio with fewer granules.232 
Mast cells underwent massive degranulation in the early stages. Mast cells were in close proximity 
to macrophages and stellate cells especially in the earlier stages of the pancreatitis when apoptosis 
was occurring and tubular complexes formed. At later time points in the models, they were mainly in 
the interstitium. 
 
In the semi-thin sections toluidine blue stains the granules metachromatically, seen in the sections of 
Figure 4.31(D-F). In electron micrographs, the mast cells were identified by their numerous electron 
dense granules in the cytoplasm, an indented nucleus, and slender, cytoplasmic filiform projections 
on the cell surface.  
 
Figure 4.32A,B demonstrate mast cells found in the regenerative phase. In this example, mast cells 
were found close to regenerated acini (A) or congregated in the interstitial space (B).  
  
106 
 
 
 
Figure 4.27 Distribution of mast cells in the rat models 
In all of the models mast cells were seen within the parenchyma as well as around blood vessels 
during experimental conditions. In light microscopy the appeared randomly distributed and not 
particularly aligned with tubular complexes or acinar islands.  
A,D,G. Caerulein, day2, day5, day10, x 200 
B,E,H. CHB, day4, day12, day18, x200 
C,F,I. Duct ligation, day4, day12, day28, x200 
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Figure 4.28 Mean ± SEM of mast cell numbers in the three models 
Single mast cells were counted in five to ten fields of x200 magnification for one whole pancreas 
section at 4µm thickness per rat per time point. As mast cells tend to be more congregated around 
large blood vessels in the pancreas and the number of blood vessels were more closely aligned in 
reduced atrophic parenchyma over time and between models a less random but consistent system of 
field choice targeting parenchyma was used. Data are the mean of four rats (n=4) per time point from 
one experiment per model. Error bars represent the standard error of the mean. Mast cells peaked 
early in the caerulein model but took some days to peak in the CHB and duct ligation models. Mast 
cell numbers remained higher than normal (time 0) in all models. One way ANOVA was used to 
compare the number of mast cells in control groups versus experimental groups. Tukey’s multiple 
comparison test was used to compare individual groups. The number of mast cells in the caerulein, 
CHB and duct ligation models were significantly higher than in the control group at time points days 
2 and 4 (P<0.0001, P<0.0001, P<0.0001, respectively) and at day 10 (P=0.0414, P<0.0001, P<0.0001, 
respectively). 
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Figure 4.29 Typical mast cell with macrophages 
This electron micrograph shows a typical mast cell with distinctive indented nucleus, high nuclear 
cytoplasmic ratio and cytoplasmic projections on the cell surface. The granules are electron dense 
and are of varying size as they degranulate and leave an empty space halo around the granule. Two 
typical macrophages are close by this mast cell in the interstitial space. By electron microscopy, mast 
cells, macrophages and stellate cells were seen closely associated in these experiments. A typical 
mast cell, with granulation is seen in the pancreatic interstitial space, close to two macrophages (top 
cells). Caerulein day2, x1000.  
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Figure 4.30 Mast cell granules  
The mast cell granules in the rat contain either finely granular electron dense material or scroll 
formations of loosely organised lamellae. In4.30B and 4.30C, the arrow indicates a scroll formation. 
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Figure 4.31 Mast cells in the rat models 
In all of the models, mast cells could be seen actively degranulating, with some almost completely 
degranulated. They were sometimes seen randomly in the inflammatory infiltrate, often close to 
macrophages and, to a lesser degree, stellate cells. Apart from different numbers, there was little to 
distinguish between the three models for mast cells. A. Mast cell degranulating. Caerulein day 4, EM 
x10000. B. Mast cell in a compact stroma. CHB day14, EM x9000. C. Mast cell partially 
degranulated. Duct ligation, EM x10000. D. Mast cell in interstitial space (arrow). Regenerated acini. 
Caerulein, toluidine blue, day 10, x 1000. E. Mast cells one almost fully degranulated (arrows), CHB 
toluidine blue, day 14, x1000. F. Mast cell close to tubular complexes. Duct ligation (arrow), toluidine 
blue, day 10, x1000. 
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Figure 4.32 Mast cells found in the regenerative phase 
In the CHB model in the later stages of the experiment, mast cells were seen to congregate in the 
inflammatory infiltrate A. Mast cell close to regenerated acini. Caerulein day10, EM x2500. B. Many 
mast cells congregated in the interstitial space. CHB, day 14, x1000.  
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4.6.4 Discussion on mast cells in inflammation and fibrosis in pancreatitis 
 
Mast cells are widely distributed throughout normal connective tissues and are closely associated 
with the vasculature and nerves. In the models discussed here we show an increase in mast cell 
numbers early in pancreatitis and increased numbers of mast cells as fibrosis is developed. Increased 
numbers of mast cells were located near parenchymal cells, around nerves, in interstitial areas, in the 
mesentery and in adjacent lymph nodes. Mast cell degranulation was noted especially around tubular 
complexes and intralobular spaces. 
 
Mechanisms proposed in the development of human acute pancreatitis are disturbance of acinar cell 
function, followed by the generation and release of inflammatory mediators combined with oxidative 
stress, that results in an exaggerated inflammatory reaction.194 Thus, mast cell activation is proposed 
to be an important factor in the development of acute pancreatitis since many of the factors that 
stimulate mast cell activation such as platelet activating factor (PAF), ROS and oxidation products 
are implicated to trigger acute pancreatitis. Furthermore, inflammation could be further sustained by 
release of reactive oxygen species and PAF from mast cells. Of the three models only the caerulein 
model showed a dramatic increase in mast cell numbers early in the course of the lesion. Mast cell 
degranulation was found also at the 3-4 hour time-point in a mild model of caerulein-induced 
pancreatitis in rats. In the caerulein model, the presence of mast cell activation and the inflammatory 
response did not lead to a severe (or anaphylactic) outcome. Esposito and colleagues 195 reported that 
the mean number of mast cells in normal human pancreas was 7.6 ± 3.0 cells/mm2 and in chronic 
pancreatitis 20.9 ± 9.3 mm2. Mast cells were abundant both in fibrous tissue and in residual acinar 
parenchyma with diffuse infiltration around ducts, vessels and nerves. The mast cell counts from 
Esposito et al were similar to the results obtained in our experiment. 
 
The role of mast cells in chronic pancreatitis is thought to follow a similar path to that of acute 
pancreatitis. According to Gruber277 mast cells may initiate fibrosis indirectly. Endothelial cells are 
activated, adhesion molecules increase, release of chemotactic factors (in particular TGFβ) leads to 
leucocyte adhesion and migration. Fibroblast adhesion is upregulated with the increase in ICAM-1 
and VCAM-1. The involvement of c-kit and other fibroblast factors leads to mast cell/stellate cell 
attachment, stellate cell activation and thus fibrosis. Concomitant with this, as mast cells degranulate, 
the release of TGFβ and TNFα stimulate stellate cell proliferation and the release of histamine, 
tryptase, heparin and MMPs.  
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In chronic pancreatitis and fibrotic disease, activated mast cells are identified as the cells responsible 
for perpetuating chronic inflammation.233, 234 In these models, the highest count of mast cells 
coincided with the peak of fibrosis. Mast cells were also present in the CHB and duct ligation models 
as fibrosis persisted and remained active, though declined in numbers in CHB. In the caerulein model, 
mast cell count dropped noticeably as fibrosis resolved. In the models where fibrosis persisted, mast 
cell counts remained high. In these models, mast cells were located singly in the interstitium in the 
vicinity of stellate cells, macrophages and the cells of tubular complexes and surrounded by collagen 
deposition. They were found associated with both stellate cells and macrophages. The adherence of 
mast cells to stellate cells may be mediated by the interaction of membrane bound stem cell factors 
on fibroblasts with the c-kit receptor on mast cells.  
 
The release of preformed mediators (histamine, tryptase, heparin, TNFα, TGFβ, bFGF, phospholipids 
and some cytokines) from mast cells is considered to be responsible for the activation of stellate cells 
which lay down ECM.235 In the CHB model, the numbers of activated PSC decreased in the same 
timeframe as mast cell numbers decreased, despite the persistence of fibrosis and partial regeneration. 
In the caerulein model, fibrosis, mast cell and stellate cell decline were inversely related to 
regeneration of acinar cells. In the duct ligation model, there was no decline in mast cell and stellate 
cell numbers or fibrosis. This forms the basis of a relationship between stellate cells, mast cells and 
fibrosis.  
 
4.7 OVERVIEW OF FIBROSIS IN PANCREATITIS 
 
Fibrosis is a common feature of failure to regenerate in pancreatitis. The persistence or withdrawal 
of PSCs affects regeneration, but their role is uncertain. Macrophages and other immune cells such 
as mast cells, also persist in fibrotic pancreatitis. Their contribution to limiting or driving 
inflammation associated with injury resolution requires further investigation. Communication 
between the fibrotic processes, inflammation and some developmental mechanisms may determine 
the outcome of regeneration. 
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CHAPTER 5 
SURVIVIN IN RAT PANCREATITIS 
 
5.1 INTRODUCTION 
 
Cell death and cell proliferation pathways are crucial to maintaining normal tissue homeostasis. 
During apoptotic cell death proteolytically-activated caspases cleave a range of substances that lead 
to nuclear and cell fragmentation. The inhibitor of apoptosis protein (IAP) family was identified in 
baculoviral genomes,236 and in humans consists of eight regulators with the ability to block apoptosis 
through caspase inhibition by a wide range of triggers. The IAP family comprises two classes of 
molecules either indicated in control of cell division or regulation of apoptosis, however one member 
of this family, survivin, is implicated in both functions.237 
 
The survivin protein has been extensively studied and is found to be unique in its differential 
expression in cancer compared with low to no expression in normal tissues and has been targeted as 
a potential cancer therapy due to its high expression in most human malignancies. It also has known 
functions in angiogenesis and cardiovascular diseases, and potentially has other roles. Most published 
reports concentrate on the involvement of survivin in cancer. The association of survivin in disease 
pathology is conceivably as important, however the expression and function of survivin in acute and 
chronic pancreatitis is not well defined. 
 
5.2 AIM 
 
The aim of this Chapter was to look at the expression and interactions of survivin with respect to 
apoptosis and cell proliferation in the rat models of pancreatitis.  
 
5.3 MATERIALS AND METHODS 
 
General materials and methods can be found in Chapter 2. IHC for survivin was performed using a 
monoclonal and a polyclonal antibody on serial sections from the experimental studies. The 
specification sheets from the antibody manufacturers suggest that both antibodies localize to the 
nucleus however examples provided for the antibodies showed some cytoplasmic staining in some 
tissues.  
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5.4 RESULTS 
 
Serial sections of IHC for survivin are presented in Figure 5.1 on alternate rows. The CST antibody 
localized well to nuclei although the cytoplasm often had a tinge of pale staining. Although there is 
the possibility that this was background staining, this appeared to be real staining as, though pale, it 
correlated with the cytoplasmic staining of the Nova antibody. The Nova antibody stained nuclei and 
cytoplasm, however it was particularly intense in the zymogen granules of acinar cells and the 
granules/cytoplasm of islet alpha cells during regeneration. Both antibodies showed some irregular 
staining or possible failed staining in random lobules, despite staining being performed in the same 
run or repeated. This was, however, a small percentage of the whole and the images presented here 
represent what is considered to be real.  
 
The pancreas has a low turnover of cells in proliferation and in apoptosis. Nuclear survivin positivity 
in the control rat pancreas was more evident in the interlobular ducts than other ducts and acinar tissue 
and was similar in both antibodies. Nuclear positivity was seen occasionally in islets. Cytoplasm 
showed only very pale staining in the Nova antibody. (Figure 5.1). At day 1 in all models there was 
increased nuclear survivin expression in the acinar population, and in cells of the inflammatory 
infiltrate (Figure 5.2A-E). In Nova staining acinar cells and particularly the zymogen granules 
stained strongly in the cytoplasm, however the cytoplasm was negative in the duct ligation model 
(Figure 5.2G,H,I). As tubular complexes formed they were nuclear positive in both antibodies and 
also pale cytoplasmic positive in CST to strong positive in Nova. For both antibodies the duct ligation 
model was not as strongly stained (Figure 5.2G-J). As regeneration progressed in the caerulein and 
CHB models, acinar nuclei were strongly positive for survivin (Figure 5.3A,B). Nuclei in tubular 
complexes and islets were moderately positive (Figure 5.3A-C). With Nova IHC, the regenerative 
acinar cell cytoplasm was strongly positive, but islet cells were palely positive. The tubular complexes 
of the CHB model stained strongly in contrast to the duct ligation model where the cytoplasm was 
pale, however the nuclei stained strongly. Residual regenerated acini continued to express survivin 
strongly in the CHB model up to 28 days. Tubular complexes had random positive nuclei and some 
pale cytoplasm (Figure 5.3G,H).  
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Figure 5.1 Control rat pancreas with survivin immunohistochemistry 
Normal pancreas has a low turnover in proliferation and apoptosis Survivin nuclear positivity was 
seen in control sections primarily around or in ducts. A. CST antibody stains a probable acinar nucleus 
brown (arrow). In B, nuclei in the interlobular duct stain positive with both antibodies (arrows). In 
the corresponding section to A with Nova (C), there is pale staining in the ductal nucleus (arrow). In 
D, the cytoplasm and/or zymogen granules in acinar tissue at the bottom and right side of the Nova 
section (d) has a slight blush of colour.  
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Figure 5.2 Distribution of survivin at early time points in the rat models 
The CST antibody stained nuclei whilst the Nova antibody stained nuclei and cytoplasm.. When 
apoptosis was active acinar cell staining was prominent. Cells of the inflammatory infiltrate were 
nuclear positive and probably proliferating. Cytoplasmic staining in acini was weak in the duct 
ligation model. When tubular complexes formed they were also nuclear and cytoplasmic positive.  
Each experimental row depicts a comparable stage in the course of the pancreatitis for each model 
but not necessarily the same time point. Antibodies and models are indicated within the figure. A,D. 
caerulein, day1 x400; B,E. CHB, day1 x400; C,F. duct ligation, day1 x400; (G,J.)caerulein, day2 
x400; H,K.) CHB, day4 x400; I,L. duct ligation, day4 x400 
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Figure 5.3 Distribution of survivin at later time points during regeneration 
Models and antibodies are indicated within the figure. Each experimental row depicts a comparable 
stage in the course of the pancreatitis for each model but not necessarily the same time point. The 
Both antibodies indicate proliferative acinar cells by nuclear staining and zymogen granules are 
strongly positive in regenerating acini with the Nova antibody. A,D . Regenerating acinar nuclei show 
brown positivity with both antibodies, and cytoplasmic staining with Nova. Ducts and islets have pale 
cytoplasmic staining. Caerulein, day4 x400. B,E. Regenerating acini show positivity. Nova staining 
is prominent in acinar and tubular complex cytoplasm. CHB, day5 x200. C,F.Random tubular 
complex nuclei are positive. Nova stain is positive in the cytoplasm of tubular complexes. Duct 
ligation, day7 x400. G,H.) CHB, day28 x200 Nuclei are positive in regenerating acini and in tubular 
complex cells. Regenerated acini are still highly positive in cytoplasm, Nova. CHB, day28 x200 
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Other cell populations stained with the survivin antibodies. This was similar in all models although 
not all examples are demonstrated here. With Nova IHC but not CST IHC, the alpha/glucagon cells 
of the islets stained strongly (Figure 5.4A,C). This was also random as many but not every islet 
showed this staining effect (Figure 5.4F). Figure 5.4C and F compare the differences in staining of 
regenerative acini between the two antibodies.  Interlobular ducts showed prolific nuclear positivity 
(Figure 5.4G,J) as did B cells and mast cells in the lymph nodes (Figure 5.4H,K). Nerve bundles 
and ganglion cells were cytoplasmic positive only in Nova but nerve bundles were negative and 
ganglion cells strongly nuclear positive in CST (Figure 5.4I,L). Cells of the inflammatory infiltrate 
were harder to judge. There were many seen strongly positive in the early time points however 
thereafter positive cells were few.  
 
The proliferation marker PCNA on similar (but not serial) areas of the same models show that survivin 
nuclear positivity correlates with cell cycling in these models (Figure 5.5). Figure 5.5A,D,G 
compared islets stained for survivin, PCNA and alpha/glucagon cells. Survivin and PCNA staining 
are compared in interlobular ducts (Figure 5.5B,E), and in tubular complexes (Figure 5.5C, F). 
Regenerated acini in the PCNA stained image (Figure 5.5D) can be compared with the CST stained 
image of Figure 5.3A. 
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Figure 5.4 Survivin staining in other cell populations 
Models and antibodies are indicated within the figure. Islets, large ducts, lymph nodes and nervous 
tissue also stained with the survivin antibodies. In serial sections (A,D), markedly positive staining 
was noted on islet alpha cells with Nova but not CST. Caerulein, day 2, x200. This also applies to 
B,E which are CHB, day 4, x400. C,F show darkly positive staining of regenerating acinar cells, and 
variation in staining between antibodies for the islet. CHB day 18, x200. G,J. Nuclear staining of 
proliferative cells is similar between antibodies. Interlobular duct, caerulein, day10 x400. H,K. 
Lymph node with staining of B cell and mast cells. (I,L.) Ganglion cell nuclei stained with CST, 
cytoplasmic only with Nova. Nerve bundles were more prominently stained with the Nova antibody. 
This pattern of ganglion staining was consistent between the antibodies.  Ganglion cell (long black 
arrow, nerve bundle (short arrow). 
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Figure 5.5 Comparison of survivin with proliferation marker PCNA 
These images are not from serial sections. A. Islet alpha cells are strongly stained in the cytoplasm 
with survivin antibody, Caerulein, day 2 x200. For comparison, the distribution of alpha cells in an 
islet are indicated with IHC for glucagon in image G, CHB, day 18, x200. Interlobular duct nuclei 
stained positively with both survivin and PCNA. B, survivin, Caerulein, day 10 x400, E, PCNA 
Caerulein, day 10 x400. Tubular complex nuclei were positive both with survivin and PCNA, C, Duct 
ligation, day 7 x400, F, Duct ligation, day 7, x400. D shows cycling regenerating acinar cells (long 
arrow), islet cells, tubular complex (short arrow). Caerulein, day 2, x400; H shows cycling acinar 
cells. CHB, day 1, x400, both with PCNA IHC.  
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5.5 DISCUSSION 
 
Survivin, the smallest member of the IAP family, is a multifunctional protein indicated in control of 
cell division and in regulation of apoptosis. It is usually found in all common cancers including 
pancreatic cancer, and selectively in normal cell development but it is not expressed in terminally 
differentiated tissues. It has a complex role in cell development as demonstrated by the impaired cell 
proliferation, apoptosis, cell cycle arrest and mitotic spindle formation that occurs when survivin is 
depleted or knocked down.238 Survivin is expressed precisely in the G2/M phase of the cell cycle. It 
is involved in the cytokinesis process of mitosis by chromosome passenger protein behaviour and 
associates to centromeres from prophase to metaphase. Survivin has an anti-apoptotic role regulated 
by several mechanisms. Inhibition of apoptosis by survivin may occur during mitosis via the mitotic 
spindle checkpoint239 or through mechanisms functionally-distinct from the mitotic role, including 
directly binding and inhibiting cell death proteases caspase-3 and caspase-7.240  
 
Survivin is located in the nucleus contained in the mitotic apparatus and in the cytoplasm 
predominantly localized to mitochondria. Consistent with its function in cell survival and cell division 
is the proposal that nuclear survivin promotes cell division and cytoplasmic survivin controls cell 
viability. However, survivin is assumed to shuffle between nucleus and cytoplasm and has a number 
of splice variants with identical amino acid peptides that differ in subcellular locality and have 
different functional properties. The antibodies used in this study recognize all or most survivin splice 
variants and do not discriminate between the splice variants, thus the exact function of survivin in the 
cellular populations in these pancreata is subject to postulation. 
 
The results show that acinar cells expressed survivin early in pancreatitis. Acinar nuclear survivin 
expression was noted also in acute necrohaemorrhagic pancreatitis in rats induced by sodium 
taurocholate.204 This group recognised that survivin expression was not in every nucleus, proposed 
that the lack of survivin expression in other nuclei indicated that apoptosis may be activated in acinar 
cells and thus the nuclear expression of survivin is the anti-apoptotic effect. In the present study, 
survivin was expressed both in acinar nuclei and in the cytoplasm, depending on the antibody. Nuclear 
survivin expression was not in every cell and indicates that some acinar cells were cycling, confirmed 
by PCNA IHC. The early acinar cytoplasmic survivin expression was consistent in both the caerulein 
and CHB models but not in the duct ligation model. Whether the effect in the duct ligation model is 
real or a possible fixation artefact is unknown. It is clear, however, that the expression of survivin is 
increased in acinar cells early in this pancreatitis. Because the majority of these positive cells soon 
became apoptotic, the expression of survivin is not likely to have an anti-apoptotic effect. It may 
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indicate only that cell death pathways are activated and other factors determine which pathway of cell 
death or survival proceeds. Alternatively, the expression of survivin may indicate that acinar cells are 
differentiating. 
 
It is important to understand the regulation of the death pathways in pancreatitis. Apoptosis, the 
primary mode of cell death in these models, is a tightly regulated process encompassing the caspase 
family of cysteine proteases. As a member of the IAP family, survivin inhibits the caspase system 
and several studies have reported the role of IAPs in regulating cell death in pancreatitis.237 In 
caerulein pancreatitis in rats and mice, where apoptosis and necrosis were the modes of cell death 
respectively, the IAP called XIAP has been studied. In the rat model, XIAP was degraded and 
caspases activated leading to apoptosis in contrast to the mouse model where XIAP was not degraded 
and caspases were inhibited, resulting in necrosis.241 PKD/PKD1 is the predominant isoform of the 
serine/threonine protein kinase family expressed in rat pancreatic acinar cells.242 It is reported to 
mediate signal pathways in pancreatitis through NF-κB zymogen granule activation. In this study of 
experimental caerulein-induced pancreatitis, the Pandol group discovered that this protein kinase 
inhibits caspase activation and apoptosis but promotes necrosis by increasing the level of anti-
apoptotic proteins such as survivin.242 
 
In tubular complexes and normal ducts, survivin expression increased from normal values in both 
nuclei and cytoplasm, depending on the antibody. Comparison with PCNA expression, in tubular 
complexes and ducts at equivalent time points, indicates that this nuclear expression represents 
cycling cells. It is tempting to describe the consistent cytoplasmic tubular complex survivin 
expression as anti-apoptotic. Duct cells have an anti-apoptotic tendency as shown by expression of 
the Bcl2 family proteins compared with the pro-apoptotic tendency of acinar cells.243 Regenerating 
acinar cells in the caerulein and CHB models strongly expressed survivin in the nucleus and in 
zymogen granules and cytoplasm. Again, the nuclear staining equated with cycling cells but the 
cytoplasmic staining is not easily explained other than survivin expression is involved in the 
regeneration of acinar cells and that the cells of the tubular complexes may not be terminally 
differentiated. 
 
In the three rat models of pancreatitis, islet cells had nuclear expression of survivin in random cells 
consistent with cycling cells. General cytoplasmic staining may be explained as anti-apoptotic. The 
islet cells remain, presumably unaffected and non-apoptotic, under caerulein, CHB and duct ligation 
pancreatitis. Islet cells do undergo apoptosis in normal development and in diabetes pathology and 
are affected by disturbances in the cell cycle in development.244, 245 With only a few exceptions, the 
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alpha cells that produce glucagon were strongly cytoplasmic positive, the beta and delta cells pale. 
These inconsistencies indicate increased survivin expression requires further investigation. IHC for 
survivin was demonstrated in human fetal alpha and beta cells but expression was noted only in alpha 
cells of newborns and adults.244 High survivin expression in islets has been reported previously.203 
Hasel and colleagues report high survivin expression with immunohistochemistry in chronic 
pancreatitis in islets surrounded by fibrosis. As islets are stimulated for the TRAIL receptor lacking 
a death domain, and pancreatic stellate cells produce TRAIL, this suggests that an apoptosis-
inhibitory program may be imposed on islet cells by stellate cell regulated TRAIL. Beta cell survivin 
expression has also been reported. Postnatal mice deficient in survivin in beta cells develop disordered 
insulin production and growth of beta cells due to lack of cell cycle progression.245 Expression of the 
survivin protein, in this case, was due to EGF signalling through the Raf-1/ERK pathway. Survivin 
was strongly expressed in the nuclei of ganglion cells with the CST antibody but not with the Nova 
antibody. In Nova IHC, the ganglion cytoplasm was moderately stained as were nerve bundles that 
were negative in CST. The pancreas is richly innervated with mainly unmyelinated nerves with 
sympathetic and para sympathetic pathways and neural cell bodies known as intra-pancreatic ganglia 
aggregated randomly throughout the lobules.14 The sensory nerves are damaged in pancreatitis by 
inflammation leaving them susceptible to factors released from inflammatory and acinar cells.246 The 
damaged and sensitized nerve cells may be utilizing an adaptive and local defence response to injury 
by activating survivin.  
 
This study in three models of rat pancreatitis has shown that survivin expression is increased in the 
major cell populations in pancreatitis. As cell death, cell proliferation and differentiation are 
implicated in pancreatitis and with survivin expression, the challenge will be to better define the role 
of survivin. The change in expression in different populations at different phases of the disease is not 
well defined and forms the basis for future investigation, particularly with respect to regeneration. 
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CHAPTER 6 
THE EFFECT OF CYANOHYDROXYBUTENE IN 
MICE 
 
6.1 INTRODUCTION 
 
The common animal models of pancreatitis have been developed in a variety of species and are 
reviewed comprehensively in Chan and colleagues.274 Models using chemical administration, diet, or 
surgically-induced have been developed in such diverse species as rats, mice, rabbits, dogs, cats, 
hamsters, pigs, opossum and ducklings. These models, whether invasive or non-invasive, simple or 
complex, employing high or low dose, induce a variety of lesions from mild interstitial to severe 
necrotising pancreatitis with considerable variation between species.  
 
Following the sequencing of the genome of the mouse, transgenic mouse models and gene deletion 
studies facilitate understanding the role of specific proteins in the complex processes where different 
proteins interact and co-react in pancreatitis.247 The model of CHB in rats eliminates all, or virtually 
all, acinar cells, produces fibrosis and regeneration occurs transiently. The possibility of using CHB 
as a model for pancreatitis in transgenic mice to study fibrosis and regeneration required exploration. 
It was, therefore, critical to assess whether the effect of CHB on the pancreas occurs, and whether 
this can be achieved safely.  
 
Bhatia et al.276 found that in mice a single intravenous dose of CHB (70mg/kg) induced apoptosis of 
pancreatic acinar cells. We are collaborating with a group at the Johns Hopkins Hospital in Baltimore, 
Maryland, USA (led by Dr Steven Leach) who has tried unsuccessfully to reproduce in mice the work 
by Bhatia et al. We reasoned that a successful regimen of subcutaneous dosage could develop a 
similar lesion in mice to that developed with subcutaneous dose in the rat, that is, with a more atrophic 
effect, and total loss of acinar cells. The effect of CHB is dose-related in rats216, 248 and a sufficiently 
high dose in mice might be expected to initiate apoptosis within a relatively short time frame. 
Subcutaneous injections provide a method for minimal handling of animals in line with current ethical 
standards.  
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6.1.1. Aim 
 
These experiments attempted to establish the CHB model of pancreatitis in mice. The aim was to 
induce pancreatitis in mice by the same method as that produced previously in rats. 
 
6.2 MATERIALS AND METHODS 
 
General materials and methods have been included in Chapter 2. Three separate experiments were 
performed to determine a dose and time frame that would produce pancreatitis in mice. Light and EM 
and IHC were used to investigate results. The weight of mice decreased between 0.5 and 2.5 g over 
the experimental period.  
 
Experiment 1 Subcutaneous dose regime of CHB to produce apoptosis in mice 
Adult mice between 27.0-34.5gms were randomly divided and housed in pairs. One pair used for 
sham control purposes was injected subcutaneously with 0.25ml normal saline. As this was an attempt 
to reproduce the work by Bhatia et al.,276 and our collaborating group had already been unsuccessful 
by following that method exactly we proposed to use subcutaneous instead of intravenous injection 
which was successful in rats. As well, we treated the attempt as a pilot experiment starting with low 
doses with the intention of increasing the dose after histological review of the previous dose pair. 
Subcutaneous doses of CHB started at 70mg/kg through 90, 110, 150, 170, 190, 210, 230, 250, 270, 
290 and up to 310mg/kg. Light microscopy, EM and IHC were used to investigate outcome. 
 
Experiment 2. Optimal dose of CHB over time 
As the results of experiment 1 were not optimal for apoptosis, we sought to expand the experiment 
with time frame to see if we had missed some effect. We chose a dose which produced cell death, 
either apoptosis and/or necrosis but did not cause excessive liver damage. Three groups of eight mice 
were injected with a subcutaneous dose of 280mg/kg and one group euthanased at each time point of 
12, 18 and 24 hrs, liver and pancreas were removed and processed as above.  
 
Experiment 3. Effect of mouse adolescent status with optimal dose of CHB  
Four smaller CD1 Swiss mice of 21 – 23 grams were given 280mg/kg subcutaneously and euthanased 
at 24 hrs, then liver and pancreas taken as above. This was performed as some effect in rats may have 
been due to the adolescent status of the animals and we wanted to test if the same applied to the mice.  
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6.3 RESULTS 
 
6.3.1 Experiment 1. Subcutaneous dose regime of CHB to produce apoptosis in mice 
 
Effects of CHB on apoptosis and mitosis are represented in Figure 6.1. The effect on mice of a 
subcutaneous injection of CHB did produce apoptosis as hoped however not to the desired degree. 
Mitosis levels were slightly above normal. Damage to acinar cells occurred but the lesion did not 
proceed to classical pancreatitis. Liver necrosis caused fatal injury to the mice before pancreatitis 
could develop. In H&E sections the control mouse pancreas demonstrates typical closely packed acini 
with basophilic nuclei basally situated and eosinophilic zymogen granules at the cell apex. The acini 
are closely packed with minimal intercellular space (Figure 6.2A). The normal liver shows typical 
rows of hepatocytes separated by sinusoids. Two central veins are visible with a portal tract on the 
far right (Figure 6.2B). At a low dose of 70mg/kg CHB, there were mild changes of intra-and inter-
lobular oedema in the pancreas shown by the increase in intra-acinus space. Both apoptotic cells and 
mitotic cells were evident in small numbers (Figure 6.2C). High power microscopy of the pancreas 
revealed vacuoles in acinar cells indicating the loss of zymogen granules via disordered autophagy, 
and change to RER was indicated by whorling. Nuclei had slightly clumped chromatin and there was 
loss of adhesion between individual acinar cells. (Figure 6.2D).  
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Figure 6.1. Effects of CHB on apoptosis and mitosis over 24 hrs  
Apoptotic and mitotic nuclei were counted in ten fields of x400 magnification for one whole pancreas 
section at 4µm thickness per mouse per time point. Data are the mean ± SEM of eight mice (n=8) per 
time point from one experiment. Error bars represent the standard error of the mean. HPF=high power 
field. The effect on mice of a subcutaneous injection of CHB did produce apoptosis at 18 and 24 hrs, 
as hoped, however not to the desired degree. Mitosis was slightly above normal (time 0). One way 
ANOVA was used to compare apoptosis and mitosis in control groups versus experimental groups. 
Tukey’s multiple comparison test was used to compare individual groups. Apoptosis counts were not 
significantly different from controls at time points 12 hrs and 18 hrs (P=0.9988, P=0.0924, 
respectively) but were significantly higher than controls at 24 hrs (P<0.0001). Mitosis was 
significantly higher than the control group at 12 hrs (P<0.0001) and 24 hrs (P=0.0315) but not 
significant at 18 hrs (P=0.4875). 
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Figure 6.2 Mouse pancreas and liver for controls and experiment 1 (70mg/kg CHB) 
Mouse control pancreas typically showed closely packed acini with minimal interacinar space, 
basophilic basal nuclei and apical eosinophilic zymogen-filled cytoplasm. The liver consisted of 
plates of hepatocytes separated by sinusoids. Central veins and portal tracts formed a typical triad 
with the bile ducts. Mild changes occurred at a dose of 70mg/kg CHB. There was intra- and 
interlobular oedema, seen by increased spacing between acini, some apoptosis and mitosis. At high 
power, vacuoles from disordered autophagy were visible, loss of zymogen granules was indicated by 
condensed cytoplasm and loss of adhesion between individual cells. Nuclear chromatin was 
condensed. A. Control pancreas with closely packed acini, luminal cytoplasm eosinophilic, basal 
cytoplasm basophilic. H&E, x400. B. Control liver, portal area and central vein of normal liver. H&E, 
x200. C. Pancreas treated with 70mg/kg CHB, intralobular oedema, mitosis (short arrow), apoptosis 
(thin arrow). H&E x400. D. Pancreas at 70mg/kg CHB, vacuoles (black arrows) distension of RER 
(white arrows), loss of cellular adhesion. H&E x1000 
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These mild pancreatic changes were consistent up to doses of 190mg/kg. At doses of 190-250mg/kg, 
the pancreatic lobules showed patchy changes consistent with increased disruption to acinar cells. 
This pathology was similar at doses of 270-310mg/kg, however the effect was more widespread. 
Basophilic and shrunken pancreatic cytoplasm reflected increased loss of zymogen granules (Figure 
6.3A). High power view of a similar damaged area showed fewer nuclei, some with condensed 
chromatin, apoptotic figures, and large autophagic vacuoles in the cytoplasm (Figure 6.3B). 
Apoptosis was more prevalent at this stage but apoptotic counts were variable between animals and 
between lobules. Cell loss was obvious in some areas with acini consisting of only a few cells and 
many acini showed loss of adhesion between the remaining cells. In some lobules apoptosis and 
mitosis were juxtaposed.  
 
There was no obvious liver pathology at doses less than 270mg/kg. Between 270mg and 310mg/kg 
mice had liver damage but four of fourteen mice had extensive liver pathology. This varied in the 
extent of necrosis, haemorrhage and apoptosis between lobules. Intact areas of liver were sharply 
demarcated from necrotic areas (Figure 6.3C). Cell death tended to be more obvious in portal areas 
of the lobule. Ghost cells coexisted beside apoptotic cells with pyknotic nuclei. Margination of 
inflammatory cells was present in veins and other cells, either apoptotic Kupffer cells or apoptotic 
bodies in Kupffer cells and/or lymphocytes were present in sinusoids (Figure 6.3D).  
 
Pancreata from experiment 1, for example samples with doses of 270, 280, 290 and 310 mg/kg were 
chosen for further study with Bax and BclxL, immunohistochemistry. Nuclei showed positivity for 
both Bax and Bcl-x however the results were inconsistent with considerable variation between and 
within pancreatic lobules (Figures 6.3E,F). 
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Figure 6.3 Mouse experiment 1. Pancreas and liver in mice treated with 270mg/kg CHB 
Apoptosis was more prevalent at this dose with apoptosis and mitosis juxtaposed. Cell loss and lack 
of adhesion was more obvious. Liver damage included necrosis and haemorrhage, intact areas of liver 
were sharply demarcated from necrotic areas. Cell death was more prominent in portal area and 
inflammatory cells marginated in veins. Nuclear positivity for Bax and Bcl-xL was inconsistent with 
significant variation between lobules. A. Slightly damaged pancreas with basophilic cytoplasm 
reflects loss of zymogen granules. H&E, x400. B. Pancreas with whorling of RER, condensation of 
cytoplasm and nuclei, apoptosis (short arrows), loss of cell adhesion and architecture. H&E, x1000. 
C. Liver, necrosis (NEC) and haemorrhage (H). x200. D. Liver necrosis, haemorrhage and apoptosis; 
intact areas are sharply demarcated from damaged areas; margination of inflammatory cells (arrow), 
ghost cells devoid of nuclei (star). H&E x400. E. Bax positive nuclei brown counterstain 
haematoxylin. X400. F. Bcl-xL positive nuclei brown counterstain haematoxylin. X200. 
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EM of the mouse pancreas showed marked dilatation and whorling of endoplasmic reticulum in acinar 
cells. Nuclei appear normal. Inclusion bodies were present in lysosomes within the cytoplasm and 
extruded into enlarged intracellular spaces (Figure 6.4A). At a higher power electron dense zymogen 
granules are seen in the cytoplasm ready to be extruded as well as enclosed in extruded bodies with 
residual RER. Mitochondria appeared normal (Figure 6.4B). In Figure 6.4C, nuclei showed early 
margination of chromatin. Intercellular spaces were distended with widening gaps between 
neighbouring cells due to failure of desmosomes and gap junctions in lateral membranes. Flocculent 
material and residual RER is seen in these gaps. Zymogen granules were depleted, those remaining 
being small. Mitochondria were changed, dilated slightly with swollen cisternae. Few and small 
zymogen granules, many vacuoles and tightly wound RER are a typical picture of apoptosis, however 
in apoptosis the nuclei are apoptotic at a similar stage, and apoptotic bodies begin to form within the 
acinar cytoplasm. The mitochondrial swelling is more typical of necrosis (Figure 6.4D). A 
macrophage appears poised to mop up debris (Figure 6.4D). 
 
A more advanced necrotic picture is depicted in Figure 6.5A,B with cell contents being extruded into 
the interstitial space through breakdown of the cell membrane. Vacuoles with debris have moved 
towards the cell surface, debris accumulating in the interstitial space. Mitochondria have increasingly 
swollen cisternae.  
 
6.3.2 Experiment 2. Optimal dose of CHB over time  
 
In mice with CHB doses over 280mg/kg, liver damage increased with dose concurrent with more 
pancreatic necrosis than apoptosis. The next experiment was designed to investigate the time effects 
on mice given a dose of CHB that achieved some apoptosis without too much liver necrosis. The 
pancreas from mice given 280mg/kg CHB in the time course from 12 to 24 hrs showed a similar 
progressive loss of zymogen granules in acinar cells. Whorling of RER, oedema and loss of adhesion 
between acinar cells and whole acini became widespread with time in most samples. The effect was 
mostly necrotic, however apoptosis and mitosis were again coexistent (Figure 6.6A). By 24 hrs 
apoptotic counts reached 1.29% compared to control 0.05%; mitosis reached 0.17% compared to 
control 0.03%. With increased time liver necrosis was more consistent, obvious and advanced, and 
haemorrhage was common in the 24 hour mice (Figure 6.6B).  
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Figure 6.4 Non-lethal acinar cell damage in mouse pancreas 
By electron microscopy damage to pancreatic acinar cells was obvious. There was marked dilatation 
and whorling of RER. Inclusion bodies were in active lysosomes, in the cytoplasm and in intracellular 
spaces. Inter- and intracellular spaces were distended with failure of desmosomes and gap junctions 
causing spaces between cells where flocculent and residual RER gathered. There was some early 
margination of nuclear chromatin. Zymogen granules were depleted and the mitochondria had slightly 
swollen cisternae. A. Intercellular separation at bottom and vacuoles with extruded residual material 
(short black arrows), RER is whorled. EM x3000. B. High power of A shows extent of whorling and 
distention of RER. Zymogen granules and RER are being extruded (black arrows). Mitochondria (M) 
appear normal. EM x9000.C. Nuclei show early margination of chromatin (short white arrows). 
Lateral membranes are separated by gaps (long black arrow) containing extruded RER (long white 
arrow). Basement membrane is disrupted (short black arrow). Few small ZGs are scattered in the 
cytoplasm (star). EM x5000. D. Acini with swollen mitochondria (M), large vacuoles (short black 
arrows), few ZG (star) and residual RER. Stellate cell (PSC), macrophage (ma). EM x2500. 
 
134 
 
 
 
Figure 6.5 Acinar injury with necrosis in the mouse model 
These images show a more advanced scenario of acinar cell damage than in Figure 6.4. This damage 
is more consistent with necrosis. A. Acini with whorled, condensed rough endoplasmic reticulum 
(RER) and swollen mitochondria. Breakdown of cell membrane with extruding debris (long white 
arrows), nuclear debris (N), extensive autophagic vacuoles (short arrows). EM x3000. B. Swollen 
mitochondria (M), debris and macrophage EM x7500 
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Figure 6.6 Experiment 2. Pancreas and liver in mice treated with 280mg/kg CHB for 24 hrs 
The pancreas of mice treated with a high dose of CHB for 24 hrs showed the most apoptosis however 
this coexisted with mitosis. The typical picture was of loss of zymogen granules and cellular adhesion, 
vacuoles, condensation of cytoplasm. Liver necrosis was more obvious and advanced with 
haemorrhage common. A. Pancreas, cytoplasmic vacuoles (white arrow), mitosis (short arrow), 
apoptosis, (thin arrows), note less numbers of cells comprising acini. H&E, x400. B. liver H&E. 
necrosis (NEC) and haemorrhage (H). x200.  
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6.3.3 Experiment 3. Effect of mouse adolescent status with optimal dose of CHB  
 
As there was no histological difference in the pancreatic or liver effects in younger mice given 
280mg/kg and euthanased at 24 hrs compared to older and heavier mice, the pathology was no longer 
considered relevant and no images are presented.  
 
6.4 DISCUSSION 
 
The desired outcome of massive synchronous apoptosis by 12 hrs, and subsequent atrophy of exocrine 
pancreas as was found in the rat under similar experimental conditions was not achieved. At 24 hrs 
after a single subcutaneous injection of CHB to mice the apoptotic count reached seven per high 
power field (HPF) magnification x400 or 1.29% of acinar cell total compared with control levels of 
0.03%. This is only a slight increase in apoptosis, far below that found in intravenous dose by Bhatia 
et al.276 In their study, when CHB was given as a single intravenous dose of 70mg/kg to mice, 
apoptotic acinar cells reached 30-40 per high power field (magnification x250) 12 – 24 hrs after 
injection but apoptotic labeling diminished between 24-36 hrs post CHB administration and at 48 hrs, 
substantial viable acinar tissue remained.  
 
Walgren and colleagues273 evaluated the sensitivity of peptide markers for pancreatitis in rats treated 
with CHB and caerulein, and mice treated with CHB. Mice were administered a single subcutaneous 
dose of CHB (50 or 150mg/kg) however details of the method of CHB synthesis was not given. 
Minimal histological changes were noted in the mouse pancreas.  Both diffuse and multifocal changes 
were seen, mainly mild vesiculation in the RER and ZG zones. No apoptosis or necrosis was reported. 
The Steven Leach group (Johns Hopkins, Boston) reported a similar unsuccessful dose response 
regime with intravenous CHB in mice (personal communication, Prof Sandra O’Toole, Garvan 
Institute of Medical Research). At low doses there was mild injury to the pancreas. At high doses, 
liver necrosis killed the mice with little change to the pancreas. 
 
Given the half-life of apoptotic bodies of 1-2 hrs249, 250 and the fact that small increments in apoptotic 
indices of the order of 1-2% can halve the total cell population of a tissue within 24 hrs,251 the 
observed high apoptotic indices in the Bhatia276 experiment should have been sufficient to delete all 
or most acinar cells by 48 hrs. The apoptotic staining methods used in that experiment (Fluorescent 
dye Hoechst H33258 and in situ staining by Apoptag method) may be demonstrating cleaved strands 
of DNA that have chosen the apoptotic pathway but go on to repair rather than continue to the final 
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stages of apoptosis. That substantial tissue remained at 48 hrs would indicate that apoptosis leading 
to acinar atrophy was also not achieved in the Bhatia model. 
 
It would appear that the results in our experiment reflect that of a mild effect of CHB, and that liver 
damage occurs before atrophy of acinar cells. The histological picture seen in our experiments with 
mice closely resembles the mild effect described by Wallig and colleagues248 on rats 150-225gm 
given a single dose of CHB (extracted from the seeds of Crambe Abyssinica) daily in 0.25-0.50ml 
corn oil. Note: corn oil is not miscible with CHB. In those experiments, the most consistent lesion 
over 1-4 days was dilatation of the cisternae of RER in pancreatic acinar cells. The degree of dilatation 
varied from cell to cell but was present to some degree on virtually all acinar cells. In most acini 1-4 
cells were reduced in size and had rounded profile, severely dilated ER cisternae, decreased numbers 
of zymogen granules and varying degrees of cytosolic condensation. Nuclei and mitochondria were 
unaltered. Some apoptosis was seen (shrunken cells and cell fragments) in acini, macrophages, 
autophagic vacuoles and within the interstitium.  
 
Clinically and experimentally, apoptotic and necrotic cell death are seen in pancreatitis. The 
mechanisms which determine whether acinar cells undergo the apoptotic or necrotic cell death 
pathway are still to be fully understood and involve an array of molecules. Mareninova et al 240 
investigated the differences in cell death responses between rats and mice in a model of caerulein-
induced pancreatitis, with up to seven hourly injections of 50µg/kg caerulein. The rat pancreatitis was 
mild and characterised predominantly by apoptosis; the mouse model more severe with 
predominantly necrosis. Detection of caspase activity determined that in the rat model the effector 
caspase-3 and the initiator caspases-8 and -9 were swiftly increased compared with no caspase 
activation in the mouse model. The intrinsic pathway of apoptosis involves mitochondrial damage 
that releases cytochrome-c to form a complex with Apaf-1 and procaspase-9 that in turn activates the 
effector caspases through caspase-9. This appeared to be the pathway initiated in both rats and mice 
however in the mice the caspases-8 and -9 were blocked in the acinar cells. In caerulein-induced 
pancreatitis, therefore, it appears that mice are more susceptible to necrosis than apoptosis and vice 
versa for rats. Furthermore this group found that caspases protected the rats from necrotic cell death.  
 
Marked depletion of pancreatic glutathione (GSH) within 1-2 hrs of CHB administration248, 252 
suggests that CHB causes oxidative injury to acinar cells that initiates apoptosis.253 In rats, there was 
a dose relationship between GSH elevation and pancreatotoxicity following intravenous and oral 
administration of CHB.248 Plasma levels would be expected to peak much higher following 
intravenous administration compared to subcutaneous and oral dosing thus toxicity and GSH 
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elevation are most likely both related to plasma levels. The data on intravenous administration showed 
that both toxicity and GSH elevation are dose dependent. Wallig and Jeffery252 showed a mild 
protective effect of low dose CHB against the toxicity of subsequent high-dose CHB. It may be that 
the induction of glutathione after CHB administration in the mouse confers a relative resistance to 
further similar insults. The Bhatia group276 showed a protective effect of CHB against caerulein 
induced injury, especially when given 12 hrs after CHB but not after 18 or 24 hrs.  
 
In this experiment there was considerable inter- and intra-lobular variability in the pancreatic lesion 
indicating that the dose effect was less than optimal. Some acinar cells had swollen mitochondria 
indicating early necrotic injury. Loss of zymogen granules was more marked than in the rat model - 
an indicator of either a necrotic or apoptotic pathway to cell death.  Necrosis in this setting may be a 
high dose effect, but at lower dose (70mg/kg) we saw little evidence of apoptosis. We have speculated 
that in the rat, early apoptosis is a mechanism protective against necrosis.216 This does not appear to 
exist in mice and this is confirmed by the study of caspases between rats and mice by Marienova et 
al.241 The morphological features of apoptosis are well defined in the nucleus as crescentic 
margination of chromatin against the nuclear membrane. In this mouse experiment, besides classical 
apoptosis, electron micrographs show margination of nuclear chromatin different from the classical 
manner of apoptosis. This partial margination bears resemblance to that depicted as the morphological 
features of nuclei in autophagic cells.254 Autophagy may be involved in the degradation of damaged 
organelles such as mitochondria and endoplasmic reticulum as a survival mechanism for cells as 
opposed to a death pathway. Vacuolisation in the cytoplasm is seen in both necrosis and autophagy. 
In this mouse lesion it can be seen that the processes of autophagy, apoptosis and necrosis are seen 
concurrently. 
 
In the mouse pancreas there was no evidence of a substantial inflammatory infiltrate. Various triggers 
dictate the course of pancreatitis whether acute or acute-on-chronic. Generally, activation of 
complement and other serine proteases and fibrinolytic cascades occurs early.194 Caerulein 
administration in rats excites a vigorous inflammatory response255 however in rats given CHB 
inflammation is delayed, reaching moderate density only at 48 hrs,215, 252 or from early in the 
subcutaneous lesion it is mainly mononuclear with the number of neutrophils remaining small 
throughout.216 Although macrophages and stellate cells were noted in the mouse pancreas their 
numbers were not observed to increase. Weight loss in most mice would suggest that some acinar 
attrition had occurred, however mitosis was present just above normal levels from 12 hrs, indicating 
that the pancreas may have been attempting to maintain homeostasis. With viable acinar cells 
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remaining it is difficult to ascertain whether regeneration was from remaining acinar tissue, from duct 
cells or from other stem cells.  
 
Mitochondrial membrane permeabilisation (MMP) is the event that defines the point of no return in 
most programmed cell death models. Bax and/or Bak are the pro apoptotic, pore-forming molecules 
of the Bcl-2 family that can trigger MMP and the release of death-inducing molecules from the 
mitochondrial intermembrane space. The anti-apoptotic Bcl-2 proteins, Bcl-2 and Bcl-xL oppose 
MMP.256 Immunohistochemistry for Bax on the mouse sections showed an increase in expression 
with dose but not an increase with time compared to controls. Bcl-xL immunohistochemistry showed 
an increase in expression compared to controls that did not relate to either dose or time and varied 
between lobules. The inconsistent balance of Bax to Bcl-xL most likely reflects the inability of this 
model to undergo significant apoptosis.  Rats may have a lower threshold for apoptosis of acinar cells 
than do mice where BclxL and Bax are evenly switched on and may protect from low threshold 
apoptosis. As these results were inconsistent no statistical analysis was completed with Bax to Bcl-
xL here however an expanded future comparison with mouse versus rat Bcl-2 family proteins may be 
worthwhile.  
 
In these experiments, the dose of CHB was not increased past 310mg/kg as this high dose proved to 
be hepatotoxic to mice. This is in itself an important and interesting observation for the role of CHB 
in the liver. In mice given 250mg/kg CHB liver necrosis was more obvious with time. When given 
orally in water to rats, CHB is toxic to liver at a lower dose than to pancreas as expected with the 
portal circulation. In contrast when given subcutaneously the pancreatotoxic effects are the first to 
occur, followed by hepatotoxicity. In rats high dose CHB was hepatotoxic when administered orally, 
intravenously and subcutaneously.216, 217, 248 Rats given high dose CHB died of massive liver necrosis 
with little or no change to their pancreata. A fine balance between the dose and route of administration 
determines the outcome between liver and pancreatic toxicity in rats. We were not able to find this 
balance in the mouse.  
 
6.5 CONCLUSION 
 
This study was a dose response study to find a dose which caused pancreatic acinar cell atrophy. We 
found that in mice, liver toxicity occurred at a lower dose than complete pancreatic toxicity, which 
limits the usefulness of it as an experimental model. Given the marked difference between our 
findings in rats and mice it may be that the pathway to cell death is completely different in these 
rodents, an interesting conundrum for the administration of pharmaceuticals in animal models. 
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CHAPTER 7 
DOG MODEL OF PANCREATITIS 
 
This chapter presents the investigations using a dog model of pancreatitis. The chapter is presented 
as a manuscript for submission “Cyanohydroxybutene (crambene) causes massive liver damage in 
dogs” by Lynne E Reid, BSc, Melanie Latter, BVSc, and Lyndell E Kelly, MBBS, PhD, FRANZCR. 
Methods are again in detailed format. Some abbreviations previously defined in this thesis are, of 
necessity for submission of a manuscript, redefined here. Please note that references for this Chapter 
are listed at the end of this Chapter. 
 
Note that mature pound dogs were the only dogs available for this experiment although an 
unsuccessful attempt was made to secure greyhounds to limit variability among breeds. Use of 
pound dogs was not optimal as it was not possible to choose dogs individually and, therefore, it was 
challenging to get dogs of similar weight and age. No veterinary history was available for the dogs 
used. Clinical veterinary checks showed that they were in good health, however the variability in 
our results would indicate that some may have had unknown underlying conditions.  
 
7.1 SUMMARY 
 
Cyanohydroxybutene (1-cyano-2-hydroxy-3-butene, CHB) is a breakdown product of glucosinolates 
in cruciferous vegetables. In rats, a dose of 150mg/kg causes selective destruction of pancreatic acinar 
tissue principally by apoptosis. CHB was given to 14 dogs (12-21kg) in doses ranging from 70 down 
to 30 mg/kg intravenously over 15-30 minutes, followed by euthanasia and necropsy. These doses 
had little effect on the pancreas, but frequently produced fatal hepatic necrosis. Dogs were well and 
active or developed fatal liver failure, perhaps indicating that antioxidant capacity had been 
overwhelmed. Hepatic injury was reflected by depression and lethargy, and sometimes by abdominal 
discomfort. Laboratory testing showed marked elevations in hepatic cytosolic enzyme activities, 
bilirubin, creatine kinase activity and moderate to severe hypoglycaemia. Haematology showed 
marked thrombocytopaenia. A coagulopathy was suggested by bleeding into the peritoneal cavity of 
some dogs with advanced hepatic necrosis. Oral administration of antioxidants did not ameliorate 
liver injury. Clearly, CHB is of no value for treating chronic relapsing pancreatitis or acinar pancreatic 
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carcinoma in canine patients. There is a remarkable similarity in physical and laboratory necropsy 
findings between intoxications referable to the 5-carbon CHB and xylitol, a 5-carbon sugar used as 
an artificial sweetener. 
 
7.2 INTRODUCTION 
 
A model of pancreatitis induced using synthetic racemic 1-cyano-2-hydroxy-3-butene (CHB), 
sometimes called crambene, had been established in rats 1. CHB is present in many foods such as 
canola and cruciferous vegetables and is a selective pancreatotoxin in the rat and mouse. It is thought 
to be beneficial in low doses because it induces glutathione, an antioxidant 2. At high doses, it causes 
apoptosis of pancreatic acinar cells. At a critical dose, this causes almost complete loss of acinar 
tissue. CHB administration results in cell death in acinar tumours transplanted into rats making it a 
potential treatment for acinar cell carcinoma of the pancreas 3. At present, it is unknown whether this 
effect occurs in other mammals.  
 
Total and permanent loss of acinar cells constitutes a valid investigation for acute relapsing or chronic 
pancreatitis, common diseases both in human and canine patients, often secondary to inherited lipid 
disorders and  ingestion of high-fat meals 4,5. One purpose of this experiment was to see if a safe drug-
induced exocrine pancreatectomy could be achieved with CHB in the dog. We have tried to assess 
the effects and potential toxicity of CHB in randomly-bred dogs. All experiments were approved by 
the University of Queensland Animal Ethics Committee (PATH/457/04/LF).  
 
7.3 MATERIALS AND METHODS 
 
CHB was synthesized by and purchased from Research Directions, Auchenflower, Queensland.  The 
Animal Research Ethics Committee of the University of Queensland gave ethics approval. This pilot 
study was conducted in stages, with the intention of finding a dose of CHB that would selectively 
destroy acinar cells of the pancreas without excessively damaging the liver, islets of Langerhans or 
other tissues. Given that the most effective parenteral doses in mice and rats are 280 mg/kg and 150 
mg/kg subcutaneously, respectively, and taking into account allometric scaling, we elected to start 
with 70 mg/kg. Based on studies in rats and mice, CHB is more toxic on a mg/kg basis in large 
animals 6.  
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Experimental subjects (N = 14) were dogs destined for euthanasia at a local pound. They were 
apparently fit and healthy as assessed by routine physical examination and were of mixed breeds. For 
ease of handling, dogs of 15-20 kg were chosen. Dogs were continuously monitored by one or two 
veterinarians for the duration of the experiment. If required, dogs were kept sedated, however, if well, 
the level of sedation was reduced, and dogs were taken on regular walks in runs to permit urination 
and defecation. At these times, strength and demeanour was assessed and the abdomen was gently 
palpated to assess if pain was evident. 
 
Dogs were given 0.05 mg/kg of acepromazine and 0.3-0.4 mg/kg of methadone subcutaneously to 
provide sedation and analgesia. The required volume of CHB was placed in a 100 ml bag of normal 
saline (0.9% NaCl) and infused intravenously through an indwelling cephalic catheter over 15 
minutes. Hartman’s solution was subsequently administered intravenously (IV) at the rate of 1 litre 
every 12 hours using an infusion pump. Blood was taken at 4, 8 and 12 hours for dogs 1 and 2, and 
at 0, 12, 24 and immediately prior to euthanasia for dogs 3-6.  
 
Dog 1 was given 70 mg/kg (x 18 kg = 1.26 g CHB). Dog 2 commenced 10 hours after Dog 1 but was 
given a reduced dose of 50 mg/kg (x 15kg = 750 mg CHB). Both dogs were kept sedated and 
comfortable using incremental doses of acepromazine and methadone, given to effect. The first dog 
was euthanased by an IV overdose of pentabarbitone sodium 12 hours after CHB administration, the 
second at 20 hours after CHB. The experiments were terminated at these time points when it was 
clear that dogs had severe liver damage, likely to be fatal, on the basis of numerous physical and 
laboratory findings.  
 
Given the apparent hepatotoxic effect on dogs 1 and 2 (Table 1), the CHB dose was reduced in 
subsequent experiments, and the drug was administered more slowly. As serum biochemistry 
demonstrated hypoglycaemia, blood glucose was monitored in subsequent experiments using a point-
of-care glucometer so that glucose infusions and boluses could be given to maintain euglycaemia. 
Two dogs received 30 mg CHB/kg (x 18 kg = 575mg; x 15.5 kg = 465 mg); two received 40 mg/kg 
(x 20 kg = 820 mg; x 12 kg = 450 mg). The IV infusion of CHB was given over 30 minutes, rather 
than 15 minutes. It was intended that one dog from each pair be euthanased at 24 hours, and the other 
dog at 48 hours. Dogs were kept sedated, analgesed and comfortable as above with continuous 
monitoring of behaviour, biochemical measurements and continuous support with intravenous fluids 
and glucose.  
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In order to assess whether a dose of CHB could be found that was consistently ‘safe’ and to assess 
the effect of CHB on tissue over a longer timeframe, dogs 7-10 were given 35 mg/kg with euthanasia 
planned for 96 hours. As the mechanism of action of CHB is thought to consist of membrane 
oxidation, a further experiment was conducted with dogs 11 – 14 following premedication with 
antioxidants vitamin C (200 mg) and vitamin E (200 mg) given orally (by mouth) 90 minutes prior 
to the 35 mg/kg dose of CHB. The intention was to use the first-pass effect following oral 
administration of these antioxidants to selectively protect the liver from CHB toxicity. 
 
Complete necropsies were performed on each of the dogs by a veterinary pathologist. Tissues were 
fixed in buffered formalin and paraffin-embedded for haematoxylin and eosin (H&E) staining (4 µm 
sections).  
 
7.3.1 Immunohistochemistry 
 
PCNA IHC was used to examine proliferation of cells in pancreatic sections. The mouse anti-human 
monoclonal PCNA (Calbiochem Oncogene Research Products cat#NA03) was used at a 
concentration of 1:100. Sections were pre-treated with 0.2N HCl for 20 minutes and processed using 
a Dako EnVision+ Dual Link System-HRP (DAB+) kit (DakoCytomation) and lightly counterstained 
with Mayer’s haematoxylin. Total acinar cells and PCNA-positive acinar cells were counted in 10 
high powered fields (HPF) for each pancreatic sample. The PCNA index was calculated as a 
percentage of total acinar cells.  
 
7.4 RESULTS 
 
7.4.1 Biochemical parameters and gross pathology 
 
Biochemical parameters after treatment with CHB are presented in Table 1. There was a marked 
variation in response to the dose of CHB. Doses up to approximately 35 mg/kg were mostly tolerated 
with eight dogs clinically normal. Doses in excess of 35 mg/kg were fatal to six dogs due to a severe 
hepatotoxic effect.  
 
Dogs given 70 mg/kg and 50 mg/kg over 15 minutes (dogs 1 & 2) after 11-12 hours showed marked 
thrombocytopenia, moderate leukopenia, slightly elevated bilirubin concentration. Alanine 
aminotransferase (ALT), alanine aminotransferase (AST) and creatine kinase (CK) activities were 
markedly elevated, while amylase and lipase were normal. These dogs were euthanased early. At 
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necropsy the liver was enlarged, dark and friable, the pancreas edematous and pale. Petechial 
haemorrhage was evident throughout the gall bladder and stomach and a large volume of free blood 
was present in the abdominal cavity in one dog.  
 
Dogs with dosage 40 mg/kg over 30 mins (dogs 4 & 6), 35 mg/kg over 30 minutes (dog 7), and 35 
mg/kg over 30 mins after oral antioxidants (dog 12) were unwell from 7-24 hrs. Blood results showed 
reduced platelet and white cell counts (WCC), markedly elevated bilirubin, AST, ALT, and CK 
activities. Amylase and lipase dropped but remained within reference intervals. One dog died at 21 
hours. The others were euthanased at 22, 24 and 33 hrs. At necropsy, the pancreata were edematous 
and swollen, the livers ranged between normal size with multiple areas of darkened parenchyma, to 
swollen and friable. There were multiple haemorrhages into the intestinal wall, urine was dark and 
there was a serous nasal discharge with dog 12.   
 
Dogs with dosage of 30 mg/kg over 30 minutes (dogs 3 & 5) were well throughout the experiment 
and were euthanased at 24 and 48 hrs. Glucose dropped slightly at 12 and 24 hours. There was 
moderate elevation of AST, ALT and CK activities. Platelets remained within the reference interval, 
but neutrophils were elevated at 12 hours, settling by 24 hours. Both liver and pancreas appeared 
normal at necropsy examination. Dogs with dosage 35 mg/kg over 30 minutes (8-10) and 35 mg/kg 
after oral antioxidants (dogs 11, 13, 14) remained clinically well, eating and evacuating normally, 
bright and responsive until euthanased.  
 
7.4.2 Histopathology 
 
7.4.2.1 Pancreas 
Compared to the normal pancreatic tissue reviewed from the archives, all dogs showed some evidence 
of histological change within the pancreas, from relatively normal pancreatic architecture with mild 
cellular damage (Figure 7.1A) to increased and variable amounts of injury. These changes varied 
within and between lobules of the same organ. Isolated single cells displayed either classic apoptosis 
7 or necrosis, both being randomly distributed (Figure 7.1A). Large clusters of acinar cells displayed 
cell shrinkage and loss of adhesion with varying degrees of pyknosis from partial to fully condensed 
nuclei (Figure 7.1B, 7.1F). Many nuclei exhibited pallor; nuclei often appeared pale with chromatin 
clumping towards the nuclear membrane. Areas of ‘dark’ cells 7 were prominent. The cytoplasm of 
acinar cells was vacuolated both apically and basally and increased basophilia was noted. (Figure 
7.1D and 7.1E). Periacinar oedema was usually evident (Figure 7.1C and 7.1D). The ductal system 
remained microscopically intact with the exception of periductal fibrosis in dog 1, most probably 
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from a pre-existing lesion. Some islet cells appeared apoptotic and occasional mitotic figures were 
seen in acini. Neutrophil numbers were increased marginally compared to control tissues in some 
sections. PCNA immunohistochemistry was positive above control levels in acinar cells, centroacinar 
cells, macrophages and stellate cells to various degrees in all tissue specimens tested (Figure 7.1G 
and 7.1H; Table 7.1).  
 
 
 
Figure 7.1 Range of pancreatic damage after treatment with CHB 
A. dog 3 x 1000 B. dog 14 x400, C. dog 14 x1000, D. dog 7 x1000, E. dog 10 x 1000, F.) dog 11. 
All x 400, all H&E. Apoptotic cells and nuclei with halos (short arrows) are shown in A,C,F. Cells 
with condensed cytoplasm and disrupted cell attachment are shown in B. and F.  D and e show 
cytoplasmic vacuoles in acinar cells, overall increased basophilia and periacinar oedema. Apoptosis 
and mitosis (arrow head) coexist F.. (G. dog 12 x 400 and H. dog 11 x 400 show range of PCNA 
immunohistochemistry with brown staining of centroacinar cell nuclei (white arrows) and stellate 
cells (thin arrows); counterstain haematoxylin.   
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7.4.2.2 Liver 
Normal dog liver from archival blocks consisted of multiple lobules organised around a central vein, 
in which hepatocytes form single cell cords from portal area to central vein, separated by sinusoidal 
spaces 8. The livers of dogs 3, 5, 8, 9, 10, 11 and 14 were histologically normal, some showing mild 
hydropic change (Figure 7.2A). Apoptosis was scattered, predominantly in Küpffer cells, and there 
was mild periacinar congestion. 
 
The livers from the other dogs demonstrated moderate to severe changes ranging from periportal 
necrosis (dogs 6, 13) to massive necrosis and haemorrhage with complete disruption of lobular 
architecture (dogs 1, 2, 4, 7, 12). Hydropic change with sinudoidal congestion is depicted in Dog 3 
(Figure 7.2B). Hepatic cells in dog 4 demonstrated necrosis, pyknosis, karyolysis and karyorrhexis, 
with haemorrhage (Figure 7.2C). In general, neutrophilic infiltration was prominent and margination 
was apparent in blood vessels, especially the central vein. The liver of dog 6 showed periportal 
necrosis with inflammation and haemorrhage whilst in dog 13 coagulative necrosis was midzonal to 
periportal with haemorrhage (Figure 7.2D, E). Periportal activation of stellate cells was noted in dog 
13. Congestion in dog 7 was extreme, with haemorrhagic necrosis, loss of sinusoidal integrity and 
haemorrhage (Figure 7.2 F).  
 
In dogs with massive liver injury, haemorrhage in other organs such as bladder and intestinal wall 
was noted consistent with thrombocytopaenia plus likely disseminated intravascular coagulation. 
Quantification of the apparent haemorrhagic diathesis was not performed apart from platelet counts 
(Table 7.1). 
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Figure 7.2. Range of liver damage after treatment with CHB. 
All images are H&E stained sections at x 400. Normal liver is demonstrated A.. Dog 3 showed 
hydropic change with sinusoidal congestion B.. Dog 4 had massive necrosis with pyknosis, 
karyolysis, karyorrhexis and haemorrhage C.. Dog 6 had periportal necrosis with inflammation and 
haemorrhage D.. Dog 13 had periportal coagulative necrosis E. Dog 7 had extreme congestion, 
massive haemorrhagic necrosis with loss of sinusoidal integrity and haemorrhage F. 
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Table 7.1  
 
DOG 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
 
Weight (kg) 18 15 18 20 15.5 12 17.6 15.4 16.2 17.8 20.6 14 29 19 
Time blood 
taken 
8hrs 12hrs 15hrs 14hrs 24hrs 24hrs 18hrs 15hrs 15hrs 15hrs 15hrs 15hrs 15hrs 15hrs 
Dose CHB 70mg/k
g 
50mg/
kg 
30mg/
kg 
40mg/k
g 
30mg/
kg 
40mg/
kg 
35mg/k
g 
35mg/
kg 
35mg/
kg 
35mg/k
g 
35mg/
kg 
35mg/k
g 
35mg/k
g 
35mg/
kg 
Absolute 
dose 
1260m
g 
750mg 575mg 800mg 465mg 480mg 616mg 539mg 567mg 605mg 700mg 490mg 850mg 665mg 
Clinical state Sick sick well sick well sick sick well well well well sick well well 
Platelets 
(200-900) 
125 4 485 11 414 247 37 324 351 clumped 176 clumped 158 248 
Neutrophil 
(4.1-9.4) 
1.0 0.8 7.4 2.5 10 15.3 2.9 13.4 11.7 6.0 14.9 4.4 13.6 16.7 
AST(1-80) 328 1348 118 4822 1738 13815 7,750 110 157 50 355 8494 730 458 
ALT(0-80) 166 1668 42 5652 1763 16795 7180 44 49 59 174 11301 809 137 
GGT(0-5) <5 5 6 6 6 10 21 6 6 6 9 7 5 <5 
CK (0-400) 5938 2888 1155 2071 1832 1830 1658 1064 2613 405 1377 1073 5074 4769 
Bilirubin 
(0-10) 
17 30 4 19 <2 23 27 3 <2 2 12 24 13 8 
Amylase 
(0-2400) 
260 310 300 370 370 350 200 550 400 610 310 140 740 460 
Time of 
death 
Early (E) 
Scheduled 
(S) 
13hrs 
E 
20hrs 
E 
48hrs 
S 
22hrs 
E 
25hrs 
S 
24hrs 
S 
22hrs 
E 
48hrs 
S 
96hrs 
S 
96hrs 
S 
72hrs 
S 
33hrs 
E 
72hrs 
S 
72hrs 
S 
PCNA % 2.5 1.2 36.6 1.5 34.6 30.3 8.1 48.1 31.9 10.2 66.9 1.4 59.6 78.9 
Aspartate aminotransferase AST, alanine aminotransferase ALT, gammaglutamyl transferase GGT, creatine kinase CK 
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7.5 DISCUSSION 
 
This experiment was an attempt to reproduce in dogs the CHB pancreatopathy which occurs in 
rats 1. The rat pancreatic lesion is unusual in that there is marked early oedema with an acute 
inflammatory infiltrate, rapid synchronous onset of acinar cell apoptosis and total acinar 
atrophy with only a very limited regenerative response. In contrast, the dog pancreas exhibited 
cellular damage of acinar cells consistent with both reversible and irreversible injury. Apoptotic 
and necrotic acinar cells were present, with cytoplasmic vacuolisation, cell shrinkage and 
increased basophilia. In acinar injury, vacuolation of the apical cytoplasm of acinar cells is due 
to loss of zymogen granules whereas in basal areas it is due to distension and whorling of rough 
endoplasmic reticulum (RER) a common feature in apoptosis of acinar cells 1,9,10. Increased 
basophilia in H&E-stained sections reflects loss of zymogen granules and subsequent cell 
shrinkage. Dark cells as described by Walker et al. 7, have markedly condensed cytoplasm and 
nuclear compaction, and are considered to be necrotic and dying.  In this study, by 96 hours, 
whilst loss of acinar cells had occurred to some extent this was not nearly as complete an effect 
as in the rat.  
 
By 18 hrs in CHB-induced pancreatitis in the rat, the apoptotic acinar cells are swollen with 
secondary necrosis followed by ingestion by macrophages. By 3-4 days no acinar cells remain 
and duct cells proliferate to convert the lobules into small groups of tubular complexes. In the 
dog, although substantial cell injury had occurred, this was not sufficient to cause considerable 
atrophy of acinar cells, nor the conversion into tubular complexes. Periacinar oedema, loss of 
zymogen granules, whorling of RER and loss of adhesion between acinar units was present in 
the necropsy specimens similar to that found in the rat. Centroacinar cells, stellate cells and 
macrophages were positive for PCNA indicating proliferation and activation of these cell 
populations, as occurs in the rat CHB model and other rat models of pancreatitis 1,9,11. PCNA 
counts varied between animals but not between lobules in the same animal (Table 1). In rat 
pancreas, the percentage of PCNA positive cells reflects the pool of cycling cells, not only 
representing S-phase cells but also cells that have recently completed the cell cycle 12. The high 
PCNA positive counts in dog acinar cells indicates that in some instances the pancreas was 
attempting to maintain a regenerative balance of cells. This was particularly, but not 
exclusively so, for those animals with less severe liver pathology.  
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All dogs had histological changes in the hepatic parenchyma ranging from mild hydropic 
change to moderate or massive liver necrosis with haemorrhage, neutrophilic vascular 
margination and parenchymal infiltration. Hepatocellular damage was more severe in dogs that 
received higher doses of CHB. The necrotic changes in liver were comparable to those 
observed in rats given high doses of CHB orally 13 and mice dosed with CHB (previous 
Chapter). In this experiment in dogs, liver toxicity appeared to occur at comparable  doses to 
those which cause pancreatic toxicity, similar to the toxicity profile in mice, but  dissimilar to 
the rat. In rats, the dose of CHB which elicited an apoptotic response in the pancreas is lower 
than that which causes liver damage. From studies of varying sized rats, as well as our 
comparative study of mice, CHB is much more toxic on a mg/kg basis in large animals, as is 
true for most toxins. It is difficult to extrapolate the variation in effect of toxins from one 
species to another.  
 
As CHB is thought to damage cells by oxidizing membranes, we attempted to protect the liver 
with antioxidants given orally, and expected this to work preferentially on the hepatic 
parenchyma because of the first-pass effect. The most effective ameliorating agent in rat 
pancreas 6, reducing both edema and apoptotic cell counts was the antioxidant 2-
octadecylascorbic acid, a synthetic vitamin C analogue with a small molecular weight and a 
high affinity for biomembranes 14,15. Recent work showed the most likely initiating lesion in 
CHB toxicity to pancreatic acinar cells in vitro was loss of mitochondrial membrane potential 
with consequent release of cytochrome c 16. Carbon tetrachloride is also a potent hepatotoxin. 
It oxidizes the hepatocyte membrane and thereby initiates a cascade of necrosis by being 
metabolized to oxygen free radicals which peroxidise fatty acids in the phospholipid 
membrane, activating both Kupffer cells and an inflammatory cascade 17. This effect is 
ameliorated by vitamins C and E. This is in contrast with our experiments where no protective 
effect could be discerned. Indeed one of 4 dogs pre-treated with these antioxidants died early 
and the others also developed liver damage as evidenced by liver enzyme elevations (Table 
7.1).  
 
The pancreatic acinar cell changes indicated damage which might proceed to cell death, or 
resolve. Ninety-six hour studies were therefore undertaken to show the progression of the 
lesion. They showed that the lesions resolved rather than progressed, but reduced cell numbers 
in acini were noted subjectively indicating apoptotic cell drop out. However, liver damage 
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worsened, indicating a possible inflammatory cytokine cascade as occurs following ingestion 
of carbon tetrachloride 17. 
 
Early and sometimes severe thrombocytopenia (dogs 2, 4 and 7) developed. We postulate this 
to be due to sequestration and a consumption of platelets on sinusoid walls as liver necrosis 
developed. The timing of venepuncture for dog 1 probably precluded observation of this effect. 
Thrombocytopenia has been reported after liver damage due to radiation in children and is 
worse with both increasing dose and volume irradiated 18. The underlying histological lesion 
is thought to be congestion of the sublobular veins, with venous congestion of both spleen and 
liver, leading to a hypersplenism with platelet sequestration. In the therapeutic setting it is rare 
for this effect to have discernible clinical consequences.  
 
Liver failure in this experiment was so fulminant that glucose metabolism was disordered. This 
could be due to either a loss of glycogen stores or a failure of gluconeogenesis, or both. It is 
quite possible also that CHB caused insulin release. This would likely be an early effect in all 
dogs and at lower doses. When euglycaemia was restored in dog 4, its mental state improved 
temporarily. Disordered glucose metabolism after CHB has been reported in rats also 19 with 
increased urine glucose at eight hours and lower than control serum levels from 24 hours, 
indicating a possible effect on the endocrine pancreas.  
 
Xylitol ingestion in dogs is associated with hypoglycaemia following increased insulin release 
20. It is known that dogs who accidentally ingest xylitol develop acute hepatic failure with a 
moderate to severe increase in liver enzyme activities, hyperbilirubinemia, hypoglycaemia (due 
in part to increased insulin release), hyperphosphatemia, prolonged clotting times and 
thrombocytopenia 21. Like CHB, xylitol is also a 5-carbon molecule. It may be that xylitol and 
CHB are metabolized to a similar compound which is the actual toxicant. Necropsy and 
laboratory findings on dogs with naturally-occurring xylitol intoxication are remarkably similar 
to those seen in our experimental subjects treated with CHB. Xylitol at a dose of 1.4-2.0 g/kg 
consistently causes increased insulin release. It is unknown whether CHB also causes this 
elevation of insulin, as acute liver failure per se can result in hypoglycemia. Direct 
measurement of insulin in subsequent studies will be able to resolve this issue. Xylitol is safe 
in humans but toxic to dogs. Interestingly, CHB also shows inter-species variability in toxic 
effects between rats and dogs.  
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Another model of experimental pancreatitis in dogs has been described, copying a well-
established model in rats and mice 22. D, l-ethionine produced exocrine necrosis in dogs leading 
to complete acinar atrophy 23. These dogs were mature pound dogs of mixed breed of either 
sex weighing 15-22 kg similar to our study. Regeneration was not complete four weeks after 
the onset of the experiment, with areas of fibrosis and inflammatory infiltrate coinciding with 
regenerative acini. As in the current study, the largest dogs, given higher absolute doses of 
ethionine, were more severely affected.   
 
In this study there was marked variation in response between animals of the same weight given 
the same dose – in some, the dose was fatal, others were clinically normal. The effects of CHB 
on the hepatic parenchyma appeared to have a marked threshold effect. Doses up to ~30 mg/kg 
appeared to be tolerated, whereas doses in excess of 40 mg/kg were almost always fatal, 
indicating that up to a certain level, the oxidant effect could be reversed, and although there 
was obvious evidence of hepatocellular injury, the changes could be somehow circumvented. 
If a threshold was exceeded, perhaps as a result of glutathione depletion, then an irreversible 
cascade of changes ensued, consisting of neutropenia (often with a left shift), 
thrombocytopenia and hyperbilirubinemia. These changes are remarkably similar to those seen 
in dogs with xylitol intoxication, and it is unclear to us whether this is because both toxicants 
have a common cellular mechanism of action such as damage to mitochondrial membranes, or 
whether they cause diffuse hepatic injury by different initial mechanisms, with an identical 
‘final common pathway’ culminating in acute liver failure. More work is required to shed light 
on this issue, however it is of great interest that recent data has shown dogs with xylitol 
intoxication appear to benefit from acetylcysteine +S-adenosyl methionine (SAM-E),  agents 
whose presumptive effect is due to repletion of glutathione levels within the liver 24. In rat liver, 
CHB initially depletes glutathione levels to about 17% 2. Bohus 19 found that the major CHB 
metabolite in urine of rats was a conjugate of N-acetyl-cysteine. Clearly further work should 
examine the benefit of acetylcysteine in CHB toxicity. 
 
Our histological observations suggest that neutropenia is due to loss of mature neutrophils into 
the damaged liver, with overwhelming demand exceeding the capacity for the bone marrow to 
respond acutely. We suspect a similar mechanism causes thrombocytopenia with loss of 
platelets into the liver, and secondary hypersplenism due to hepatic vascular congestion and 
acute portal hypertension. Although disseminated intravascular coagulation is another 
possibility, we could find no evidence for this in histological specimens examined. Another 
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consistent biochemical finding was moderate to severely elevated CK activity in plasma, 
suggesting diffuse damage to muscle cell membranes in skeletal muscle and possibly the 
myocardium.  
 
7.6 CONCLUSION 
 
One purpose of this experiment was to see if a safe drug-induced exocrine pancreatectomy 
could be achieved with CHB in the dog. In rats, this is routinely achieved with a dose of 150 
mg/kg subcutaneously. It is clear that there will not be a safe and reliable medical 
pancreatectomy with CHB in the dog. Even more importantly, extensive primate studies would 
be required before any attempt is made to trial it in humans. This study indicates there is a 
possibility of unpredictable fatal hepatotoxicity. From a veterinary standpoint, the similarity 
between toxicity due to CHB and xylitol is of interest, and further studies may shed light on a 
final common pathway involved in the pathogenesis of both intoxicants.  
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CHAPTER 8 
DISCUSSION 
 
8.1 OVERVIEW 
 
Pancreatitis is an inflammatory disorder of the exocrine pancreas in both acute and chronic 
forms. It causes considerable morbidity and mortality, as the disease varies widely in severity, 
and the approach to management and outcome is uncertain. Due to the relative inaccessibility 
of pancreatic tissue for examination, animal models are used to investigate the pathogenesis of 
the disease. Fibrosis is a serious complication of pancreatitis and leads to the destruction of the 
exocrine gland, pancreatic insufficiency and ultimately death. Understanding the processes of 
fibrosis and its role in the imbalances that drive the pancreas to regenerate or not is the basis 
for this study. 
 
8.2 MODELS 
 
Experimental animal models of pancreatitis vary in their relevance to clinical disease, their 
ease of use, reproducibility and the basic features of injury and reparation. For this reason it 
was decided as wise to compare more than one model to examine the progressive and 
overlapping pathology of the disease. The caerulein and duct ligation models are well-
established models in rats with simplicity, strong reproducibility and predictable results. 
Fibrosis can be established in mice with both models however depends on the right mouse 
strain in the case of caerulein.257 The CHB model is not reported widely, is simply achieved 
with one subcutaneous dose and is reproducible with the caveat that results do vary between 
rat colonies. This latter effect is not restricted to the CHB model and creates substantial 
inconvenience for researchers from personal experience. Unfortunately, CHB does not 
translate into a mouse model, however the beauty of the CHB model in rat pancreatitis is that 
regeneration does occur briefly, but does not persist. This provides a perfect medium between 
the caerulein and duct ligation models and a good model to investigate how the pancreas can 
retain the capacity to regenerate but cannot sustain the regenerated population. One would 
suppose that this has some relevance to the human chronic disease. A summary and comparison 
of results of the parameters studied in the three models is presented in Figure 8.1. 
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Figure 8.1 Timeline of events in pancreatitis in the rat models 
Experimental animal models of pancreatitis vary in their relevance to clinical disease, including 
the basic features of injury and repair, regeneration, proliferation, atrophy, cell death and 
inflammation. These models form a basis for studying pancreatic regeneration during 
pancreatitis, because of their inherent similarities and differences. The caerulein model 
regenerated quickly and comprehensively, whereas the regeneration was focal and non-
progressive in the CHB model and the duct ligation model did not show any regeneration. 
 
8.3 REGENERATION  
 
In humans one of the issues with the pancreas being inaccessible to direct observation applies 
to regeneration. That the pancreas regenerates when symptoms wane is an assumption but there 
is no direct evidence that this occurs. Tissue replacement and turnover, the role of pluripotent 
stem cells and the mechanical aspects of embryonic development are central to understanding 
regeneration. Stem cells play a role in other organs, for example liver, during regeneration, 
however a true stem cell has not been identified in pancreas. The tubular complexes, also 
known as acinar to ductal metaplasia, are the epithelial structures remaining after injury and 
they upregulate normally duct specific proteins, such as cytokeratins, as seen in this report. In 
the caerulein model though large numbers of acinar cells are destroyed, viable acinar cells 
158 
 
remain in most lobules. Ultrastucturally and in immunohistochemistry regenerating acinar cells 
are seen protruding from tubular complexes, in duct to acinar differentiation however one can 
assume that many acinar cells are replaced by expansion of the surviving cells in this model as 
has been reported before.222 Duct to islet differentiation was noted in this caerulein model, as 
also seen in other pancreatic injury.105, 258 In a diphtheria toxin transgenic mouse model where 
acinar cells are obliterated regeneration of acinar cells is due also to duct to acinar 
differentiation and not self-renewal.56 In the CHB and duct ligation models no acinar cells 
remain. In the CHB model no acinar cells were seen in electron microscopy forming from the 
tubular complexes however they were seen frequently forming next to islet cells and forming 
in nests in the middle of connective tissue as did new islet tissue. The source of this regeneration 
was not determined and the acinar cells though normal looking did not persist. Acini, duct cells 
and tubular complexes died by apoptosis until rats had pancreatic exocrine insufficiency, 
maldigestion and muscle wasting and were euthanased. The duct ligation model showed no 
regeneration at all. Persistent injury in the form of ductal ligation ensured that the tubular 
complexes did not retain the capacity to regenerate acinar cells. How or if the tubular complex 
cells contribute signals towards ongoing inflammation is a question that requires answers. 
Acinar cells are normally a source of inflammatory cytokines in pancreatic injury, however 
once destroyed, other cells, presumably the inflammatory cells provide ongoing signalling 
towards fibrosis or regeneration.  
 
8.4 FIBROSIS  
 
Excess fibrosis deposition is a system failure. The deposition of ECM in response to injury 
provides a scaffold so that injured tissue may repair in a supported environment.  The repair of 
tissue such as in wound healing is usually fast and efficient, however restoration of cell 
populations in pathological repair often fails due to miscommunication of the ECM to 
coordinate regeneration. This malfunction leads to chronic conditions. Fibrosis, produced by 
the stellate cells, is a known feature of chronic pancreatitis and pancreatic cancer.169 The 
disappearance or persistence of stellate cells correlates with regeneration in the models. In the 
caerulein model, stellate cells disappear as regeneration occurs. In the duct ligation model, 
stellate cells persist and regeneration does not occur. In the CHB model stellate cells wane, 
though fibrosis remains, which suggests that once deposited stellate cells are not required to 
maintain fibrosis. The persistence of fibrosis may depend on the type of collagen deposited as 
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the difference between the deposition of collagen I and collagen III in these models was clear. 
Fibrosis in the caerulein model consisted mainly of collagen III the thinner collagen, however, 
in the CHB and duct ligation models the collagen laid progressed to more dense collagen I. 
Collagen I was unable to be degraded by the balance of MMPs and TIMPs in these models.  
Stellate cells in the duct ligation model may have continued to deposit collagen as they 
persisted around ducts and tubular complexes.  
 
Mast cells and neutrophils are reported as the first responders in inflammation for host 
defence,259 and macrophages and neutrophils in parallel influx in pancreatitis.95 Dendritic cells, 
B cells and T cells are reported to infiltrate the injured pancreas early and are able to modulate 
repair,53 however, they were not studied here. Early in the rat pancreatitis large numbers of 
macrophages and stellate cells were observed migrating in the inflammatory infiltrate. 
Counting of the inflammatory cells was carried out in random fields though concentrated on 
the areas containing the parenchyma, acinar cells and tubular complexes, rather than areas 
containing mostly or only connective tissue. For this reason mast cell counts are perhaps lower 
in totals than the other inflammatory cells as they were often in larger numbers congregated 
around blood vessels or in connective tissue at the periphery of lobules compared to in the 
parenchyma and interlobular inflammatory infiltrate.  The stellate cells were assessed by area 
of stained cytoplasm and not as individual cells. As the αSMA immunohistochemistry, a 
standard method for stellate cells,79 is a cytoplasmic stain and stellate cells had extremely long 
processes it was more difficult to separate individual cells, particularly when they were 
overlapped, encircling tubular complexes. Fibroblasts were not easily distinguished from 
macrophages in light microscopy. In the literature there are conflicting views on the definition 
of fibroblasts/myofibroblasts/stellate cells.148 Their derivation, progenitors, phenotype and 
function clearly differ in different tissues and they comprise heterogeneous populations. At 
present, there is no reliable marker to differentiate between quiescent stellate cells versus 
resident fibroblasts in the pancreas.148 In this study, ultrastructurally, fibroblasts were identified 
in the control tissue, just few residing in inter-acinar spaces, containing no lipid droplets. Soon 
after insult, stellate cells were filled with RER and full and emptied lipid droplets but by day 
two of the experiments most of the stellate cells had no remaining lipid droplets. Only in the 
caerulein model after regeneration cells resembling fibroblasts without lipid were seen. Some 
unidentified inflammatory cells appeared to be apoptotic at later time points in CHB and duct 
ligation sections, however this was not noted in electron microscopy samples which may have 
facilitated identification. Stellate cells and macrophages disappeared with regeneration and 
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fibrosis in the caerulein model, only mast cells remained higher than normal. CHB stellate cell 
numbers declined much faster and further from 10 days than fibrosis which began to decline 
from 18 days but still remained higher than control levels. Macrophages paralleled the decline 
of stellate cells, however mast cell numbers remained high. It appears in the CHB model that 
stellate cells and macrophages were not required to maintain the level of fibrosis. In duct 
ligation fibrosis, stellate cells, macrophages and mast cells remained at high levels.  
 
Macrophages are also labelled by phenotype, position and activity. The labelling of 
macrophages into pro and anti-inflammatory macrophages is perhaps overly simplistic as they 
are highly plastic cells that change their active state via a spectrum of chemical and physical 
signals from cellular and environmental cues.190, 260 Whether resident tissue macrophages were 
supplemented here by an active recruitment of blood monocytes as has been shown by others261 
was not obvious. Resident macrophages can proliferate in intestinal tissue in response to IL-4 
without requirement for blood monocyte recruitment.262 Mitosis of macrophages was not noted 
but could have been easily missed as inflammatory cells that were seen in mitosis were not 
readily identifiable. Macrophages are considered the main inflammatory cell in pancreatitis 
although peritoneal macrophages are largely responsible for the severity of pancreatitis.189 
Early in the rat pancreatitis the macrophages actively phagocytosed apoptotic acinar cells as 
previously reported.216, 222, 263 Macrophages were closely associated with stellate cells in all 
models and persisted with fibrosis in the CHB and duct ligation models. They may be 
regulating both inflammation and fibrosis in this pancreatitis. Cross talk between macrophages 
and stellate cells via the IL-4/IL13 pathway has been demonstrated in chronic pancreatitis in 
vivo and in vitro.264 Pancreatic stellate cells expressed the cytokines that are required to 
alternatively activate macrophages to a pro fibrotic phenotype and alternatively, macrophages 
expressed levels of TGFβ and PDGFβ to directly promote stellate cell activation and 
proliferation. These macrophages also regulated ECM turnover by expressing higher levels of 
MMPs and TIMPs. Cytokines and growth factors from macrophages regulate the balance of 
MMPs and TIMPs during nerve repair that potentiates the rate of regeneration.265 This 
interaction between macrophages and stellate cells likely determines the balance between 
fibrosis deposition and resolution and this provides the diversion from the regenerative to the 
fibrotic state.  
 
 Mast cell mediators, chemokines and cytokines are diverse and heterogeneous in both humans 
and animals.192 Granule-stored specific proteases and heparin have significant biological 
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effects relevant to fibrosis including increased collagen synthesis, fibroblast proliferation or 
differentiation and activating TGFβ.  Clinical data from fibrotic pathogenesis in human lung, 
kidney, cardiac, skin and liver indicates that activated mast cells are implicated in the 
progression and severity of fibrosis which is supported by pro-fibrotic cell-to cell contact 
between human mast cells and fibroblasts in co-culture and strong evidence that, in humans, 
mediators secreted by mast cells exert pro-fibrotic effects directly to fibroblasts.192 In contrast, 
mouse and rat models of fibrosis in lung, skin, cardiac, liver, lymph node, adipose tissue using 
deletion of mast cells has given rise to the incongruity of anti-fibrotic, pro-fibrotic or not 
involved in fibrosis results.192 As mast cell numbers were increased, they degranulated and 
persisted to a certain degree in all models, a role for mast cells in fibrosis in these models is 
indicated. TGFβ which is upregulated in duct cells in chronic pancreatitis is a stimulator of 
mast cells and they have been known to induce collagen 1 gene expression in mouse skin 
fibroblasts.195 In the fibrotic rat pancreata they were found around tubular complexes, close to 
stellate cells and macrophages and in the stroma.  Mast cells are a source of pro fibrotic stimuli 
such as TGFβ, PDGF, FGF2 and granulocyte macrophage colony-stimulating factor and they 
store and release into the interstitial space, matrix components such as hyaluronic acid and 
chondroitin sulphate all of which can contribute to ECM remodeling.266 
 
IHC showed that laminin a component of the basement membrane was disrupted early in the 
rat pancreatitis, presumably as cells shrank and rounded up with apoptosis. Basement 
membrane progressed to lay thickly and unevenly around tubular complexes. In the caerulein 
model laminin levels and basement membrane returned to normal appearance by 10 days, in 
the CHB and duct ligation models expression was strong and the thick fuzzy appearance looked 
to be interweaved with stellate cells around some tubular complexes. The abnormal deposition 
remained in the CHB and duct ligation models at day 18 however were more ordered around 
regenerating acini in the CHB model. The basement membrane contains laminins and collagens 
and proteins that crosslink and anchor these fibres. Cellular skeletal architecture and tissue 
cohesion maintained by laminin and collagen integrity is regulated by integrins. The βintegrin 
receptor group is largely responsible for cell attachment to the ECM and the lack of integrins 
interferes with laminin and basement membrane assembly in various other tissues.267 
Pancreatic acini have integrin receptors in their basal lamina268 but which pancreatic cells 
express the proteins for cell/basement membrane linkage is unknown. The group of Riopel et 
al used a loxP-mediated recombination and col1a2-CreERT transgene and tamoxifen 
administration to remove integrinβ1 from mouse pancreatic cells.  This resulted in decreased 
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ECM protein and integrin loss from acinar cells that further caused disrupted basement 
membrane and impairment of acinar function. This indicates that integrin-ECM interactions 
are essential for maintaining exocrine epithelial integrity and that stellate cells regulate 
pancreas function through maintenance of basement membrane.269 In the CHB model stellate 
cell numbers were reduced considerably by 18 days, basement membrane was abnormally laid 
around tubular complexes and regeneration continued to fail. In the duct ligation model stellate 
cells remained in high numbers, basement membrane was abnormally laid around tubular 
complexes and regeneration was non-existent. Basement membrane appeared normal around 
blood vessels. It follows in the CHB model that absence of stellate cells may have contributed 
to the failure of basement membrane integrity to influence regeneration however this theory 
does not hold true in the duct ligation model. Future studies exploring the role of integrins in 
these models may provide some answers. Macrophage-derived MMPs also facilitate basement 
membrane disruption to expedite movement of inflammatory cells to injury sites.190  
 
Indisputable in the rat models is that stellate cells, macrophages and mast cells increased in 
number with the onset of pancreatitis. Local and circulating inflammatory cytokines from 
inflammatory cells acting through inflammatory signalling pathways such as NFκB and JAK-
STAT pathways and developmental signals such as Pdx1, Notch, hippo and Wnt pathways 
regulate pancreatic regeneration. These complex interactions are the subject of debate and 
findings are conflicting however recent literature alludes to their important roles in promoting 
or inhibiting pancreatic regeneration.53 This suggests that interactions between fibrotic and 
developmental mechanisms regulate pancreatic regeneration.   
 
8.5 SURVIVIN 
  
Survivin expression was increased in the pancreatitis of the rat models in cells that were 
proliferating, differentiating and pro or anti apoptotic. Its expression early in pancreatitis may 
reflect that survivin is involved in determining the cell death pathway that proceeds by either 
inhibiting or promoting caspase activation. Other authors have reported a role for members of 
the IAP family, including survivin, to regulate the cell-death response in caerulein-induced 
pancreatitis.242, 270 The role of survivin in regeneration is more difficult to define. Survivin 
expression indicated that cells proliferating, acinar, ductal and inflammatory cells correlated 
with PCNA staining for cycling cells. Tubular complexes were positive for survivin both in the 
nucleus and cytoplasm. Tubular complexes showed mitosis when forming so will express 
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survivin as proliferating cells. They do become apoptotic as was seen particularly in the CHB 
model so the effect cannot be seen as anti-apoptotic. In the duct ligation model where rats were 
kept up to 52 weeks the duct cells and tubular complexes persist for many months but finally 
atrophy (personal communication, Prof Neal Walker, Envoi Pathology, Brisbane, Australia). 
Tubular complexes were also survivin positive in the caerulein model where acinar cells appear 
to transdifferentiate from them. Survivin expression in tubular complexes may indicate then 
that these cells are not terminally differentiated. Survivin expression in alpha cells of islets and 
in ganglion cells may also reflect their differentiation status or propensity to undergo apoptosis. 
The adult cells of the islets of Langerhans have little regenerative capacity although conversion 
of δ and α cells into β cells has been reported in ablation approaches in animal examples271 and 
neurons are known to be changed in pancreatitis and contribute to fibrosis.14 Exactly how or if 
survivin is involved in the process of regeneration in these models is not clear. The availability 
of antibodies for the individual splice variants of survivin would be advantageous towards 
teasing out functions of survivin in pancreatitis. What is apparent is that survivin has increased 
expression in the cell populations that feature in pancreatitis and therefore provides a subject 
for future investigation.  
 
8.6 MOUSE  
 
The attempt to produce a model of pancreatitis in the mouse with CHB that had apoptosis as 
the model of cell death was unsuccessful. Apoptosis occurred arbitrarily between lobules, was 
not in great numbers except in random areas and coexisted with necrosis. Liver damage 
occurred at higher doses such that the mice died before sufficient acinar cell death of any type 
could lead to the loss of parenchyma and pancreatitis. Mice dosed with 50µg/kg caerulein 
appeared to develop both apoptosis and necrosis to the same degree as this experiment272 or no 
cell death effect.273 Other mouse models have shown necrosis to be the primary mode of cell 
death in mice. Mice treated with arginine or fed a choline-deficient diet supplemented with 
DL-ethionine developed necrotic pancreatitis.274 These models in mice do proceed to 
pancreatitis of various degrees. The difference in cell death responses between rats and mice 
was demonstrated as a caspase block in mice.270 Mice appear to be more susceptible to necrosis 
than apoptosis through blockage of caspases -8 and-9 in acinar cells. Although this was a failure 
for our purposes CHB in mice would be an appropriate model to investigate the early events in 
cell death pathways and a model for investigating liver damage.  
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8.7 DOG  
 
The CHB model in dogs did not produce complete apoptotic cell death in the pancreas. Results 
in the dogs were inconsistent probably because they were pound dogs of indeterminate history 
and therefore with possible unknown pre-existing condition. Nonetheless, the result of CHB 
administration was primarily liver damage before a significant pancreatic effect, useful 
information if your small dog has a passion for over consumption of cruciferous vegetables or 
your forage animals escape into the wrong field. The similarity to xylitol poisoning in dogs is 
particularly interesting as this is a veterinary presentation in the USA and increasingly in 
Australia as xylitol is used in snack foods. Further research to elucidate the mechanism of CHB 
liver damage in dogs may be the key to unlock the mechanism of xylitol poisoning with clinical 
translation. Speculation on the pancreatic cell death response in dogs is not possible with these 
results. Assuming pound cats would have the same issues with history as the dogs it would be 
useful to investigate the effect of CHB in a different higher mammal with purpose breeding 
such as pigs with due regard to the age of the animals. Pancreatitis in dogs remains a clinical 
issue for veterinarians and is worthy of further investigation.  
 
8.8 FUTURE DIRECTIONS  
 
Currently I am collaborating with a group of researchers at the University of Otago, Dunedin, 
New Zealand on a project with activins. Activins are members of the TGFβ family likely 
involved with pancreatic stellate cell activation, and fibrosis. We are investigating 
immunohistochemistry for activins and their regulators Smads on tissue microarrays made 
from the paraffin tissue blocks from the rat models along with a commercial tissue array for 
human pancreatic pathologies. This work is novel and thus far shows promising results.  
 
8.9 CONCLUSION  
 
This research has the potential to add to the emerging field of regeneration biology. We must 
understand the mechanisms to restore cell populations and their function to damaged tissues. 
Understanding embryonic development, analysing cell and tissue growth, identifying 
pluripotent and stem cells and the supportive cells that promote tissue repair is required to 
develop cell-based therapies for those with chronic disease. It is clear from this report that 
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inflammatory cells and basement membrane play an important role as a permissive or 
detrimental local environmental in regeneration from pancreatitis. The roles of the individual 
cell populations, their mechanisms and mediators are complex but interconnected.  Uncovering 
the obstacles to tissue regeneration remains an important goal for researchers to develop 
clinical therapies especially in organs with limited regenerative capacity. There are differences 
between humans and rats in metabolic terms, in genetic background, with laboratory rats 
subject to clinical inbreeding and strict environmental conditions and diet likely affecting 
disease mechanisms and phenotypes. Human tissue is collected mainly in the later stages of 
pancreatitis or is rarely available consequently it is necessary to continue the search for suitable 
animal models that share general histological and pathological responses with regards to 
inflammation, cell death and regeneration in pancreatitis. 
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APPENDIX 1 
 
Puchtler’s (Picro-) Sirius Red for fibrosis 
 
Picro-sirius red solution 
Sirius red F3B     0.5g 
Saturated aqueous picric acid   500ml 
Acetic Acid water    5ml 
Distilled water     110ml 
 
Bring sections to water. Optionally stain nuclei with an acid resistant nuclear stain. Wash well 
with water. Stain in Picro-Sirius red solution for 1 hour. Wash with 2 changes of acetic acid 
water. Dehydrate with ethanol, clear in xylol, mount with depex. 
 
Nuclei=blue, cytoplasm=yellow, collagen=red 
Histological and Histochemical Methods, J.A. Kiernan (1999), Butterworth Heinemann 
Oxford, England, and Woburn, MA., USA; Sirius Red F3B,BDH laboratory supplies, Poole, 
England. 
 
Alcian Blue/Nuclear-fast Red for mast cells 
 
1% Alcian Blue in 0.7N HCl 
0.7N HCl rinse 
Nuclear Fast Red    0.1g 
5% aluminium sulphate aqueous  100ml 
Filter before use 
 
Bring sections to distilled water. Stain in Alcian blue solution for 1.5 hours. Rinse quickly in 
distilled water. Wash in 0.7N HCl for 1 minute. Stain in Nuclear Fast Red solution 10 minutes. 
Rinse quickly in water. Dehydrate in ethanol, clear in xylol, mount with depex.  
 
Alcian Blue 8GX, BDH Laboratory Supplies, Poole England. 
Nuclear Fast Red, Chroma 1A 402, Chroma-Gesellschaf, Stuttgart. 
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Toluidine Blue stain for semi thin epoxy sections 
 
Epoxy sections cut 0.5-1.0 µm thick 
 
Distilled water    100 mls 
Toluidine blue    1 gram 
Sodium tetraborate    1 gram 
 
Add chemicals to boiling water and agitate for 30 minutes. Allow to cool before use. Heat 
slides on the hot plate for 5 minutes; apply 3 drops of stain; leave for 30-60 seconds. Do not 
let slide dry. Rinse under running water to remove excess stain. Differentiate in three changes 
1-2 mins each of absolute ethanol. Wipe back of slide and dry on hotplate. Blow gently on slide 
to avoid ‘tide’ lines. Coverslip with depex.  
 
Mayer’s Acid Haemalum  
 
Haematoxylin     1.0g 
Sodium iodate     0.2g 
Potassium aluminium sulphate  50g 
Distilled water     1000 mls 
Dissolve overnight then add 
Chloral hydrate     50g 
Citric acid      1.0g 
 
The stain has a working life of one month and may be stored for six months. The original 
formula of Mayer (Mitth. Zool. Stat, Neapel., X, 1, 1891; Toxic) differed in detail from that 
given, however the latter is accepted as Mayer’s formulation. 
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Eosin 
 
Eosin     1 gm  
70% Ethanol     1 litre 
 
[HCl precipitated Eosin Y, C.I. 45380] 
 
10% neutral buffered formalin 
 
37% formaldehyde is the approximate saturation point for formaldehyde gas in water. 10% 
formalin is a histologist’s term and refers to a 1:10 dilution of 37% formaldehyde in buffer, 
effectively 4% formaldehyde. 
 
NaH2PO4.2H2O   4.5 grams 
Na2HPO4    5.85 grams 
Formaldehyde 37%   100 mls  
Distilled water    900 mls 
 
4% neutral buffered paraformaldehyde 
 
Made by mixing 4 grams of paraformaldehyde powder in 0.1M phosphate buffer pH 7.4. 
Paraformaldehyde will readily dissolve in neutral to alkaline-buffered solutions. It will not 
dissolve in distilled water or acidic solutions without the addition of large quantities of 
sodium hydroxide.  
 
Paraformaldehyde    4 grams 
0.1M phosphate buffer   100 mls 
 
Heat the buffer to 50oC and add the paraformaldehyde, stir till dissolved. It is important that 
the temperature of the buffer is not significantly higher than 50oC as 1 or more small NaOH 
pellets may need to be added to help dissolve the paraformaldehyde. Cool and check pH Fix 
for 12 to 24 hours depending on size, use/store at room temperature. 
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Fixed tissues are transferred to 70% ethanol, or 0.1M phosphate buffer if the samples are for 
electron microscopy. Paraformaldehyde solutions should be prepared fresh or used within a 
month. 
 
0.1M Phosphate buffer  
 
Add 36 mls of dibasic sodium phosphate with 14 mls of mono sodium phosphate and 50 mls 
of distilled water, pH to 7.4  
 
Karnovsky’s fixative 
 
Fixative/perfusate for electron microscopy. Addition of calcium chloride to the solution will 
improve the preservation of cell membranes. 
 
4% paraformaldehyde, 4% glutaraldehyde, 0.1% calcium chloride in 0.1M sodium cacodylate 
pH 7.3 buffer. 
Sodium cacodylate  2.14 grams 
Paraformaldehyde  4.0 grams 
Calcium chloride  0.1   gram 
Water   84    mls 
Glutaraldehyde 25% 16    mls 
 
Heat water to 50oC and add the paraformaldehyde, stir till dissolved. 1 small NaOH pellet 
may need to be added to help dissolve the paraformaldehyde. Cool to room temperature and 
add the sodium cacodylate and calcium chloride. Stir till dissolved and pH to 7.3. 
Immediately before use add the glutaraldehyde and mix thoroughly.  
 
Either perfuse animals with Karnovsky’s for 10 - 20 minutes, remove the target tissues, dice 
into blocks 1mm3 and fix for a further 2 hours by immersion or remove target tissues dice in 
to 1mm3 blocks and fix by immersion for a minimum of 4 hours 
 
Warning sodium cacodylate contains arsenic, a known carcinogen. Paraformaldehyde is a 
suspected carcinogen. Glutaraldehyde in highly toxic by contact and its vapours can cause 
sensitisation and respiratory distress. 
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Antigen Retrieval 
 
0.01M Citrate pH6.0, 5 minutes at 125oC  
0.001M EDTA/0.01M Tris pH 8.8, 15 minutes at 105oC   
0.1% porcine trypsin 30 minutes at room temperature 15 mins at 37oC 
20ug/ml proteinase K in 0.05M Tris-Hcl, 0.01M CaCl2 pH8.0 10 minutes at room 
temperature 
HCl  0.2N 15 mins at 37oC 
Chymotrypsin 0.5% 10 mins at 37oC 
Heat retrieval was performed in a Biocare Medical Decloaking Chamber 
 
Proteinase K Digestion 
 
To make 20μg/ml Proteinase K add: 
100 microlitres of 2.0 mg/ml Proteinase K to  
10 ml of 0.05M Tris.Cl /0.01M calcium chloride pH 8.0  
Proteinase K  Promega cat# V302B 155567 
 
Chymotrypsin Digestion  
 
Chymotrypsin 0.05g, Sigma Aldrich C4129-1G  
CaCl2  0.05g, Sigma Aldrich C2661-500g 
dH20, 10 ml 
Incubate for 10 min at 37oC, adjust pH to 7.8 using NaOH.  
 
0.01M (10mM) sodium citrate buffer pH 6.0 for antigen heat retrieval 
 
Sodium Citrate Buffer (10mM) - Tween 20 (0.05%) pH 6.0  
Dissolve 2.94 g Tri-sodium citrate in 1000 ml distilled water  
Adjust to pH 6.0  
Add 0.5 ml of Tween 20 and mix well 
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0.001M ethylenediamine tetra acetic acid (EDTA) pH 8.8-9.0 for antigen heat retrieval  
 
Tris/EDTA (10/1 mM) pH 9  
Add 1.21 g of Tris and 0.37 g of EDTA to 1000 ml of distilled water  
Adjust to pH 9 if necessary  
 
0.01M Phosphate buffered Saline  
 
100ml saline + 0.026g KH2PO4 + 0.115g Na2HPO4 
 
Tris buffer/Tween 
 
Tris Buffer (10mM) - Tween 20 (0.05%) pH 10  
Dissolve 1.21 g Tris Base in 1000 ml distilled water  
Adjust to pH 10 using 1M NaOH  
Add 0.5 ml Tween 20 and mix well 
 
Secondary antibody/detection reagent:  
 
DAKO EnvisionTM + Dual Link System-HRP (DAB+), Dako Code K4065 
MACH1 Universal HRP-Polymer detection, Biocare Medical 
Jackson donkey goat ant- rabbit 1:300 20 minutes at RT 
 
Glass slides, Menzel Superfrost Plus 
 
Selected antibody and supplier details 
 
Amylase rabbit anti-human, lot 86H8840, Sigma  
Caspase rabbit anti-cleaved caspase3, ASP175, Cell Signaling cat  no 9661S 
Caerulein sulfated C9026, lot 121H02111,  CAS No. 17650-98-5 Sigma peptides and amino 
acids 
CD68, monoclonal mouse anti-human clone PG-M1 code M0876, Lot 016, DAKO  
CD117/c-kit rabbit polyclonal cat CP151a, Biocare Medical   
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Cytokeratin AE1/AE3 mouse anti-human, lot 0019B, DAKO  
Glucagon porcine anti-human NCL-GLUCp, Novacastra  
PCNA (Proliferating cell nuclear antigen) (AB-1) Monoclonal mouse NA03, Oncogene 
research products, Calbiochem   
αSMA smooth muscle actin, monoclonal mouse IgG2a isotype, clone 1A4, Sigma A2547 
Survivin rabbit anti-human clone 71G4B7, Cell Signaling cat #2808 
Survivin rabbit polyclonal, NB500-201, lot P1, Novus Biologicals  
 
Biocare Medical, 60 Berry Drive, Pacheco, CA 94553, USA 
Calbiochem 10394 Pacific Centr Court, San Diego, CA 92121 
Dako Australia Pty Ltd  Berry Street, North Sydney, NSW.   
Jackson Immunoresearch Inc, 872 West Baltimore Pike, West Grove, PA, USA 19390 
Novacastra, Leica Biosystems, Wetzlar, Germany  
Novus Biologicals, In Vitro Technologies 7-9 Summit Road Noble Park North, VIC 3174 
Sigma-Alrich Merck, 12 Anella Ave, Castle Hill NSW 2154 
 
